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OVERVIEW
Aggression poses a substantial burden for society. It is estimated that world-wide, between 
1 and 2 million people die on a yearly basis as a direct result of violence. Many millions 
more suffer other consequences as a result of aggression, such as disabilities, mental health 
problems, and employment difficulties, placing a considerable emotional and financial 
burden on society (WHO, 2007). Most interventions designed to reduce aggression - 
pharmacological or non-pharmacological - typically have small effects, reflecting our 
limited understanding of its causes (McGuire, 2008; van Schalkwyk et al., 2017). While 
aggression has multiple determinants, including environmental factors, characterization of 
the genetic and neural correlates of aggression is needed to better understand the biological 
basis of aggression, and may ultimately lead to improved prevention and treatment options 
(Fergusson et al., 2005a; Rosell and Siever, 2015).
This thesis is aimed at gaining improved insight into the genetic and neurobiological 
architecture of aggression. More specifically, the focus is on exploring behavioral subtypes 
of aggression and related etiological heterogeneity, as well as on combining knowledge at 
the levels of genetic and neural architectures underlying the subtypes. In the following 
sections, different conceptualizations of aggression are discussed, followed by an overview 
of the current knowledge of the underlying genetics and neurobiology of aggression. An 
outline of the thesis chapters and the used study samples is given in the final section of this 
introduction. 
THE AGGRESSION PHENOTYPE
Heterogeneity in the aggression phenotype
When we think of the word ‘aggression’, many different types of behavior might come 
to mind; anything from a child throwing a temper tantrum in anger, to threatening or 
intimidating acts, to physical violence, or even criminals murdering for money. Aggressive 
behaviors can be adaptive, and have an important role in survival (for example in the case 
of self-defense) and competition for resources (Georgiev et al., 2013). However, aggression 
is often maladaptive and associated with negative consequences in society, causing 
psychological and somatic burden to victims as well as to aggressive individuals themselves 
(Fergusson et al., 2005b; Reef et al., 2010). Traditionally, aggression has been defined as 
any behavior directed toward the goal of causing harm or injury to others (Baron and 
Richardson, 1994). This definition of aggression relies heavily on the intent to harm. More 
psychological accounts of aggressive behavior put emphasis on emotions and motivations 
postulated to mediate aggressive behaviors, such as fear or irritability (Miczek et al., 2002). 
The Diagnostic and Statistical Manual of Mental Disorders, created to provide a common 
language for describing psychopathology, is widely used to classify psychiatric disorders 
(APA, 2013). It recognizes disruptive, impulse-control, and conduct disorders, providing 
categorical definitions for aggression based on frequently co-occurring clinical symptoms. 
Although this has proven useful in clinical communication and in the treatment of 
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psychiatric illness, a categorical system implies discrete differences between diagnosed and 
healthy individuals or even between different disorders. However, there is increasing evidence 
that categorical behavioral diagnoses fail to align with underlying biological mechanisms. 
Most mental disorders are now thought to represent the impairing tail on a continuum 
of normal behavior (Coghill and Sonuga-Barke, 2012). Moreover, pathophysiological 
mechanisms have been shown to overlap between different disorders, for example at the 
genetic level (Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013). 
Therefore, a rigid classification system may hamper scientific progress, as case-control study 
designs may be suboptimal models to study the biological causes of psychiatric behaviors. 
Rather, the incorporation of dimensional conceptualizations in research may provide a 
way forward into understanding underlying pathophysiology (Coghill and Sonuga-Barke, 
2012). Looking at dimensional aspects has the advantages of tackling issues of comorbidity 
between disorders, as well as tackling the problem of heterogeneity within psychiatric 
disorders. Different subgroups of patients experience different symptoms and impairments, 
and might respond differently to treatment. Especially in the field of aggression research, 
a wide range of behaviors has been investigated in different contexts and populations. 
There has been increasing evidence that clinical diagnoses of aggression encompass a 
notably heterogeneous group of behaviors (Moffitt et al., 2008). This heterogeneity in the 
aggression phenotype has let to inconsistencies between studies investigating the underlying 
mechanisms of aggression. Heterogeneity as a potential source of inconsistencies between 
studies will be highlighted throughout this thesis.
The above described heterogeneity issues may be tackled by the use of consistent subtyping 
approaches (Hyde et al., 2015). Different subtyping approaches have been proposed in 
aggression literature, for example those based on age of onset (Moffitt, 1993), or occurrence 
of overt aggressive versus covert rule-breaking behaviors (Burt, 2012; Loeber and 
Stouthamer-Loeber, 1998). In this thesis, the focus is on a subtyping approach, which is 
based on biological hypotheses and distinguishes reactive and proactive types of aggression. 
Additionally, other, data-driven subtyping strategies of aggressive behavior in the context of 
neurodevelopmental disorders are investigated, as well as cross-disorder comorbidity. In the 
next sections, the most prominent aggression disorders are discussed in the context of their 
comorbidity with other neurodevelopmental disorders, followed by an overview of reactive 
and proactive subtyping in aggression research.
Aggression as a comorbidity in neurodevelopmental disorders
The two most investigated categories of psychiatric disruptive behaviors are conduct 
disorder (CD) and oppositional defiant disorder (ODD). These disorders are highly 
comorbid, and in many cases CD is preceded by ODD (Buitelaar et al., 2013). Conduct 
disorder is characterized by a repetitive and persistent pattern of behavior that violates the 
rights of others or leads to conflict with societal norms or authority figures (APA, 2013). 
In DSM5, a specifier of CD with callous-unemotional (CU) presentation has been added, 
distinguishing a subgroup of children capable of premeditated aggressive behaviors and at 
risk for developing psychopathy in adulthood. CU traits include symptoms related to lack 
of remorse, lack of empathy, unconcern about performance and shallow affect (Frick and 
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Viding, 2009; Viding et al., 2012). These traits where also shown to distinguish children 
with more severe ODD symptoms (Hawes et al., 2013). In ODD, two symptom clusters 
have been recognized. An affective symptom cluster associated with irritability and temper 
tantrums, and a defiant headstrong cluster that is associated with a pattern of negativistic, 
defiant, disobedient and hostile behavior towards authority figures (APA, 2013). These types 
of aggressive behaviors have in common that they tend to be more prevalent in males than 
females, and that first onset predominantly occurs in childhood or adolescence. They are 
also an often occurring comorbidity in other psychiatric disease, such as attention-deficit/
hyperactivity disorder (ADHD) or autism spectrum disorders (ASD) (Goldin et al., 2013; 
King and Waschbusch, 2010; Yamamuro et al., 2017) and have been investigated as such. 
ADHD is a common neurodevelopmental disorder characterized by developmentally 
inappropriate levels of inattentiveness, and/or increased impulsivity and hyperactivity (APA, 
2013). It affects about 5% of children and adolescents and 2.5% of adults, with a male-
to-female sex ratio of around 4:1 in childhood and adolescence, which levels out during 
adulthood (Faraone et al., 2015). Co-morbid presence of oppositional defiant disorder 
(ODD) is a clinically important dimension of ADHD heterogeneity, and occurs in up to 
60% of individuals with ADHD (Connor and Doerfler, 2008). Individuals with ADHD, 
who show comorbid aggression-related problems, have a considerably worse prognosis than 
individuals without them. A defiant/vindictive behavioral pattern is associated with an 
increased risk for criminal outcomes later in life (Aebi et al., 2013), and irritable mood is 
thought to underlie the developmental link between ODD and later affective disorders 
(Loeber et al., 2000; Stringaris et al., 2009). This emphasizes the need to identify risk 
factors for aggression co-morbid with ADHD. However, little is known yet about the 
etiological basis of this comorbidity. Shared and unique genetic influences between these 
disorders have been postulated to play a role (Dick et al., 2005; Faraone et al., 1991).
Other neurodevelopmental disorders, in which aggressive behavior is highly prevalent, are 
ASDs and intellectual disabilities (ID). Children with ASD - a neurodevelopmental disorder 
associated with a specific pattern of behavioral, communication, and social problems - 
are at higher risk for displaying aggressive and oppositional behavior compared to other 
populations, with prevalence estimates of up to 68% (Hill et al., 2014). In intellectual 
disabilities (ID), such as in Fragile X syndrome, a high prevalence of aggressive behaviors 
is also observed (Newman et al., 2015). Fragile X syndrome, in which the Fragile X Mental 
Retardation 1 (FMR1) gene is mutated, is one of the most common causes of inherited 
ID, with a 85% incidence of ID in males and a 25% incidence in females (Hagerman 
and Hagerman, 2002; Loesch et al., 2004). It has been estimated that 38% of males and 
14% of females with the full mutation engage in aggressive behavior (Bailey et al., 2008). 
Like in ADHD, disruptive behaviors in ASD and ID are risk factors for poor outcomes, 
family stress and greater functional impairment later in life (Lecavalier, 2006), making 
them an important target for early prevention and treatment opportunities. Identification 
of underlying risk factors will be indispensible to the development of such interventions.
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Reactive and proactive subtypes of aggression
Dodge and Coie introduced first introduced the distinction between reactive and proactive 
aggression in 1987, assimilating different previous accounts of aggression and recognizing 
that aggressive behavior manifests itself in multiple forms (Dodge and Coie, 1987; Kempes 
et al., 2005). Proactive aggression, also referred to as instrumental aggression, is defined as 
goal-oriented, organized behavior often associated with low autonomic arousal and affect. 
Reactive aggression on the other hand, also known as impulsive or affective aggression, 
occurs in response to threat, provocation, or a negative emotional state (Raine et al., 2006; 
Stanford et al., 2003). A distinction of proactive and reactive subtypes of aggression may 
help to shed light on different etiological pathways to aggression. These subtypes differ 
significantly in their behavioral correlates. For example, the reactive subtype of aggression 
has been associated with constructs like impulsivity, anxiety, and hostile interpretation bias 
(Brugman et al., 2015; Bubier and Drabick, 2009), while proactive aggression has been 
related to psychopathic traits and delinquent behavior (Cima and Raine, 2009; Cima et 
al., 2013). 
Reactive and proactive subtypes of aggression can be measured by use of the Reactive 
Proactive Questionnaire (RPQ), a self-report questionnaire consisting of 23 items (Raine 
et al., 2006). Recently, Smeets and coworkers conducted an exploratory factor analysis 
of this questionnaire in an adolescent sample, and proposed a further subdivision of the 
reactive subtype based on the resulting best fit for a three-factor model (Smeets et al., 
2016). Besides a proactive factor, the analysis suggested a subdivision of reactive aggression 
into one subtype associated with external provocation or threat (based on items like for 
example ‘Hit others to defend yourself ’ and ‘Reacted angrily when provoked by others’) 
and another subtype associated with internal frustration (based on items like for example 
‘Gotten angry when frustrated’ and ‘Gotten angry or mad when you lost a game’). 
Although it should be noted that these proactive and reactive subtypes often co-occurred 
in the same individuals (no individuals with predominantly proactive aggression (without 
reactive aggression) where found), subtypes did differ in their association with behavioral 
correlates. Reactive aggression due to internal frustration showed stronger association 
with anxiety compared to reactive aggression due to external provocation or threat, and 
internalizing problems were uniquely predicted by frustration-induced aggression (Smeets 
et al., 2016). The three-factor model may further reduce phenotypic heterogeneity in the 
assessment of aggression. Importantly, these subtypes are thought to be associated with 
distinct genetic, neurocognitive, and neural characteristics (see below for a summary of the 
current knowledge), and they may therefore direct and facilitate the hitherto difficult search 
for genes and neural circuits involved in aggression etiology.
Sex differences in aggression 
Important inter-individual differences in the etiology of aggression are thought to arise 
from sex differences. Both in terms of prevalence and type of aggression displayed, males 
and females differ markedly. A striking difference in crime rate statistics exists, with males 
more likely to commit serious offenses than females. For example, over 70 percent of the 
persons arrested in the United States in 2015 were males (www.fbi.gov). Males are also more 
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likely to display antisocial behavior than females, and are overrepresented in aggression-
related disorders (Stephenson et al., 2014). One example is CD, where the male to female 
gender ratio is approximately 2.5 (Hill, 2002). Sex differences are also found in the type of 
aggressive behavior displayed (Collett et al., 2003). Males have an increased risk for physical 
aggression (Baillargeon et al., 2007; Côté, 2007; Hill et al., 2006), while females may show 
slightly more indirect aggression (also termed social aggression, usually relating to non-
physical forms of aggression) compared to males (Card et al., 2008). Partly, sex differences 
in the expression of aggression may be confounded by social and cultural aspects. However, 
the clear gender-specificity of aggression is thought to have evolved by sexual selection, and 
to reflect differences in optimal strategies in the competition for resources for males and 
females (Georgiev et al., 2013). Incorporation of sex in aggression studies may facilitate the 
identification of underlying biological mechanisms of aggressive behaviors. Knowledge on 
any biological aspects of sexual dimorphism may be important in the management of the 
social consequences of aggression.
GENETICS OF AGGRESSION
Heritability 
Twin studies can provide useful insights into the contribution of genetic and environmental 
factors to behavior, such as aggression. These types of studies make use of the fact 
that monozygotic twins share 100% of their genetic material as well as their family 
environments, whereas dizygotic twins share on average 50% of their genetic material and 
their family environments. Concordance rates for aggression are higher in monozygotic 
twins compared to dizygotic twins, which points to the fact that genetic factors indeed 
play a role in this phenotype. Heritability of aggression in general is estimated to be around 
50% (Tuvblad and Baker, 2011; Veroude et al., 2016). These estimates differ as a function 
of the population and the type of aggression that is investigated (Waltes et al., 2016). With 
regard to reactive and proactive aggression subtypes, there is significant heritability for 
both, confirmed in study samples including individuals as young 9 years of age. Heritability 
estimates are slightly higher for proactive aggression (32-50%) than for reactive aggression 
(20-38%) (Baker et al., 2008). Aggressive behavior in children with high CU score was 
show to be under stronger genetic influence (81%) than aggressive behavior in children 
without elevated levels of CU-traits (30%) (Viding et al., 2005). Some twin studies have 
found gender effects for heritability estimates. Especially when using self-report measures 
and around or after adolescence, heritability estimates are higher for boys than for girls 
(Baker et al., 2008; Wang et al., 2013). Highest heritability estimates (up to 68%) have 
been found for physical aggression (Burt and Klump, 2012; Chen et al., 2015; Lacourse et 
al., 2014; Yeh et al., 2010).
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Challenges in gene finding
Despite the considerable heritability of aggression, the identification of specific genetic 
risk factors has been difficult. As discussed in the above sections, heterogeneity in the 
aggression phenotype presents a huge complication. Different subtypes of aggression might 
link to quantitatively or qualitatively different underlying genetic risk factors. For example, 
in the case of aggression comorbid with ADHD, the presence of aggression in ADHD 
has been shown to index higher genetic loading (Hamshere et al., 2013). An additional 
factor complicating gene-finding is the largely polygenic nature of aggression. While some 
monogenic disorders leading to aggression phenotypes do exist (the most well-known 
example perhaps being Brunner syndrome (Brunner et al., 1993)), multiple genetic variants, 
each with a small effect size, contribute to the aggression phenotype in most individuals. 
Moreover, different combinations of these variants can lead to similar phenotypes (Franke 
et al., 2009). The involvement of epigenetics and gene-environment interactions further 
complicate the matter. Besides genetic factors, environmental influences early in life (for 
example family dysfunction, low parental income and hostile parenting styles) are predictive 
of aggression (Tremblay, 2004). These early life events and other external conditions are able 
to cause changes in epigenetic modifications, such as DNA methylation (McGowan et al., 
2009), which in turn regulate the activity of gene expression throughout life (Bird, 2007). 
The study of epigenetic marks in aggression is still in its early stages, but may identify genes 
that are differentially regulated in individuals with high and low levels of aggression (van 
Dongen et al., 2015).
Because of the hypothesized polygenic model of multiple common variants with small 
effects underlying aggression, studies have investigated the role of these common variants 
by conducting association studies. Early studies investigated single candidate genes and 
variants suspected to play a role in aggression. Next to these candidate genetic approaches, 
which rely on a priori biological hypotheses, genome-wide hypothesis-generating approaches 
to gene finding exist. These circumvent the need for prior selection. Candidate gene studies 
and genome-wide association studies (GWAS) for aggression will be discussed in the next 
sections. 
Candidate gene studies
With regard to candidate gene studies of aggression, the main focus has been on genes 
related to monoaminergic neurotransmission, like the genes underlying serotonergic and 
dopaminergic signaling, and on genes related to neuroendocrine signaling. Alterations in 
serotonergic, dopaminergic, and neuroendocrine systems are thought to play a key role 
in aggression for several reasons. First, they are important regulators of several cognitive 
functions related to aggression. For example, the serotonergic system plays an important 
role in social cognition, emotion regulation, and cognitive control (Lesch et al., 2012), while 
the dopaminergic system is relevant for understanding aggression, because of its effects on 
reward signaling, motivated behavior, and decision making (Costa et al., 2012). Second, 
central serotonin and dopamine neurotransmission levels have been shown to be associated 
with aggressive behavior: levels of the serotonin metabolite 5-HIAA in cerebrospinal fluid 
(e.g. (Brown et al., 1979; Coccaro and Lee, 2010), or manipulations of central serotonin 
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function through tryptophan depletion/loading (e.g. (Bjork, 2000), have revealed a highly 
significant relationship between serotonin availability and aggression (Rosell and Siever, 
2015). Dopamine D2-receptor antagonists have been used effectively to treat aggressive 
behavior (Nelson and Trainor, 2007). The neuroendocrine system, which includes both 
stress-related hypothalamic-pituitary-adrenal (HPA) axis signaling and sex-hormone-
related hypothalamo-pituitary-gonadal (HPG) axis signaling, is a major candidate system 
for the development of aggressive behaviors as well, e.g. because early life stress is known 
to increase risk for the development of mood and aggression-related disorders (Agid et al., 
1999; Éthier et al., 2004; Fonagy, 2006; Heim et al., 2001). Levels of the stress hormone 
cortisol have repeatedly been related to aggression (Alink et al., 2012; Loney et al., 2006; 
Popma et al., 2007; Shirtcliff et al., 2005; van Bokhoven et al., 2004). The HPG axis 
involves signaling between hypothalamus, pituitary, and the gonadal glands, which 
produce estrogen and testosterone. These steroid hormones have been related to human 
aggression repeatedly as well (Book et al., 2001; Brown et al., 2008; Chichinadze et al., 
2010; Yu and Shi, 2009), and it has been hypothesized that the interplay between cortisol 
and sex steroids in particular is important in determining aggression liability (Pavlov et al., 
2012; Terburg et al., 2009). While initial studies supported a model of increased aggression 
risk for higher testosterone in combination with lower cortisol levels (Popma et al., 2007), 
more recent studies have revealed that the story may be more complex, as the nature of 
testosterone-cortisol interactions likely differs as a function of gender as well as specific 
aggression phenotype of interest (Cima et al., 2008; Denson et al., 2013; Welker et al., 
2014).
Extensive reviews of aggression candidate gene studies list the specific candidate genes in 
the monoaminergic and neuroendocrine systems that have been investigated for association 
with aggressive behaviors so far (Pavlov et al., 2012; Veroude et al., 2016; Waltes et al., 
2015). Although a moderate number of studies has been conducted, a meta-analysis 
including 12 candidate genes did not reveal any significant associations with aggressive 
behavior (Vassos et al., 2014). However, this meta-analysis might have suffered from the 
extensive heterogeneity of assessed phenotypes. A later meta-analysis, which investigated 
candidate variants in the SLC6A4 and MOAO genes specifically, did confirm association 
with antisocial behaviour (Ficks and Waldman, 2014). Specifically for the MAOA gene, 
more meta-analysic evidence for association of genetic variation with aggression is available. 
MAOA is an enzyme that breaks down monoamine neurotransmitters like serotonin and 
dopamine through oxidative deamination (Youdim and Bakhle, 2006). Meta-analysis 
showed significant interaction between MAOA genotype and environmental adversity, 
affecting antisocial behavior in a sex-dependent manner. Males with an allele of a common 
variable number tandem repeat (VNTR) polymorphism in the promoter region of this 
gene, causing low enzyme activity, appear to experience a stronger effect of maltreatment on 
antisocial behavior compared to males with the high activity variant. In females, an opposite 
and weaker effect of MAOA genotype was suggested by the data, with the high activity 
variant increasing risk for antisocial behavior after maltreatment (Byrd and Manuck, 2014; 
Caspi, 2002). The specific association pattern of this gene with aggression again nicely 
illustrates the heterogeneity issues discussed earlier in this introduction.
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Genome-wide studies
Hypothesis-free genome-wide association studies (GWAS) of aggression have not yet 
identified genome-wide significant single nucleotide polymorphisms (SNPs), but the top-
findings from these studies have pointed towards novel pathways and functions potentially 
relevant to aggressive behaviors (Fernandez-Castillo and Cormand, 2016). Only one large-
scale GWAS has been conducted to date (within the framework of the EArly Genetics and 
Lifecourse Epidemiology (EAGLE) consortium), including a large cohort of children and 
adolescents (N=18,988) from the general population. Common genetic variation was found 
to contribute to the phenotypic variation in aggressive behavior, with SNP-based heritability 
estimates ranging between 10 and 54%. In this study, aggressive behavior assessed using 
parent-report questionnaires in nine population-based studies was combined. The GWAS 
meta-analysis of the total cohort identified a region on chromosome 2p12 reaching near 
genome-wide significance. The top-SNP of this analysis is located near a gene involved 
in the regulation of excitatory synapse development (LRRTM4). A candidate gene-based 
association test (genes were selected as candidates based on previously having been tested 
for association with aggressive behavior (Craig and Halton, 2009; Vassos et al., 2014)), 
using the summary statistics of the total sample, showed association of the AVPR1A gene 
with childhood aggression after correcting for 21 candidate genes tested (Pappa et al., 
2015). Only a few other GWAS of aggression have been performed (Anney et al., 2008; 
Merjonen et al., 2011; Mick et al., 2014; Mick et al., 2011; Tielbeek et al., 2012; Viding 
et al., 2010), and one GWAS studied the interaction between genes and environmental 
risk factors (GxE) (Sonuga-Barke et al., 2008). These studies investigated a wide range of 
aggression related phenotypes, including conduct problems in ADHD, hostility, proneness 
to anger, dysregulated behavior, antisocial behavior and antisocial behavior with callous-
unemotional personality traits. Interestingly, two genes showed evidence for association 
based on more than one GWAS, NFKB1 and A2BP1. NFKB1 encodes the nuclear factor 
of kappa light polypeptide gene enhancer in B-cells 1, a transcription regulator involved in 
axonal regeneration and degeneration (Haenold et al., 2014). A2BP1 (also called RBFOX1) 
encodes the RNA binding protein, fox-1 homolog (C. elegans) 1, a neuron-speciﬁc RNA 
splicing factor that regulates the expression of large genetic networks during early neuronal 
development (Fogel et al., 2012). Enrichment analyses, using the top-signals of the combined 
GWAS, allowed the identification of overrepresented pathways and functions associated 
with aggressive behavior. These bioinformatics approaches identified signaling pathways 
involved in axon guidance, neuroactive ligand-receptor interaction, MAPK signaling, 
and plasma membrane estrogen receptor signaling, and, more generally, functions related 
to neuronal development (Fernandez-Castillo and Cormand, 2016). Such genome-wide 
approaches thus highlight the importance of neurodevelopmental and synaptic plasticity 
genes for aggression risk. Nevertheless, larger sample sizes and in-depth homogeneous 
phenotyping will be required to further identify and confirm responsible genes, as well 
as genetic variation contributing to specific types of aggressive behavior. Future genetic 
association studies might focus on the reactive - proactive distinction of aggression, to 
reduce wide heterogeneity in investigated phenotypes to date.
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AGGRESSION AND THE BRAIN
Connecting neuro-cognition with behavioral subtypes
Aggression has been recognized as a neurodevelopmental phenotype, meaning that 
symptom development is thought to be related to abnormal brain development. Imaging 
studies have identified structural and functional brain differences in aggressive compared 
to control subjects. Several neuro-cognitive systems have been recognized to play a role 
in aggression. Efforts have been made to distinguish different forms of neuro-cognitive 
dysfunction associated with different subtypes of aggressive behavior. Below is a summary 
of these efforts in the context of the reactive - proactive distinction, along with an overview 
of specific imaging findings for implicated neural systems. Emphasis is on a framework that 
integrates neural, cognitive, and symptom levels (Blair et al., 2016).
The main forms of cognitive dysfunction that have been recognized in the context of 
aggression are decreased empathy, an increased acute threat response, and impaired decision-
making. Different neural systems underlie these cognitive impairments, which associate with 
different sets of aggressive symptoms linked to different aggression subtypes (Figure 1). 
The main neural substrates of empathic processing are the ventromedial prefrontal cortex 
(vmPFC) (Corradi-Dell’Acqua et al., 2014; Shamay-Tsoory et al., 2010) and the amygdala. 
The amygdala, which is important in the processing of emotional expressions, is of 
specific interest (Fusar-Poli et al., 2009). Reduced responses of this structure to fearful 
and sad expressions have been found particularly in subjects with psychopathic or callous 
and unemotional (CU) traits (Jones et al., 2009; Lozier et al., 2014; Marsh et al., 2008; 
Passamonti et al., 2010; Viding et al., 2012; White et al., 2012). Increased CU traits are 
associated with increased proactive aggression. Interestingly, this relation was found to be 
mediated by amygdala response to distress cues of others (Lozier et al., 2014). Reduced 
activity of the amygdala was also found in individuals with psychopathy, while observing 
others in pain (Marsh et al., 2013). Thus, functional studies support an important role for 
amygdala dysfunction in proactive forms of aggression.
The acute threat response is mediated by the amygdala-hypothalamus-periaqueductal gray 
neural system (Coker-Appiah et al., 2013; Mobbs et al., 2010). Dysfunction in this system 
is associated with increased reactive aggression (Blair, 2004; Yu et al., 2014). While both 
reduced and increased amygdala responses to visual threat stimuli have been found for 
aggressive compared to comparison subjects (Herpertz et al., 2008; Stadler et al., 2007; 
Sterzer et al., 2005), these inconsistencies have been attributed to the presence or absence 
of CU traits, in such a way that individuals with low CU traits have increased amygdala 
responses to social threats or provocations (Sebastian et al., 2014; Viding et al., 2012; White 
et al., 2016b). All in all, increased amygdala responsiveness to threat or provocation is 
associated with increased reactive forms of aggression (Choe et al., 2015). 
Impairments in reward sensitivity, processing of punishment, and regulation of avoidance 
behaviors are thought to be the basis of poor decision-making in individuals with aggressive 
behavior (Fairchild et al., 2009). The neural loci thought to underlie dysfunction in these 
systems are the striatum and vmPFC. Functional imaging studies indicate that aggressive 
individuals show a reduced response to reward both within the striatum and the vmPFC 
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(Cohn et al., 2015; Crowley et al., 2010; Finger et al., 2011; Rubia et al., 2009; White et 
al., 2013), but an increased response to punishment (Crowley et al., 2010; Finger et al., 
2011; Finger et al., 2008; White et al., 2013). Poor decision-making might lead to increased 
reactive aggression due to frustration, but also to proactive forms of aggression, for example 
when an individual does not learn to avoid actions that harm others (Blair et al., 2016; 
White et al., 2016a).
The functional imaging studies described above, indicate an important role for subcortical 
structures in aggression etiology, most notably amygdala and striatum. Studies investigating 
functional connectivity of these subcortical structures with the vmPFC (Marsh et al., 2011; 
Marsh et al., 2008), support the idea that vmPFC has a regulatory function in response 
selection through its role in representing value information (Hare et al., 2009). Anatomical 
imaging studies support the importance these structures for aggressive behavior risk as 
well. Differences in amygdala volume between aggressive and healthy individuals have been 
reported in many studies. Volume reductions of the amygdala were found predominantly 
(Caldwell et al., 2015; Fairchild et al., 2013; Noordermeer et al., 2016; Pardini et al., 2014; 
Sterzer et al., 2007; Thijssen et al., 2015; Wallace et al., 2014; Zhang et al., 2013). For 
striatum, both volume reductions and volume increases have been related to aggressive 
phenotypes, especially with regard to the caudate nucleus and nucleus accumbens 
substructures (Cha et al., 2015; Ducharme et al., 2011; Fairchild et al., 2013; McAlonan 
et al., 2007; Nosarti et al., 2005; Schiffer et al., 2011). For orbitofrontal/vmPFC, volume 
reductions have been observed in people with aggressive behavior, and vmPFC lesions are 
associated with increased aggressiveness compared to lesions in other regions of the brain 
(Ducharme et al., 2011; Grafman et al., 1996; Young et al., 2010).
Hypothesized pathways from gene to brain to behavior
The above-mentioned neuro-cognitive systems can be hypothesized to be regulated by 
different genetic influences. However, strict categorical lines cannot likely be drawn, as 
genetic overlap as well as differences may exist between aggression subtypes, and different 
genetic systems are likely to interact with each other. For example, the serotonin and 
dopamine neurotransmitter systems have been shown to interact intricately (Oades, 2008). 
Nevertheless, specific genetic systems are likely to play a more important role in one 
cognitive function than another. Figure 1 represents a hypothetical representation of gene-
brain-behavior relationships adapted from a schematic of Blair et al., which illustrates the 
proposed neuro-cognitive relationships described above (Blair et al., 2016). It was adapted 
to incorporate the dimensional relationship of these neuro-cognitive mechanisms to reactive 
and proactive symptoms as well as the main candidate genetic systems currently implicated 
in aggression. It has been speculated that serotonergic and dopaminergic neurotransmission 
regulate both reactive and proactive aggression, whereas endocrine signaling seems to be 
more involved in the regulation of reactive aggression (Waltes et al., 2016). As dopamine 
is part of the neural reward system, dopaminergic genes are thought to be involved in 
aggression etiology primarily through effects on the reward neurotransmitter system 
(Chen et al., 2005), thus affecting decision-making. However, because it is also involved in 
hormonal regulation through the tuberoinfundibular pathway of dopamine transmission, as 
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well as in mood regulation through the mesolimbic pathway, dopamine likely plays a role in 
connecting reward signaling and the stress response (Pivonello et al., 2007). Dopaminergic 
genes may thus be involved in both proactive and reactive aggression. The same is true 
for serotonergic genes, candidate variants in which have been associated with very diverse 
aggressive phenotypes (Veroude et al., 2016). The endocrine systems, specifically the HPA 
axis, are involved in regulation of impulsivity and the stress response, which are closely 
related to reactive aggression (Waltes et al., 2016). However, system-specificity of effects 
needs to be further investigated before we can make conclusive statements on gene-subtype 
associations. While neuroimaging genetics studies, investigating genetic influences on 
neuroimaging measures, are still scarce for aggression, they can be of particular interest in 
elucidating specific pathways from gene to behavior via the brain.
THESIS OUTLINE
Aim and structure of this thesis
The overall aim of this thesis was to improve our understanding of the genetic and 
neurobiological architecture of aggression. In this, my work contributes to the reduction 
of heterogeneity issues in aggression research by looking into subtype- and sex- specific 
gene identification and by investigating specific pathways to disease. A combination of 
Figure 1: Tentative representation of genetic, neuro-cognitive, and behavioral relationships in aggression 
(adapted from Blair et al. (2016)). See text for a detailed description of the relationships between genes, neu-
ronal functioning, cognition, and behavior.
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well-phenotyped local study cohorts and large scale consortium-based samples was used to 
overcome power issues related to the polygenic nature of aggression. This work also adds to 
the scarce imaging genetics literature on aggression and formulates recommendations for 
future imaging genetics studies. The thesis in divided into two parts.
In PART 1, I focused on the potential of reducing phenotypic heterogeneity to elucidate 
genetic mechanisms involved in aggression. Different subtyping approaches were 
employed, followed by genetic association studies aiming at the identification of the genetic 
mechanisms underlying these subtypes. In chapter 2, I report the results of a latent class 
analysis that was conducted to identify conceptually meaningful subtypes of oppositionality 
in childhood ADHD. Additionally, I present a novel genetic landscape for oppositional 
behavior based on the results of a multivariate GWAS on identified subtypes. In chapter 
3, I describe our findings from a GWAS meta-analysis conducted in adult patients with 
ADHD. The phenotype of interest was childhood aggression, a predictor of worse outcomes 
in adulthood. In chapter 4, I aimed to confirm the existence of reactive and proactive 
subtypes of aggressive behavior in the general population as well as to identify subtype-
specific association of candidate gene-sets with aggressive behavior. I report the results of 
a confirmatory factor analysis followed by gene-set association analysis for serotonergic, 
dopaminergic, and neuroendocrine genes.
In PART 2, the focus is on neuroimaging genetics approaches to study associations between 
genes implicated in externalizing behaviors and brain phenotypes. Chapter 5 is a review 
of the existing imaging genetics studies performed for aggression as well as for several 
neurodevelopmental phenotypes with high comorbidity with aggression (ADHD, ASD, 
and selected IDs). I provide a wide overview of the imaging genetics field and formulate 
specific recommendations for future research. In chapter 6, I used large-scale GWAS meta-
analysis data on aggression and subcortical brain volumes from several large consortia, to 
conduct cross-trait meta-analysis. I used gene-wide association statistics with the aim of 
identifying genes with pleiotropic effects on both subcortical brain volume and aggression 
risk. Additionally, I report subtype-specific association of identified genes with aggression.
STUDY COHORTS AND CONSORTIA
Aggressotype: All work in this thesis was conducted in the context of the Aggressotype 
consortium, which focuses on aggression subtyping for improved insight and treatment 
innovation in paediatric psychiatric disorders (www.aggressotype.eu). Its main aims are 1) 
to gain new insights into the mechanisms underlying pathological aggression by improving 
the subtyping of aggression and building a knowledge chain for aggression aetiology from 
the molecular level via cellular, brain-network, and cognitive levels to behavior, and 2) to 
translate preclinical findings into predictive, preventive, and therapeutic strategies for the 
benefit of vulnerable patients with paediatric conduct disorders. Aggressotype is funded by 
the European Community’s Seventh Framework Programme (FP7/2007 – 2013) and has 
twenty-eight participating research groups from eleven countries.
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IMAGE: The International Multicenter ADHD Genetics study was conducted by a 
consortium of seven European countries and Israel, with the aim to identify genetic risk 
factors for ADHD (Brookes et al., 2006; Muller et al., 2011a; Muller et al., 2011b). Families 
with at least one child with ADHD as well as at least one biological sibling (irrespective 
of ADHD diagnostic status) were recruited. IMAGE collected extensive phenotyping, 
neuropsychological and genotypic information of these families. The IMAGE project 
participated in the Genetic Association Information Network (GAIN) to enable genome-
wide genetic studies. In the Netherlands, it was followed-up by the NeuroIMAGE study, 
enriching the data-set with structural and functional MRI data, current clinical status, and 
additional collection of neuropsychological measures and DNA (von Rhein et al., 2015).
IMpACT: The International Multicentre persistent ADHD CollaboraTion is a consortium 
of clinical and basic researchers from several European countries (The Netherlands, 
Germany, Spain, Norway, The United Kingdom, Sweden), from the United States of 
America, and from Brazil (www.impactadhdgenomics.com). The aim of IMpACT is to 
perform and promote high quality research in ADHD across the lifespan. It includes the 
identification of novel genetic variants for adult ADHD and improving the understanding 
the mechanisms underlying the effect of these genetic variants on disease risk. IMpACT 
currently coordinates biosamples and phenotypic information of over 4000 cases with 
persistent ADHD and over 8000 controls. In this thesis, data from Germany, Norway and 
Spain was used. 
BIG: The Brain Imaging Genetics study was set up in 2007 by the Human Genetics 
department of the Radboud university medical center and the Donders Centre for 
Cognitive Neuroimaging of the Radboud University (www.cognomics.nl/big). In 2010, 
the Max Planck Institute for Psycholinguistics in Nijmegen also joined. BIG aims to study 
relations between genes, brain structure and function, and cognition and behavior in 
healthy individuals. For this, a continuously growing database has been created with data of 
structural and functional magnetic resonance imaging (MRI)-based brain scans and DNA 
as well as cognitive and behavioral data derived from internet-based testing.
ENIGMA: The Enhancing NeuroImaging Genetics through Meta Analysis network brings 
together researchers in imaging genomics to understand brain structure, function, and 
disease, based on brain imaging and genetic data (http://enigma.ini.usc.edu/). Currently, 
more than 30 working groups have been formed within the ENIGMA consortium. In 
this thesis, summary statistic data of the ENIGMA GWAS meta-analysis on subcortical 
volumes and intracranial volume is used (Hibar et al., 2015).
EAGLE: The EArly Genetics and Lifecourse Epidemiology Consortium is a consortium 
of pregnancy and birth cohorts that aims to investigate the genetic basis of phenotypes in 
antenatal and early life and childhood. All participating cohorts have GWAS data available. 
In this thesis, summary statistic data of the EAGLE GWAS meta-analysis on childhood 
aggressiveness is used (Pappa et al., 2015).
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ABSTRACT
Oppositional Defiant Disorder (ODD) is a frequent psychiatric disorder seen in children 
and adolescents with Attention-Deficit-Hyperactivity Disorder. ODD is also a common 
antecedent to both affective disorders and aggressive behaviors. Although the heritability 
of ODD has been estimated to be around 0.60, there has been little research into the 
molecular genetics of ODD. The present study examined the association of irritable 
and defiant/vindictive dimensions and categorical subtypes of ODD (based on latent 
class analyses) with previously described candidate gene polymorphisms (DRD4 exon3 
VNTR, 5-HTTLPR, and seven OXTR SNPs) as well as with dopamine, serotonin and 
oxytocin genes and pathways in a clinical sample of children and adolescents with ADHD. 
In addition, we performed a multivariate genome-wide association study (GWAS) and 
integrated the top-ranked findings into a landscape of functionally interacting proteins and 
molecules that regulate biological signaling cascades. Apart from adjusting the analyses for 
age and sex, we controlled for “parental ability to cope with disruptive behavior”. None of 
the hypothesis-driven analyses revealed a significant association with ODD dimensions 
and subtypes. Parenting behavior was significantly associated with all ODD dimensions 
and subtypes, most strongly with defiant/vindictive behaviors. The GWAS did not result 
in genome-wide significant findings. Bioinformatics and literature analyses revealed that 
the proteins encoded by 28 of the 53 top-ranked genes interact in a molecular landscape 
centered around β-catenin signaling and involved in the regulation of neurite outgrowth. 
Our findings provide new insights into the molecular basis of ODD and inform future 
genetic studies of oppositional behavior.
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INTRODUCTION 
Oppositional Defiant Disorder (ODD) shows strong comorbidity with Attention-Deficit-
Hyperactivity Disorder (ADHD), Conduct Disorder (CD), and mood disorders (Angold 
et al., 1999), in both epidemiological and clinical samples. To date, the etiological basis 
of this comorbidity is unclear, although shared genetic influences between these disorders 
have been postulated to play a role (Dick et al., 2005; Faraone et al., 1991). Research into 
ODD has gained momentum due to its relation to later psychopathology such as affective 
disorders (Copeland et al., 2009) and antisocial personality disorder (Langbehn et al., 1998). 
Youths with ADHD frequently show severe impulse control problems and are at high risk 
for developing ODD. A better understanding of the developmental pathways from ADHD 
to ODD is crucial to prevent further antisociality and psychopathology. However, there 
has been little research on the genetics of ODD, perhaps because this disorder has been 
viewed primarily as the result of ineffective parenting (Frick et al., 1992). Nevertheless, the 
heritability of ODD has been estimated to be around 0.60 (Coolidge et al., 2000; Nadder 
et al., 1998) and ODD is familial among families of ADHD youth (Petty et al., 2009).
ADHD has been the focus of considerable genetic research. Meta-analyses of candidate gene 
studies of ADHD have yielded evidence for a number of genes involved in the dopaminergic, 
serotonergic, noradrenergic, and nicotinergic neurotransmission and receptor function 
(Gizer et al., 2009). Genome-wide Association Studies (GWAS) of ADHD did not yet reveal 
any significant association (Neale et al., 2010). There is comparatively little work into the 
molecular genetics of oppositional and disruptive behaviors in children and adolescents . A 
recent meta-analysis showed a significant association of the short allele of the polymorphic 
region (5-HTTLPR) in the promoter region of the serotonin transporter gene 5-HTT/
SLC6A4 with antisocial behaviors (including aggression) (Ficks and Waldman, 2014), 
although evidence for this association is conflicting (Vassos et al., 2014). The short allele 
has been found to affect negatively the transcription rate of the gene compared to the long 
allele (Heils et al., 1996), putatively affecting the availability of serotonin in the synaptic 
cleft and thus increasing the risk for aggressive behavior. Further studies also support the 
role of dopamine genes in the development of ODD and/or CD. The variable number 
tandem repeat polymorphism (VNTR) within exon 3 of the dopamine receptor D4 gene 
(DRD4) has been frequently investigated in psychiatric genetic studies and the 7-repeat 
allele was found to lead to less efficient dopamine binding and reduced receptor sensitivity. 
Several studies found individuals with the 7-repeat allele to have an increased risk for ODD 
and CD symptoms (DiLalla et al., 2009; Holmes et al., 2002). In accordance with the 
findings for DRD4 and 5-HTTLPR, high levels of dopamine and low levels of serotonin 
were associated with aggression and irritability in humans (Duke et al., 2013; Ryding et 
al., 2008). Deregulation of oxytocin (OXT) signaling – for example as a consequence of 
genetic variability - also predisposes an individual to antisocial and aggressive behaviors 
and disrupts prosocial behaviors (Malik et al., 2012). Two studies found that low levels 
of OXT are linked to aggressive behaviors in adult males (Fetissov et al., 2006; Lee et al., 
2009). In genetic studies, single nucleotide polymorphisms (SNPs) within the oxytocin 
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receptor gene (OXTR) were associated with callous-unemotional and aggressive behaviors 
in males and females (Malik et al., 2012; Zai et al., 2012).  To date, seven OXTR SNPs 
(rs1042778, rs6770632, rs237885, rs4564970, rs1488467, rs53576, rs13316193) have been 
found to be related to aggression, CU behaviors, and/or behavior problems (Beitchman et 
al., 2012; Campbell et al., 2011; Johansson et al., 2012a; Johansson et al., 2012b; Malik 
et al., 2012; Park et al., 2010). Most of the molecular genetic studies of OXTR have been 
limited by small sample sizes, though, and therefore warrant replication.
The phenotypic heterogeneity of ODD complicates the identification of genetic involvement 
with the occurrence of the disorder. An increasing number of studies supports the need for 
discrimination of ODD irritable and defiant/vindictive dimensions in community samples 
of preschoolers, school-aged children, and adolescents (Ezpeleta et al., 2012; Krieger et al., 
2013; Stringaris and Goodman, 2009a, b) as well as in children and adolescents referred for 
ADHD or autism (Aebi et al., 2010; Mandy et al., 2014), which may inform genetic studies. 
Irritable mood has been suggested to underlie the developmental link between ODD and 
later affective disorders (Stringaris et al., 2009), and a defiant/vindictive behavioral pattern 
of ODD is associated with CD and the presence of callous unemotional (CU) traits (Kolko 
and Pardini, 2010) as well as later criminal outcomes in adulthood (Aebi et al., 2013). 
A genetic link between ODD irritable behavior and depression, on the one hand, and 
between ODD defiant/vindictive aspects and delinquent behavior, on the other, was found 
in a UK twin sample (Stringaris et al., 2012).
In this study, we aim to investigate the genetic underpinnings of ODD using data from 
the International Multicentre ADHD Genetics (IMAGE) study (Müller et al., 2011a, b) 
including 750 subjects. We first defined conceptually meaningful dimensions/subtypes of 
oppositionality, in order to improve the power of our analyses by reducing the known 
heterogeneity of the ODD phenotype (Burke et al., 2005). We subsequently tested genetic 
variants in dopamine, serotonin and oxytocin signaling pathways for their association 
with the two dimensions and the two categorical subtypes. We first tested individual 
polymorphisms earlier found related to such traits, i.e. the DRD4 VNTR 7-repeat allele, 
the 5-HTTLPR short allele and variants in the OXTR gene. In a second step, gene-wide 
analysis for DRD4, 5-HTT, OXTR and gene-set analysis of the dopamine, serotonin and 
oxytocin pathways was performed to test their association with the two dimensions and the 
two categorical subtypes. Besides adjusting the analyses for age and sex, we also controlled 
for “parental ability to cope with disruptive behavior”, because parenting behavior has been 
identified as a major source of ODD (e.g. Burke et al., 2008). We also tested the interaction 
between genetic polymorphisms and “parental ability to cope with disruptive behavior” 
and ODD subtypes/dimensions. In addition to the hypothesis-driven analyses, we aimed 
to generate new hypotheses about genetic involvement in ODD. Because genetic overlap 
as well as differences can be expected to exist between the two dimensions and the two 
categorical ODD subtypes (Dowell et al., 2010) and to maximize power of our analyses 
(Galesloot et al., 2014), we used a multivariate genome-wide association testing framework. 
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Employing bioinformatics and literature mining we integrated top-ranked findings from 
the GWAS into a landscape of proteins and molecules that regulate biological signaling 
cascades, providing important new insights into the genetic etiology of ODD. 
MATERIALS AND METHODS
Sample 
The present study is based on 750 probands and their parents from the International 
Multicentre ADHD Genetics (IMAGE) study. Participants of the IMAGE study were 
European Caucasians aged 5-17 years, who had been recruited in 12 child and adolescent 
psychiatry clinics representing eight countries: Belgium, Germany, Switzerland, Holland, 
Ireland, Israel, Spain, and the United Kingdom. Approval was obtained by the Institutional 
Review Board of SUNY Upstate Medical University and from ethical review boards within 
each country. A detailed description of the study design and assessment procedures has 
been provided in previous publications (Müller et al., 2011a, b). In short, entry criteria for 
probands were a clinical diagnosis of ADHD based on DSM-IV criteria and access to one 
or both biological parents and one or more full siblings for DNA collection and clinical 
assessment. Exclusion criteria applying to both probands and siblings included autism, 
epilepsy, IQ < 70, brain disorders, and any genetic or medical disorder associated with 
externalizing behaviors that might mimic ADHD. The full sample of the IMAGE project 
amounts to 1067 subjects. Out of this sample with ADHD combined type, 774 subjects 
with full information on ODD phenotypes and covariates (see below) were included in 
the analyses. Genome-wide imputed genotypes (HAPMAP2) and Variable Number of 
Tandem Repeats (VNTR) were available for 750 subjects. Attrition analyses showed that 
the 317 subjects who were not included in the analyses, did not differ from the participating 
750 subjects in terms of sex (male sex 86.8% vs. 87.7%; χ2=0.20, df=1, p=n.s.), age (10.94 
vs. 10.67 years; t=1.43, df=1065, p=n.s.), and ODD diagnosis (69.0% vs. 64.1%; χ2=2.32, 
df=1, p=n.s.).
Measures
The long form of the revised Conners Parent Rating Scale (CPRS-R:L) was used in the present 
study (Conners, 1997; Conners et al., 1998). Subtypes and dimensions of oppositionality 
were assessed by use of the 10 items (0 = not true, 1 = little true, 2 = much true, 3 = very 
much true) of the CPRS-R:L oppositional scale. In total, four different phenotype (two 
dimensional and two categorical) measures were included in the present study and tested 
for differences in the candidate-based and hypothesis-free analyses (see below). The use 
of dimensional as well as categorical measures of ODD is in line with previous research 
confirming (a) separate but correlated dimensions of ODD (Aebi et al., 2010; Aebi et al., 
2013; Ezpeleta et al., 2012; Krieger et al., 2013; Stringaris and Goodman, 2009a, b) and (b) 
distinct subtypes of irritable and severe forms of ODD (Althoff et al., 2014; Burke, 2012; 
Kuny et al., 2013).
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a) Two dimensions were defined on theoretical grounds, which reflected the two 
previously described dimensions of ODD (Aebi et al., 2013; Stringaris et al., 2012), 
namely defiant/vindictive (P1) and irritable (P2). The items related to P1 with scores 
ranging from 0 to 18 and P2 with scores from 0 to 12 for P2 are shown in Figure 1. 
Internal consistencies (Cronbach alpha) amounted to 0.79 and 0.82 for the defiant/
vindictive and the irritable dimension, respectively. Because of a right skewed 
distribution, a Blom transformation (Blom, 1958) of P2 was performed. 
b) Two further dichotomous subtypes were based on findings from a latent class analysis 
(LCA). LCA was performed using poLCA package (Linzer and Jeffrey, 2011) in R 
statistic software (R Development Core Team, 2011). All of the 10 dichotomized 
CPRS-oppositionality items (0 and 1 were scored as absent; 2 and 3 were scored as 
present) were included in analysis. One to five class models were compared, and the 
Bayesian Information Criterion (BIC) and the Akaike Information Criterion (AIC) 
were used to determine the number of classes. The four class solution, which fitted 
the data best (BIC=11169; AIC= 10955), contained classes labeled low oppositionality 
(OPP), moderate OPP, irritable OPP, and severe OPP (see Figure 1). Because of our 
interest in severe forms of ODD, we defined the following dichotomous phenotypes: 
a dichotomous subtype P3, with 0 representing ‘low OPP/moderate OPP’ (n=331) 
and 1 representing ‘irritable OPP/severe OPP’ (n=419), and a dichotomous subtype 
P4, with 0 representing ‘low OPP/moderate OPP/irritable OPP’ (n=534) and 1 
representing ‘severe OPP’ (n=216). 
Figure 1: Mean scores of dichotomized items of the Conners Parent Scale (CPRS-R:L) oppositional scale 
assessing irritable (IRR1- IRR4) and defiant/vindictive (DV1 – DV6) behaviors as a function of latent classes 
for children and adolescents with ADHD combined type (N = 750). OPP = oppositionality.
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The DSM-IV diagnoses of ODD / CD and parental ability to cope with disruptive 
behaviors was coded from the diagnostic interview (Parental Account of Childhood 
Symptoms, [PACS]; Chen and Taylor, 2006; Taylor et al., 1986) A parent (usually the 
mother) responded to a 7-point Likert-scale ranging from 0 (efficient coping) to 7 (abusive 
parental behavior) measuring maternal and paternal coping with disruptive behaviors. A 
mean score was used when information for both parents was available. Furthermore, the 
oppositional scale of the Conners’ Teacher Rating Scale (CTRS- R:L;Conners, 1997) and 
the conduct problem scale of the Strengths and Difficulties Questionnaire (Goodman, 
1997) were used for phenotype description.
DNA collection and genotype assays
Sample collection and DNA isolation has been described previously (Brookes et al., 2006). 
Genome-wide genotyping and data cleaning was performed as part of the GAIN study 
using the Perlegen 600K genotyping platform, as described in (Neale et al., 2008). To 
increase genomic coverage, imputation was performed using MACH and the Hapmap 2 
(Release 22 Build 36) reference data set (Li et al., 2010). Quality control was performed 
on the imputed data, and SNPs with imputation quality scores lower than 0.30, a minor 
allele frequency lower than 0.01, and those failing the Hardy-Weinberg equilibrium test at 
a threshold of p≤10–5 were excluded. In addition, SNPs and subjects with missingness rates 
higher than 0.05 were removed from the data. Distributed over 22 autosomes, 1,871,025 
SNPs were left for analysis.
Genotyping of candidate polymorphisms (DRD4 exon 3 VNTR; 5-HTTTLPR) was 
performed at the SGDP laboratories in London or at the Human Genetics department of 
the Radboudumc in Nijmegen, the Netherlands. Standard PCR protocols were used, as 
previously described (Brookes et al., 2006; Thissen et al., 2015). 
Statistical analyses
Analysis of candidate polymorphisms
Linear and logistic regression analyses were used to test the effects of the DRD4 exon 3 
variant (presence/absence of the 7-repeat allele: 7R/7R and 7R/other versus other/other) 
and the 5-HTT variant (presence/absence of the 5-HTTLPR short allele: S/S and S/L versus 
L/L) on the ODD dimensions/subtypes. Variables included in the model were age, sex, 
and parental ability to cope with disruptive behaviors, as well as the interaction of DRD4 
and 5-HTTLPR genotype with parental ability to cope with disruptive behaviors. For the 
oxytocin receptor gene OXTR, only one of the seven SNPs previously linked with aggression 
was present in the data (rs1488467). Therefore, outcome of the association analysis of all 
SNPs located in that region was plotted to find out if an association signal was presented by 
closely related linked SNPs.
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Gene-wide and gene-set analyses
Gene-wide analysis was applied for 5-HTT as well as for DRD4 and OXTR using a mass-
univariate approach, to take potential allelic heterogeneity into account and test if a 
combination of SNPs located in these genes showed association with the ODD dimensions/
subtypes. Similarly, gene-set analysis was performed for all genes involved in serotonin, 
dopamine and oxytocin neurotransmission. A list of genes included in each pathway-wide 
analysis can be found in Supplementary Table S1. All available variants of each gene were 
extracted, including variants within a 100 kilobase (kb) flanking region of each gene to 
capture regulatory sequences. The effect of common variants of each gene or gene-set of 
interest on the two dimensions and the two categorical subtypes was investigated using the 
statistical approach described by Bralten et al. (2013) consisting of SNP-by-SNP regression 
and estimation of the effect of the whole gene or gene-set. For both gene-wide and gene-set 
based analyses, linkage disequilibrium-pruned genotyping data were prepared, using the 
‘indep’ command in Plink (Purcell et al., 2007) with a r2 threshold of 0.8.
Correction for multiple testing
Results were considered to be significant if they reached the Bonferroni corrected p-value 
threshold for multiple testing (0.05 divided by the number of phenotypes, polymorphisms 
and gene(-sets) tested; p-value threshold=1.4E-3).
Multivariate genome-wide association study
We performed a multivariate GWAS to capture covariance among the different correlated 
ODD dimensions/subtypes and to increase the power for finding genetic associations. 
Using only a single test for association instead of four, has the additional advantage of a 
reduced multiple testing burden. Following analysis of correlation between traits we assessed 
association between genetic markers and the two dimensions and the two categorical 
subtypes using the MQFAM multivariate extension of PLINK (Ferreira and Purcell, 2009). 
Residuals obtained for each subtype after adjustment for age, sex, parental ability to cope 
with disruptive behavior, and four population components derived from multidimensional 
scaling analysis were used as input. The MQFAM method uses canonical correlation 
analysis to identify the linear combination of traits that maximizes the covariance between 
a marker and the traits. It can be used for analysis of a combination of quantitative and 
binary traits (Ferreira and Purcell, 2009; Galesloot et al., 2014). For each SNP included 
in the analysis, a loading is calculated in the output which reflects the contribution of 
each phenotype to the association results. Top-SNPs (p<1.00E-5) from the multivariate 
GWAS were investigated for their location in or around genes and for their performance in 
univariate analysis, which provided information on the direction of effect.
Molecular landscape building: bioinformatics and literature analyses
To increase the understanding of the molecular basis of ODD, we aimed at integrating 
the top findings from the GWAS into a landscape of functionally interacting proteins and 
molecules that regulate biological signaling cascades. First, a list of independent association 
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regions was obtained by clumping the results using PLINK (Purcell et al., 2007). SNPs 
in LD (r2≥0.2) within 10000 kb of a more significant index SNP were discarded. Second, 
a threshold of p<1.00E-04 was applied for index SNPs, resulting in 75 LD-independent 
regions. The chosen statistical cut-off for association of p<1.00E-04 is often used to designate 
‘suggestive’ association and has been previously used in studies of neurodevelopmental 
disorders (ADHD and autism) (Poelmans et al., 2013; Poelmans et al., 2011b). Third, a 
list of top genes was compiled. Gene annotation was performed when an index SNP was 
located within an exon, an intron or untranslated region of the gene, or when an index 
SNP was located within a region 100 kb downstream or upstream of the gene to capture 
regulatory sequences (Gherman et al., 2009; Nicolae et al., 2010; Pickrell et al., 2010; 
Veyrieras et al., 2008). 
We then conducted a canonical pathway analysis of the list of top-ranked genes from the 
multivariate GWAS, using the Ingenuity software package (http://www.ingenuity.com). 
For this pathway enrichment analysis, Ingenuity draws on the Ingenuity Knowledge 
Base which is based on information from published literature as well as on various other 
sources including gene expression and gene annotation databases. An enrichment P-value 
is calculated for each pathway with the right-tailed Fisher’s exact test and correction for 
multiple testing is performed using the Benjamini-Hochberg correction.  Subsequently, 
we searched the literature for the function of the proteins encoded by all the top-ranked 
genes from the multivariate GWAS, using UniProtKb (http://www.uniprot.org/uniprot) 
and Pubmed (http://www.ncbi.nlm.nih.gov/). The landscape building approach described 
here has been used in earlier studies of neurodevelopmental disorders (Poelmans et al., 
2011a; Poelmans et al., 2013; Poelmans et al., 2011b) Lastly, the genes from the list with top 
findings were investigated for previous implication in the etiology of neurodevelopmental 
or neuropsychiatric disorders using Ensembl release 75 (Flicek et al., 2014) and the NCBI 
databases (http://www.ncbi.nlm.nih.gov/).
RESULTS
Descriptives
The final sample (N=750) consisted of 680 boys (87.9%) and 94 girls (12.1%) aged 5 to 
18 years (mean 10.67 years, SD=2.77). According to the PACS interview, 481 (64.1%) 
children and adolescents fulfilled DSM-IV criteria for ODD and 170 (22.7%) for CD. 
Bivariate correlations of the two dimensions and the two categorical subtypes are shown in 
Supplementary Table S2. All correlations were significant and moderate. Furthermore, all 
dimensions/subtypes were slightly correlated to teacher ratings of oppositionality (CTRS), 
and moderately correlated to SDQ conduct problems and DSM-IV diagnosis of ODD / 
CD (also shown in Supplementary Table S2). 
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Candidate polymorphisms
No associations of DRD4 and 5-HTTLPR were observed for any of the four measures, 
nor were any interactions of parental ability to cope with disruptive behaviors with these 
genotypes observed (Table 1). Parental ability to cope with the child’s disruptive behaviors 
was significantly associated with all four ODD measures (except for 5-HTTLPR analysis 
of severe oppositionality (P4). Age was positively associated with irritability (P2) and 
irritable/severe oppositionality (P3), both in the DRD4 model as well as in the 5-HTTLPR 
model. There appeared to be no SNPs closely located to, and in high linkage disequilibrium 
with, OXTR SNP rs1488467 that show association with the ODD dimensions/subtypes 
(Supplementary Figure S1).
Gene-wide and gene-set analyses
Findings for the 5-HTT, DRD4 and OXTR genes and the neurotransmission pathways are 
shown in Table 2. None of the analyses revealed a significant association with any of the 
four ODD phenotypes.
Table 1: Linear and logistic regressions of the DRD4 genotype (presence/absence of the seven repeat allele: 
7R7R and 7R/other versus other/other) and of the HTTLPR genotype (presence/absence of the short allele: 
S/S and S/L versus L/L) predicting the four phenotypes of ODD.
Phenotypes P1 P2 
(transformed)
P3 P4
Variables Β Β Β Β
DRD4 genotype
  DRD4 (7R7R and 7R/other vs   
  other/other) -0.39 n.s. -0.08 n.s. 0.00 n.s. -0.10 n.s.
  Parent coping (centered) 0.65*** 0.16*** 0.28*** 0.27***
   DRD4 (7R7R and 7R/other vs 
other/other) x  parent coping 
(centered) 0.02 n.s. -0.08 n.s. -0.10 n.s. -0.12 n.s.
  Sex (0=female, 1=male) 0.69 n.s. 0.19 n.s. 0.33 n.s. 0.35 n.s.
  Age 0.09 n.s. 0.04** 0.07*. 0.05 n.s.
HTTLPR genotype
  5-HTTLPR (S/S and S/L vs. L/L) 0.51 n.s. -0.02 n.s. -0.03 n.s. 0.20 n.s.
  Parent coping (centered) 0.73** 0.16** 0.25* 0.23 n.s.
   5-HTTLPR (S/S and S/L vs. L/L) x 
parent coping (centered) -0.13 n.s. -0.04 n.s. 0.00 n.s. -0.02 n.s.
  Sex (0=female, 1=male) 0.64 n.s. 0.19 n.s. 0.34 n.s. 0.28 n.s.
  Age 0.08 n.s. 0.04** 0.07* 0.04 n.s.
Note: P1= defiant vindictive dimension, P2= irritable dimension, P3= irritable/severe oppositionality,  P4= se-
vere oppositionality, +=significance (two sided), p<.010, *=significance (two sided), p<.05, **=significance (two 
sided), p<.01, ***=significance (two sided), p<.001.
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Table 2: P-values of gene-wide and gene-set based analysis of 5-HTT, DRD4 and OXTR genes and the neu-
rotransmission pathways for serotonin, dopamine and oxytocin.
Phenotype Gene-wide analysis Gene-set analysis
5-HTT
(20 SNPs)
DRD4 
(14 SNPs)
OXTR
(71 SNPs)
Serotonin
(942 SNPs)
Dopamine 
(2568 SNPs)
Oxytocin
(360 SNPs)
P1 0.2508 0.2756 0.3101 0.3458 0.5612 0.6798
P2 0.6463 0.9455 0.5737 0.5493 0.4726 0.9272
P3 0.9445 0.3128 0.9649 0.515 0.276 0.9991
P4 0.1632 0.7257 0.5579 0.5012 0.274 0.9377
Note: P1= defiant vindictive dimension, P2= irritable dimension, P3= irritable/severe oppositionality,  P4= 
severe oppositionality.
Multivariate genome wide association study
As expected given the modest sample size (n=750), multivariate GWAS did not result 
in genome-wide significant findings (p< 5.0E-08; Dudbridge and Gusnanto, 2008) (see 
Figure 2, and Supplementary Figure S2 for the Quantile- Quantile plot). Supplementary 
Table S3 presents the 65 SNPs showing association with the ODD dimensions and 
subtypes at p<1.00E-5, together with their respective loadings reflecting the contribution 
of each phenotype to the association results and their performance in univariate analysis. 
The top three findings were for rs7204436 (p= 1.98E-07) located in an intergenic region 
on chromosome 16, rs1278352 (p=1.24E-06) located in an intronic region of the ADAM12 
gene on chromosome 10, and rs12370275 (p=2.41E-06) located in an intergenic region 
on chromosome 12 (Figure 2). Also of interest is a region on chromosome 20 with a large 
number of SNPs in high LD showing a strong association signal. This region is located on 
chromosome 20q11.21 and is spanning several genes (COX4I2, BCL2L1, TPX2, MYLK2, 
FOXS1, TTLL9) (also depicted in Figure 2).
Molecular landscape building
From 76 independent SNPs with a p<1.00E-04, a list of fifty-three top-ranked genes was 
derived using the criteria as described in the Methods section (Supplementary Table S4). 
The bioinformatics analysis with Ingenuity revealed significant enrichment of the canonical 
pathways ‘Inhibition of matrix metalloproteases’ (Pcorrected=1.19E-2), ‘Axonal guidance 
signaling’ (Pcorrected=2.60E-02), and ‘Wnt/ B-catenin signaling’ (Pcorrected=2.60E-02), with 
the proteins encoded by nine of the top-ranked genes belonging to one more of these 
pathways (Table 3). Importantly, all proteins encoded by these nine genes play a role in 
neurite outgrowth. In addition, the subsequent literature analysis revealed that in total, 
28 of the 53 top-ranked ODD genes (53%) interact in a molecular landscape centered 
around β-catenin signaling and involved in regulating neurite outgrowth (depicted 
in Figure 3). This landscape encompasses signaling cascades that are important for the 
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neural modulations necessary for the growth of axons in a specific direction. The evidence 
linking the molecules in the landscape to neurite outgrowth is described in detail in the 
Supplementary Information. 
Fifteen of the top-ranked genes have also been implicated previously in the etiology of 
neurodevelopmental and/or neuropsychiatric disorders. A summary of these genes and 
previous findings from literature can be found in Supplementary Table S5.
Table 3: Three canonical pathways that were significantly enriched in the top 53 ODD GWAS genes, using 
Ingenuity pathway analysis (www.ingenuity.com). The genes encoding proteins that could be directly 
placed in the ODD landscape are indicated in bold.
Canonical pathway Genes Significance* Adjusted significance**
 
Inhibition of Matrix 
Metalloproteases
 
 
ADAM10, ADAM12, 
MMP7
 
1.20E-04
 
1.19E-02
Axonal Guidance 
Signaling
ABLIM2, ADAM10, 
ADAM12, MMP7, 
PAK7, SLIT1
6.46E-04 2.60E-02
Wnt/β-catenin Signaling MMP7, RARB, SFRP4, 
SOX5
7.86E-04 2.60E-02
* Single test P value calculated with the right-tailed Fisher’s exact test and taking into consideration both the 
total number of molecules from the analysed dataset and the total number of molecules that is linked to the 
same gene category according to the Ingenuity Knowledge Base.
 ** Multiple test-corrected P values using the Benjamini-Hochberg correction (p<0.05).
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Figure 2: Top: Manhattan plot of multivariate GWAS including ODD subtypes P1 (defiant vindictive), P2 
(irritable), P3 (0 representing ‘low OPP/moderate OPP’ and 1 representing ‘irritability/severe OPP’) and P4 (0 
representing ‘low OPP/moderate OPP/irritability’ and 1 representing ‘severe OPP’). Bottom: Top four regions 
(indicated by arrows in the manhattan plot) containing SNPs showing association at p<1.00E-5 in the multi-
variate GWAS. Top SNPs for each region are depicted in purple; rs7204436 on chromosome 16 (p=1.98E-07) 
, rs1278352 on chromosome 10 (p=1.24E-06), rs60193286 on chromosome 12 (p=2.41E-06) and rs6060960 
on chromosome 20 (p=3.00E-06). OPP = oppositionality.
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DISCUSSION
The aim of this study was to reduce the known heterogeneity in the ODD phenotype 
in order to improve the power to detect the genetic underpinnings. We first identified 
four conceptually meaningful subtypes and dimensions of oppositionality in the IMAGE 
sample. We then tested the VNTRs and genes/gene-sets that have been previously 
implicated in aggression/disruptive behavior for their effect on the two dimensions and 
the two categorical subtypes. In addition to these hypothesis-driven analyses, we aimed to 
generate new hypotheses about genetic involvement in ODD by performing multivariate 
GWAS. By using bioinformatics analysis and literature mining, we found that top findings 
obtained from the GWAS fit into a neurite outgrowth- regulating molecular landscape.
Figure 3: Neurite outgrowth- regulating molec-
ular landscape implicated in ODD.The evidence 
linking the molecules in the landscape to neurite 
outgrowth can be found in the Supplementary 
Information.
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Previous research has focused on various dimensions within oppositional defiant behaviors 
(Aebi et al., 2010; Stringaris and Goodman, 2009b).  Further studies have attempted to 
identify discrete classes of children and adolescents according to their oppositional behavior 
profiles. Consistent with previous research (Althoff et al., 2014; Kuny et al., 2013), LCA 
in the present study revealed a low symptom endorsement type, an irritable type, and a 
severe type with elevated scores on all symptoms. In contrast to these previous findings, we 
additionally found a moderate oppositional type with intermediate scores on all symptoms, 
but not a specific defiant/vindictive type. Considering the large sample size and the multi-
site data collection for the sample of the present study (Müller et al., 2011a, b) one may 
conclude that, most probably, children with ADHD more often show the full range of 
ODD symptoms rather than defiant/vindictive symptoms only. In contrast, irritability 
symptoms are frequently co-occurring in ADHD children and may represent a specific 
subtype of ADHD (Fernandez de la Cruz et al., 2015).
Although we tried to reduce the heterogeneity of ODD by identifying conceptually 
meaningful subtypes and dimensions of oppositionality, we did not observe any significant 
associations or interactions with previously postulated candidates (SNPs, genes, and 
pathways). This is not surprising in light of inconsistent reports of DRD4, 5-HTT, and 
OXTR effects on externalizing behaviors (e.g. Beitchman et al., 2012; Kirley et al., 2004; 
Lavigne et al., 2013; Malik et al., 2012), and the small effect sizes of most genetic risk factors 
for behavioral measures. A recent meta-analysis did not confirm a relation of DRD4 exon3 
and 5-HTTLPR to aggression and violence (Vassos et al., 2014).  Furthermore, our findings 
mirror those of a previous study that did not find a DRD4/5-HTTLPR- interaction with 
parental support for ODD in 4 year old children (Lavigne et al., 2013). Parenting behavior 
was moderately to strongly associated with the defined ODD dimensions and subtypes. In 
line with behavioral theories on negative parent-child interactions (e.g. coercive behaviors; 
Patterson, 1982), parenting behavior was most strongly associated with defiant/vindictive 
behaviors. Since parental ability to cope with the child’s disruptive behavior was rated by 
PACS interviewers, and symptoms of oppositionality were rated by parents, confounding 
of these variables by rater-effects is unlikely.
In order to obtain new insights into genetic risk factors for ODD that can inform future 
investigations of the neurobiology related to oppositional behavior, we also conducted a 
multivariate GWAS using the four ODD subtypes. We found 65 markers that showed 
association with at least one of the four phenotypes at p<1.00E-5. The strongest association 
with oppositional behavior was found for rs7204436 (p=1.98E-07) located in an intergenic 
region on chromosome 16. Although no genes are located nearby, a novel microRNA 
was found 30 kb from the marker which might regulate genes involved in the etiology of 
oppositional behavior. 
Out of 65 markers with p<1.00E-05, 46 were located in a region on chromosome 20q11.21 
spanning the genes COX4I2, BCL2L1, TPX2, MYLK2, FOXS1 and TTLL9. It can be 
hypothesized that of these genes, BCL2L1 is the most likely candidate causing suggestive 
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association of the region with oppositional behavior. The long isoform Bcl-S(L) is an anti-
apoptotic regulator expressed at high levels in both the developing and the adult brain 
(Krajewska et al., 2002). Interestingly, it regulates neurotransmitter release and retrieval of 
vesicles in neurons, thereby influencing presynaptic plasticity (Li et al., 2013). Recently, it 
has also been shown that BCL2L1 is associated with volume of the putamen in a GWAS of 
subcortical volumes in 30,717 individuals from 50 cohorts (Hibar et al., 2015). BCL2L1 is 
not present in our top gene list because of filtering during the clumping procedure.
Genomewide studies of aggression phenotypes are starting to emerge. A GWAS of CD had 
been performed before in the current ADHD sample (Anney et al., 2008), where one of the 
three phenotypes used was defined as the sum score for 12 CPRS-R:L items, giving perhaps 
a better representation of ODD than CD. In contrast, we assumed in the present study that 
combining biologically valid and less heterogeneous subtypes of ODD through a multivariate 
approach would improve power to define new hypotheses about the genetics of ODD. 
The top SNPs reported by Anney et al. (2008), who performed family-based Transmission 
Disequilibrium Tests (TDT), did not reach suggestive significance (p<1.00E-04) in our 
study (Supplementary Table S6). A few other GWAS of aggression- related phenotypes 
have been reported to date. We compared our association results for the oppositional 
phenotypes to the top results of four published aggression related genome-wide association 
studies (Alliey-Rodriguez et al., 2011; Dick et al., 2011; Mick et al., 2014; Tielbeek et al., 
2012). None of the SNPs in a 100 kb region surrounding these reported top results reached 
the threshold for suggestive association in our study (p<1.00E-4) (supplementary figure 
S3). Interestingly though, among our list of top genes is EPDR1 (ependymin related 1). 
Ependymin is involved in control of aggressive behavior in fish, where it is a neurotrophic 
factor that plays a role in neuronal regeneration and adhesion (Sneddon et al., 2011). The 
mammalian ependymin related protein 1 shows significant sequence similarity to piscine 
ependymins and has been proposed to be the human homologue of the piscine ependymin 
(Nimmrich et al., 2001). These findings make EPDR1 an interesting candidate gene for 
future investigations of genetic contributions to aggression phenotypes.
As could be expected based on sample size, our multivariate approach did not retrieve any 
region that yielded genome-wide significant association with ODD. Nevertheless, using 
the described landscape building approach, we have integrated the top-ranked findings 
of the GWAS into a molecular landscape involved in regulating neurite outgrowth. More 
than half of our top-ranked ODD genes were found to interact functionally within this 
landscape, identifying neurite outgrowth as a biological process that is important for the 
etiology of ODD. This is in line with neuroimaging studies indicating that aggressive 
behavior is associated with dysfunctional brain circuitry involved in emotion regulation 
and decision making (Blair, 2013). Moreover, current models of aggression postulate an 
impaired structural and functional connectivity between prefrontal areas and subcortical 
structures such as the amygdala (Rusch et al., 2007; Saxena et al., 2012; Siever, 2008). 
Indeed, alterations in the efficiency or direction of neurite outgrowth may underlie these 
dysfunctions.
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The identified molecular landscape centers around β-catenin (CTNNB) signaling. CTNNB 
has a pivotal function in an important signaling cascade leading to neurite outgrowth. The 
process of neurite outgrowth can be initiated at the neuronal cell membrane, where the 
binding of ligands from the extracellular matrix to their receptors leads to the modulation 
of downstream molecular cascades in the cytoplasm, cytoskeleton and nucleus that are 
involved in regulating neurite outgrowth. Importantly, several proteins and signaling 
molecules in the landscape (highlighted in yellow in figure 3) –including serotonin, 
testosterone, triiodothyronine, growth hormone and retinoic acid - have been associated 
with ODD or aggressive behavior through genetic or functional evidence. Starting with the 
discovery of a nonsense mutation in the MAOA gene leading to a syndrome characterized 
by violent behaviour (Brunner et al., 1993), the key role of monoamines and especially 
serotonin in aggression has been demonstrated in a wide variety of human and animal 
studies (Anholt and Mackay, 2012). Several studies also show a correlation of levels of the 
male hormone testosterone and aggression (Pavlov et al., 2012) and it has been proposed 
that an altered testosterone-to-cortisol ratio may be associated with aggression in humans 
(Haller, 2012; Montoya et al., 2012). Further, thyroid hormones are associated with stress, 
and elevated levels of the active thyroid hormone triiodothyronine (T3) are associated with 
conduct disorder and criminal behavior (Ramklint et al., 2001; Stalenheim, 2004). In 
addition, several animal studies suggest that growth hormone (GH) influences aggressive 
behavior. For example, GHRH knock- out mice with GH deficiency show reduced 
aggressive behavior which can be normalized by GH replacement (Sagazio et al., 2011). 
Lastly, chronic administration of synthetic retinoic acid to rats reduced aggression- and 
increased flight-related behaviors in the resident-intruder paradigm (Trent et al., 2009). 
The fact that these and other molecules active within our landscape have been associated 
previously with aggressive behavior provides corroborating evidence for the involvement of 
neurite outgrowth in aggression etiology.
Of note, alterations in neurite outgrowth are not specific to the etiology of ODD, as neurite 
outgrowth has also been shown to play a role in the pathogenesis of other neurodevelopmental 
disorders such as ADHD, Autism spectrum disorders (ASD), dyslexia and schizophrenia 
(Penzes et al., 2011; Poelmans et al., 2011a; Poelmans et al., 2013; Poelmans et al., 
2011b).  It has been hypothesized in these studies that each of these disorders may in part 
be explained by different functional consequences and different primarily affected brain 
regions of disturbed neurite outgrowth. Psychiatric disorders, including ODD, are currently 
classified based on clinical presentation rather than underlying etiology. Hence, shared 
genetic etiology can be expected to exist not only between definable subtypes of psychiatric 
disorders, but also between different psychiatric disorders as currently classified in clinical 
practice. This notion is also supported by a recent study (Cross-Disorder Group of the 
Psychiatric Genomics et al., 2013) that detected substantial genetic correlations between 
five major psychiatric disorders and by the fact that 15 out of the 53 top ranked genes of 
our study have previously been associated with neuropsychiatric and neurodevelopmental 
disorders.
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This study is based on a representative clinical sample from eight European countries. 
Psychometrically reliable and valid measures and methods (e.g. LCA) were used for 
phenotype definitions and advanced methods were performed in gene-set and genome 
wide analyses. However, the present study is limited to data obtained from children and 
adolescents with ADHD combined type (which is often comorbid with ODD) and although 
our findings may not be generalized to other clinical and community samples, the overlap 
of our top findings with results in other genetic studies of psychiatric disorders suggests 
a broader validity. Our results were based on Caucasian subjects only and the sample 
consisted mostly of male subjects. Due to missing information in the PACS and other 
instruments, our sample was reduced to 750 probands. However, attrition analyses did not 
show significant differences between probands included in the sample and drop-outs.  
A potential source of bias in our bioinformatics analysis arises from the fact that brain-
expressed genes are relatively large. Therefore, brain-expressed genes may be over-
represented in our GWAS results. If large genes are more likely found to be associated 
by chance (because they contain more SNPs), this should be the case in GWASs of both 
psychiatric disorders and non-psychiatric disorders that do not originate in the brain. 
However, previous studies have compared enrichment results for psychiatric disorders with 
results from Crohn’s disease and diabetes mellitus (Poelmans et al., 2013; Poelmans et 
al., 2011b) and showed that the ‘neurological disease’ category enriched in the psychiatric 
GWASs showed very little or no enrichment in Crohn’s disease or diabetes. Combined with 
the fact that 53% of our ODD top genes also fitted in the molecular landscape for neurite 
outgrowth based on extensive literature mining, we argue that although some genes in the 
landscape may have been chance findings, most candidate genes from the GWAS represent 
true findings contributing to our phenotype. Future studies conducting pathway analyses 
using algorithms that address potential confounders such as the large size of brain genes 
will be of additional information (Holmans et al., 2009; Lee et al., 2012).
In summary, the present findings confirmed the existence of various subgroups of youths with 
different oppositional symptom profiles. However, against our expectations the examined 
ODD dimension and subtypes were not associated with previously described candidate 
genes and pathways. By employing a multivariate genome-wide association approach, we 
identified several genetic susceptibility loci that may inform future theories on the etiology 
of oppositional behavior. We also identified a biological landscape of molecular signaling 
cascades involved in neurite outgrowth providing new insights into the etiology of ODD. 
In part, our findings may reflect shared genetic risk factors for psychiatric disorders. We 
hope to encourage further investigations towards a biologically informed classification of 
psychopathology.
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SUPPLEMENTARY MATERIAL
Supplemental description of the molecular ODD landscape and legend (Figure 3)
The ODD candidate gene/proteins that were implicated by our GWAS (Supplementary 
Table S4) and the other ODD/aggressive behavior candidate genes/proteins/molecules 
(Supplementary Table S7) are indicated in bold. 
Signaling through the landscape can be initiated at the neuronal cell membrane, where the 
binding of ligands from the extracellular matrix to their receptors leads to the modulation 
of downstream molecular cascades in the cytoplasm, cytoskeleton and nucleus that are 
involved in regulating neurite outgrowth.  Furthermore, modulation of the neuronal 
extracellular matrix is necessary for the neurite to grow in a certain direction. The main 
signaling cascade in the landscape centers around β-catenin (CTNNB), a protein that has 
a dual function as a peripheral membrane/cytoplasmic protein and nuclear transcription 
factor and regulates neurite outgrowth (Bhardwaj et al., 2013; Votin et al., 2005; Yanagisawa 
et al., 2010). 
CDH2 and CDH4, two proteins that mediate cell adhesion (UniProt, 2014) and regulate 
neurite outgrowth (Hansen et al., 2008) (Burden-Gulley et al., 2010; Oblander & Brady-
Kalnay, 2010), are anchored in the neuronal cell membrane through forming a functional 
complex with each other and the peripheral membrane proteins CTNNB and CTNND1 
(Agiostratidou et al., 2009; Hazan & Norton, 1998; Ishiyama et al., 2010; Rubio et al., 
2005; Shan et al., 2000; UniProt, 2014). The activity of CTNND1 is regulated by the 
neurite outgrowth-implicated kinase PAK7 (Dan et al., 2002; Wong et al., 2010) and both 
CTNNB and CTNND1 can function as a transcription factor (see below).  Moreover, 
SLIT1 binding to the ROBO1 axon guidance receptor inactivates CDH2, which leads to 
CTNNB being released from CDH2 and targeted to the cytoplasm and subsequently the 
nucleus (Rhee et al., 2007). Through degrading CDH2, the extracellular metalloprotease 
ADAM10 also promotes the translocation of CTNNB from the peripheral membrane 
to the nucleus (Kohutek et al., 2009; Maretzky et al., 2005). In addition, ADAM10 is 
involved in regulating the expression of MAGI2 (Prinzen et al., 2009), a scaffolding protein 
that binds and regulates the activity of CTNNB (J. Xu et al., 2001) and that has been 
implicated in neurite outgrowth (UniProt, 2014; X. Wu et al., 2000). MAGI2 also binds 
and functionally modulates the neuronal membrane receptor LPHN2 (Tobaben et al., 
2000) and, through binding and regulating CTNNB, it is functionally linked to TRPC4, 
a calcium channel that directly binds and interacts with CTNNB (Graziani et al., 2010) 
and stimulates neurite outgrowth (Weick et al., 2009; D. Wu et al., 2008), and the CDH2-
CDH4-CTNND1 complex (see above; not shown). Furthermore, extracellular SFRP4 
regulates the activity and localization of CTNNB (Berndt et al., 2003) while PCDH20, a 
membrane protein that like CDH2 and CDH4 mediates (neuronal) cell adhesion (UniProt, 
2014), inhibits the cytoplasmic/nuclear translocation and function of CTNNB (Lv et al., 
2015) and the STK39 kinase binds and functionally interacts with CTNNB (Miyamoto-
Sato et al., 2010). 
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After having translocated to the nucleus, CTNNB functions as a transcription factor. The 
transcriptional activity of CTNNB is inhibited by two other transcription factors, i.e., 
SOX5 (Martinez-Morales et al., 2010) and the androgen receptor (AR) bound to and 
activated by testosterone (Pawlowski et al., 2002), the male sex hormone that positively 
regulates neurite outgrowth (Estrada et al., 2006; Marron et al., 2005),  and is produced 
by a number of enzymes in the endoplasmic reticulum, including HSD17B3 (UniProt, 
2014). Further, the expression of CTNNB is upregulated by nuclear and PAK7-activated 
(see above) CTNND1 (Gavard et al., 2004) and RUNX1T1 (Muller-Tidow et al., 2004), 
a transcription factor that binds and activates ZBTB16, another transcription factor (A. 
Melnick et al., 2000a; A. M. Melnick et al., 2000b). In turn, ZBTB16 binds and inhibits 
the transcriptional activity of retinoic acid receptor alpha (RARA) (Martin et al., 2003), 
a nuclear receptor that, when bound and activated by retinoic acid, forms a functional 
complex with CTNNB (Easwaran et al., 1999) and downregulates the expression of the 
retinoic acid receptor beta (RARB) (Q. Wu et al., 1997), a transcription factor with 
an established role in stimulating neurite outgrowth (Agudo et al., 2010; Hoecker et al., 
2013; Puttagunta et al., 2011; So et al., 2006). In addition, C1D binds and modulates the 
transcriptional activity of THRB (UniProt, 2014; Zamir et al., 1997),  a nuclear receptor 
that when bound and activated by triiodothyronine (T3) - the active thyroid hormone 
that promotes neurite outgrowth (Walter, 1996) -  upregulates the expression of CTNNB 
(O’Shea et al., 2012; UniProt, 2014). 
When activated, CTNNB (up)regulates the expression of the growth hormone (GH) 
receptor (GHR) (Renou et al., 2003), PDE1C (Morkel et al., 2003) and MMP7 (Dey 
et al., 2013) while it downregulates the expression of the nerve growth factor (NGF) 
receptor (NGFR) (Grigoryan et al., 2013).  The GH-GHR complex is involved in inducing 
neurite outgrowth (Baudet et al., 2008; Grimbly et al., 2009) while NGF regulates this 
process through binding specifically to NGFR or NTRK1 (E. J. Huang & Reichardt, 
2001; UniProt, 2014), with the NGF-NTRK1 complex also being bound and functionally 
modulated by the adaptor protein SHC3 (Nakamura et al., 1998; UniProt, 2014). In 
addition, NGF promotes neurite outgrowth through upregulating the expression of the 
sodium channel ASIC2 (Drummond et al., 2006; Mamet et al., 2002). Furthermore, 
PDE1C is a cytoplasmic enzyme that degrades cyclic AMP (cAMP) (UniProt, 2014), a 
second messenger molecule that regulates many physiological processes  through activating 
protein kinase A (PKA) (Jones & Kuhar, 2006), which itself is an important regulator of 
neurite outgrowth (Aglah et al., 2008; Kao et al., 2002; Shea et al., 1992). PKA is activated 
through serotonin binding to the HTR7 receptor (Gervasi et al., 2007; UniProt, 2014), 
which is directly bound and modulated by RHOBTB3 (Matthys et al., 2012), and activates/
stabilizes CTNNB (Hino et al., 2005) and CDC42 (Chen et al., 2003), an important 
mediator of directed neurite outgrowth (Brown et al., 2000; Nikolic, 2002) that binds and 
activates PAK7 (Dan et al., 2002). CDC42 is also activated downstream of TENM4, a 
membrane protein that promotes neurite outgrowth (Suzuki et al., 2014). 
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Furthermore, PKA is directly involved in remodelling the neuronal cytoskeleton - which 
is essential for neurite outgrowth to take place -  through regulating the stability of actin 
filaments that together with microtubules form the cytoskeleton (Juliano, 2002), and both 
ABLIM2 (Barrientos et al., 2007; Klimov et al., 2005) and AFAP1 (UniProt, 2014; X. Xu 
et al., 2009) have a similar effect through directly binding and affecting the stability of 
actin filaments in the (neuronal) cytoskeleton. 
As already indicated above and in addition to cytoskeletal remodelling,  the neuronal 
extracellular matrix has to be modulated for the neurite to grow in a certain direction (Ma 
et al., 2008). In this respect, the brain-expressed metalloproteinases  ADAM10, ADAM12, 
ADAMTSL3 and MMP7 - which are also upregulated by CTNNB (see above) - regulate 
neurite outgrowth through degrading the neuronal extracellular matrix (Malinin et al., 
2005; Seetharaman et al., 2011; Szklarczyk et al., 2007; UniProt, 2014; J. Y. Wang et al., 
2014). Moreover, MMP7 is involved in upregulating the expression of ADAM12 (X. Wang 
et al., 2009) and ADAMTSL3 degrades fibrillin-1 (FBN1) (Sengle et al., 2012) which in 
turn regulates the expression of SFRP4 (Bayle et al., 2008). Furthermore, in addition to 
the interactions already described above, ADAM10 regulates the expression of SOSTDC1 
(Prinzen et al., 2009), a brain-expressed extracellular matrix protein (Park et al., 2009). 
Lastly, ISPD is an extracellular enzyme that, similar to the SLIT1-ROBO1 complex (see 
above), is involved in regulating axon guidance and hence neurite outgrowth (Wright et 
al., 2012).
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Supplementary Table S1: Lists of genes included in each of the gene-set analyses.
Dopamine gene-set Serotonin gene-set Oxytocin 
gene-set
ADCY1 DRD3 PPP1R14A PPP2R2C PRKAR2A DDC HTR6 EZH2
ADCY10 DRD4 PPP1R14B PPP2R3A PRKAR2B GCH1 HTR7 GNAQ
ADCY2 DRD5 PPP1R14C PPP2R4 PTS HTR1A IL4I1 GRK5
ADCY3 GCH1 PPP1R14D PPP2R5A QDPR HTR1B PCBD1 HTT
ADCY4 IL4I1 PPP1R1B PPP2R5B SLC18A1 HTR1D PTS IGF1
ADCY5 NCS1 PPP1R3A PPP2R5C SLC18A2 HTR1E QDPR OXT
ADCY6 PCBD1 PPP1R3C PPP2R5D SLC18A3 HTR2A SLC18A1 OXTR
ADCY7 PPM1J PPP1R3D PPP2R5E SLC6A3 HTR2B SLC18A2 PPARA
ADCY8 PPM1L PPP1R7 PRKACA SMOX HTR3A SLC18A3
ADCY9 PPP1CA PPP2CA PRKACB SPR HTR3B SLC6A4
CALY/
DRD1IP
PPP1CB PPP2CB PRKACG TH HTR3C SMOX
COMT PPP1CC PPP2R1A PRKAG1 HTR3D SPR
DDC PPP1R10 PPP2R1B PRKAG2 HTR3E TPH1
DRD1 PPP1R11 PPP2R2A PRKAR1A HTR4 TPH2
DRD2 PPP1R12A PPP2R2B PRKAR1B HTR5A
Supplementary Table S2: Bivariate correlations of ODD subtypes.
P1 P2 P3 P4 CTRS 
OPP
SDQ
CP
PACS 
ODD
PACS 
CD
P1 defiant vindictive dimension 1 0.68 0.62 0.73 0.21 0.63 0.42 0.31
P2 irritable dimension 1 0.75 0.53 0.10 0.56 0.42 0.25
P3 irritable/severe oppositionality - 1 0.57 0.14 0.52 0.38 0.23
P4  severe oppositionality 1 0.16 0.45 0.32 0.26
Note: CTRS OPP = Conners’ Teacher Rating Scale Oppositionality, SDQ CP = Strengths and Difficulties 
Questionnaire Conduct Problems, PACS = Parental Account of Childhood Symptoms, ODD = Oppositional 
Defiant Disorder, CD = Conduct Disorder, all correlations were significant at a threshold of p<0.05.
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Supplementary Table S6: SNPs showing association signal P<1.00E-5 in the GWAS by Anney et al.  
(Anney et al., 2008) and their performance in our multivariate GWAS.
CHR SNP BP P value
9 rs10815798 8225633 1.51E-02
3 rs13061352 22203581 1.69E-02
1 rs2064648 30410603 2.43E-02
1 rs2180233 30400299 2.89E-02
1 rs4949546 30406270 2.89E-02
1 rs1543424 30392051 3.31E-02
7 rs10229603 112415609 5.07E-02
1 rs6661210 155399012 5.73E-02
1 rs10796972 155399761 5.73E-02
1 rs6700498 155399774 5.73E-02
1 rs1176542 155400100 5.73E-02
1 rs1176543 155400219 5.73E-02
1 rs1176551 155402280 5.73E-02
1 rs1176555 155403165 5.73E-02
11 rs1557488 126124400 5.87E-02
11 rs1557487 126124791 5.87E-02
11 rs10831284 94307612 6.04E-02
1 rs11264625 155395329 6.14E-02
1 rs6427356 155397190 6.14E-02
16 rs4889240 79714023 8.80E-02
11 rs10736554 126120771 9.29E-02
8 rs4734494 101986897 9.56E-02
8 rs4734495 101986993 9.62E-02
8 rs931812 101988497 9.62E-02
1 rs701157 228741449 1.48E-01
12 rs789560 68618094 1.64E-01
14 rs1951082 26329883 1.92E-01
14 rs8021717 26333357 1.98E-01
10 rs2764978 3273385 2.11E-01
10 rs2764980 3274007 2.11E-01
10 rs2814925 3274061 2.11E-01
2 rs1521883 202657917 2.40E-01
1 rs10797919 182119537 2.44E-01
1 rs4079923 182113907 2.53E-01
15 rs4533251 95063431 2.81E-01
16 rs16973500 70522697 2.85E-01
12 rs7297018 78586361 3.30E-01
2 rs939745 202649555 3.66E-01
2 rs1521882 202658096 3.67E-01
2 rs1521879 202661472 3.72E-01
4 rs6536350 159660267 3.79E-01
13 rs10492664 107614226 4.32E-01
13 rs8002852 107616886 4.70E-01
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CHR SNP BP P value
18 rs7236632 53585200 5.07E-01
2 rs6733379 34333579 5.51E-01
2 rs7595103 77928752 6.93E-01
13 rs9512900 27327738 7.16E-01
5 rs1644305 133231495 7.40E-01
5 rs1644308 133227448 7.55E-01
21 rs2826340 20807173 8.38E-01
16 rs1381102 62512948 8.54E-01
2 rs1487044 77918912 9.54E-01
2 rs1487045 77918966 9.54E-01
16 rs12921846 - -
Supplementary Table S7: Genes/proteins/molecules from the molecular landscape linked to aggressive 
behavior through genetic and/or functional evidence.
Genes/proteins/molecules Link to aggressive behavior
Serotonin The role of serotonin in aggression has been demonstrated in a wide variety of 
human and animal studies (Anholt & Mackay, 2012).
Testosterone Levels of the male hormone testosterone were shown to be correlated with 
aggression (Pavlov et al., 2012). Altered testosterone-to-cortisol ratio may be 
associated with aggression in humans (Haller, 2012; Montoya et al., 2012).
Triiodothyronine Elevated levels of the active thyroid hormone triiodothyronine have been 
associated with conduct disorder and criminal behavior (Ramklint et al., 
2001; Stalenheim, 2004).
Growth hormone GHRH knock- out mice with growth hormone (GH) deficiency show reduced 
aggressive behavior which can be normalized by GH replacement (Sagazio et 
al., 2011).
Retinoic acid Chronic administration of synthetic retinoid acid to rats reduced aggression 
in the resident-intruder paradigm (Trent et al., 2009).
Nerve growth factor NGF is thought to be involved in aggression and alcohol dependence and 
changes in levels of nerve growth factor have been observed in rodents follow-
ing aggressive intermale interactions (Pardon, 2010).
NTRK1 Fighting in male mice potentiates mRNA for the high affinitiy nerve growth 
factor receptor TrkA (encoded by the NTRK1 gene in humans) in the subven-
tricular zone and hippocampus (Fiore et al., 2005).
Protein Kinase A Coronin 1 deficiency in mouse and human causes severe neurobehavioral 
defects, including increased aggression and social deficits, through modula-
tion of cAMP/Protein Kinase A Signaling (Jayachandran et al., 2014).
cAMP Coronin 1 deficiency in mouse and human causes severe neurobehavioral 
defects, including increased aggression and social deficits, through modula-
tion of cAMP/Protein Kinase A Signaling (Jayachandran et al., 2014).
AR The androgen receptor (AR) CAG repeat motif has been associated with 
aggressive and violent behavior in men (Craig & Halton, 2009; Hurd et al., 
2011).
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Supplementary Figure S1: Outcome of the association analysis of the four ODD subtypes for all SNPs 
located in the OXTR region.
A. P1 (defiant vindictive), B. P2 (irritability), C. P3 (0 representing ‘low OPP/moderate OPP’ and 1 repre-
senting ‘irritable OPP/severe OPP’) and D. P4 (0 representing ‘low OPP/moderate OPP/irritable OPP’ and 
1 representing ‘severe OPP’). SNP rs1488467 and linked SNPs are depicted in color. 
Supplementary Figure S2: Quantile quantile plot for the multivariate GWAS.
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ABSTRACT
Aggressiveness is a behavioural trait that has the potential to be harmful to individuals 
and society. With an estimated heritability of about 40%, genetics is important in its 
development. We performed an exploratory genome-wide association (GWA) analysis 
of childhood aggressiveness in attention deficit hyperactivity disorder (ADHD) to gain 
insight into the underlying biological processes associated with this trait. Our primary 
sample consisted of 1060 adult ADHD patients (aADHD). To further explore the genetic 
architecture of childhood aggressiveness, we performed enrichment analyses of suggestive 
genome-wide associations observed in aADHD among GWA signals of dimensions 
of oppositionality (defiant/vindictive and irritable dimensions) in childhood ADHD 
(cADHD). No single polymorphism reached genome-wide significance (p<5.00E-08). 
The strongest signal in aADHD was observed at rs10826548, within a long noncoding 
RNA gene (beta = -1.66, standard error (SE) = 0.34, p = 1.07E-06), closely followed by 
rs35974940 in the neurotrimin gene (beta = 3.23, SE = 0.67, p = 1.26E-06). The top GWA 
SNPs observed in aADHD showed significant enrichment of signals from both the defiant/
vindictive dimension (Fisher’s p-value = 2.28E-06) and the irritable dimension in cADHD 
(Fisher’s p-value = 0.0061). In sum, our results identify a number of biologically interesting 
markers possibly underlying childhood aggressiveness and provide targets for further 
genetic exploration of aggressiveness across psychiatric disorders. 
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INTRODUCTION
Aggressiveness can be defined as any behavior directed towards an individual with the 
immediate intent to cause harm (Anderson and Bushman, 2002). Violence, which is 
strongly related to aggressiveness, is the sixth leading cause of burden of disease for people 
aged 15–44 years worldwide (WHO, 2008). To date, most interventions designed to reduce 
violence risk typically have small effects, reflecting our limited understanding of its causes 
and stressing the need for further studies (McGuire, 2008; Moffitt, 2005a). 
As a complex phenomenon, aggressiveness spans across numerous facets of human behavior, 
ranging from emotional lability and temperamental traits (e.g. hot-tempered, short fuse, 
irritable) to physical violence (Lesch et al., 2012). These traits are frequently found among 
youth with attention deficit hyperactivity disorder (ADHD), a common child and adolescent 
psychiatric disorder with a prevalence of about 5% and a rate of persistence into adulthood 
of about 50% (Faraone et al., 2015). ADHD is defined by symptoms of inattention and 
hyperactivity/impulsivity, and youth with ADHD often have co-existing disorders, some of 
which are closely related to aggressiveness and violence, such as conduct disorder (CD) and/
or oppositional defiant disorder (ODD) and disorders characterized by symptoms defined 
within the broader term of antisocial behavior (Dalsgaard et al., 2002). These disorders put 
youth with ADHD at high risk of problems associated with aggressiveness in adulthood 
(Klassen et al., 2010), especially when the aggressive behavior has an early onset (Hofvander 
et al., 2009). This can be illustrated by the fact that around 30% of youth and 25% of adult 
prison inmates are found to qualify for an ADHD diagnosis (Young et al., 2014). Studies 
of childhood aggressiveness in adults can, therefore, be of great importance to improve our 
understanding of adult ADHD. 
The etiology of ADHD as well as traits of aggressiveness is complex, with genetics playing 
an important role. The heritability of ADHD has been estimated to be up to 88% across 
the lifespan (Larsson et al., 2013), while the estimates of genetic influence on aggression 
vary across studies, collectively reaching about 40-50% (Brendgen et al., 2006; Tuvblad 
and Baker, 2011). Such diversity in the estimation of aggression heritability may result from 
inconsistency in measures across studies. Several different aggression measures have been 
utilised to assess the genetic and environmental influences on its development (Veroude 
et al., 2015), reflecting that there is no consensus regarding its definition (Ramirez and 
Andreu, 2006). Furthermore, the estimates of aggressiveness are influenced by the age of 
the study participants. The literature reports stability of aggressiveness between childhood 
and adulthood, with adolescence as a transient period with little stability in this trait 
(Moffitt, 2005b). Genes seem to explain little variation in adolescent aggression, but are 
likely to account for individual differences in childhood and adult aggression (Lyons et al., 
1995). Also, given higher levels of aggression in males and higher genetic load in males with 
antisocial behaviour compared to females, it is an open question whether genetic propensity 
is of greater importance in one sex over the other (Miles and Carey, 1997; Tuvblad and 
Baker, 2011). Interestingly, similar considerations of age and sex effects are also present in 
studies of ADHD as well as when ADHD is co-morbid with aggressive behavior (Faraone 
et al., 2015; Faraone et al., 1991). 
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Given that ADHD and aggression often co-occur and that both traits are heritable, twin 
studies have noted the possibility of shared genetic etiology between ADHD and aggression. 
A common genetic factor has been reported among ADHD and symptoms of aggression in 
9-10 year old children (Tuvblad et al., 2009). Likewise, it has been suggested that impulsivity 
and aggression are genetically mediated to a similar extent (Seroczynski et al., 1999).
Influenced by major theories on neuronal circuits, genetic association studies of ADHD 
and/or aggression have been dominated by candidate gene studies, focusing on the 
regulation of monoaminergic transmission (Faraone et al., 2015; Veroude et al., 2015). In 
line with twin studies, these candidate gene analyses have provided further support towards 
a shared genetic component between ADHD and aggression. Many genes associated with 
ADHD point towards the same biological mechanisms as those associated with aggressive 
behavior, including genes that are involved in the synthesis, binding, transport and 
degradation of neurotransmitters, especially dopamine and serotonin (Faraone et al., 2015; 
Veroude et al., 2015). It has been reported, for example, that the genes MAOA, DRD2, 
DRD4, COMT, SLC6A4, TPH1 and TPH2 may contribute to the development of ADHD 
as well as aggressive behaviors (Gizer et al., 2009; Vassos et al., 2014). However, these 
candidate gene studies suffer from the lack of replication in independent samples (where 
available) and small effect sizes suggest that some of these genes play a more limited role in 
the susceptibility to ADHD and/or aggressive behavior, or that their involvement may be 
limited to rare familial cases (Halmoy et al., 2010; McKinney et al., 2008; Tiihonen et al., 
2014). Thus, the overall genetic architecture of ADHD and/or aggression remains largely 
unknown and warrants studies using a hypothesis-free approach (Vassos et al., 2014). 
Genome-wide association (GWA) studies allow interrogation of the entire genome to 
generate new hypotheses. To date, few GWA studies have been performed for ADHD 
and/or aggressiveness, with no finding passing the stringent Bonferroni-corrected genome-
wide significance level (p<5.00E-08) for either phenotype (Dick et al., 2011; Mick et 
al., 2014; Salvatore et al., 2015; Tielbeek et al., 2012). Nonetheless, as these studies were 
generally underpowered, some understanding of biological processes behind ADHD and/
or aggressiveness may emerge from the convergence of identified nominally significant 
loci. Previous GWA studies on aggressive behaviors in ADHD have noted a number of 
suggestive association signals, generating biological hypotheses regarding the etiology of 
ADHD and/or aggression (Aebi et al., 2015; Anney et al., 2008). In addition, a recent GWA 
study revealed a positive linear correlation between ADHD polygenic scores and comorbid 
aggression scores, indicating that the presence of aggressive symptoms in ADHD is likely 
to index a greater genetic load (Hamshere et al., 2013). Similarly hypothesis-free, genome-
wide linkage analyses have also reported evidence of significant co-segregation between 
ADHD and disruptive behavior (Jain et al., 2007).
The lack of robust genetic association signals may be explained by the modest sample 
sizes and the complex nature of both ADHD and aggressiveness, where genetic factors 
are intertwined with environmental influences (Brendgen et al., 2006). In addition, 
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heterogeneity in genetic susceptibility, phenotypic manifestation and operationalization of 
aggressiveness may depress association signals (Cross-Disorder Group of the Psychiatric 
Genomics et al., 2013). The phenotypic heterogeneity in ADHD may potentially be 
exacerbated by its high rates of comorbidity with not only aggressive behaviors, but also 
mood and anxiety disorders (Biederman et al., 1992). Another possible reason behind the 
lack of replicable genetic findings is the limited annotation of the human genome. The 
annotation has mostly been focused on protein-coding genes that represent only ~1% of 
our genome, making it difficult to evaluate possible biological pathways involved in ADHD 
and/or aggressiveness, as the majority of GWA findings tend to reside outside the traditional 
protein-coding regions (Dick et al., 2011; Schizophrenia Working Group of the Psychiatric 
Genomics, 2014).
In the present study, we aimed to perform exploratory genome-wide association tests to 
shed light on the genetic susceptibility loci and biological processes possibly involved in the 
etiology of childhood aggressiveness in ADHD. We utilized the GWA method to analyze 
childhood aggressiveness in adults with ADHD gathered in studies across Europe. To 
minimize phenotypic heterogeneity between samples, we derived our measure of childhood 
aggressiveness in adult ADHD (aADHD) from the Wender Utah Rating Scale (WURS). 
This questionnaire was used as part of the assessment procedure at all sites. As the WURS 
reflects childhood recollections, we also explored a possible genetic overlap of association 
signals observed in aADHD with those of irritable and defiant/vindictive dimensions 
of ODD in youth with ADHD (cADHD) (Aebi et al., 2015). Finally, we performed an 
examination of non-protein coding genes in order to obtain a better understanding of the 
biological processes underlying childhood aggressiveness in aADHD. 
METHODS AND MATERIALS 
Subjects 
aADHD samples
Recruitment of adult ADHD patients was conducted at three sites within an international 
multi-center persistent ADHD collaboration (IMpACT, http://www.impactadhdgenomics.
com): Germany, Norway and Spain. All individuals were of Caucasian ancestry. Only 
participants who gave written informed consent were enrolled in the studies, which 
complied with the Declaration of Helsinki.
German sample: Patients with a diagnosis of aADHD were recruited by experienced 
psychiatrists at the University of Würzburg (Würzburg, Germany). Unrelated in– and 
outpatients of self-reported central-European descent completed a semi-structured clinical 
interview according to DSM-IV. Inclusion criteria were onset before the age of 7 years, 
life-long persistence, current diagnosis and age of recruitment between 18 and 65 years. 
Exclusion criteria were the appearance of symptoms restricted to the duration of any other 
Axis I disorder; current diagnosis of active alcohol or other drug abuse or dependence; 
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lifetime diagnosis of bipolar I disorder, schizophrenia, or any other psychotic disorder; 
and an IQ score below 80. For a more detailed sample description, please confer previous 
publications (Franke et al., 2010; Reif et al., 2009). The study was approved by the Ethic 
Committee of the University of Würzburg (Würzburg, Germany).
Norwegian sample: Participants were recruited at the University of Bergen (UiB, Bergen, 
Norway) as described elsewhere (Halmoy et al., 2009). In short, adult patients with ADHD 
were recruited through a Norwegian national medical registry as well as by psychologists 
and psychiatrists working at outpatient clinics. All patients had been previously diagnosed 
with ADHD using either DSM-IV or ICD-10. The ICD-10 criteria were adapted to the 
DSM-IV criteria by allowing the inattentive subtype as sufficient for the ADHD diagnosis, 
and by accepting the coexistence of other neuropsychiatric disorders as long as they appeared 
after the criteria of ADHD were fulfilled. Individuals with IQ below 70 were excluded from 
the study. All participants provided either blood or saliva samples for DNA extraction. 
The study was approved by the regional committee for medical and health research ethics, 
western Norway.
Spanish sample: Participants were recruited at the Department of Psychiatry from the 
Hospital Universitari Vall d’Hebron (HUVH, Barcelona, Spain) as described elsewhere 
(Sanchez-Mora et al., 2015).  Patients were adults of Caucasian origin and met Diagnostic 
and Statistical Manual for Mental Disorders-IV (DSM-IV) criteria for ADHD. The 
diagnosis of ADHD was evaluated with the Structured Clinical Interview for DSM-IV 
Axis I and II Disorders (SCID-I and SCID-II) and the Conner’s Adult ADHD Diagnostic 
Interview for DSM-IV (CAADID Parts I and II). Consensus eligibility criteria for the 
current study were a diagnosis of ADHD according to the diagnostic criteria of DSM-IV, 
onset before the age of 7 years via retrospective diagnosis (which was confirmed by a family 
member, wherever possible), lifelong persistence and current diagnosis. DNA was extracted 
from either peripheral blood or saliva samples. The study was approved by the ethics 
committee of the institution.
cADHD sample
Youth with ADHD were participants in the International Multicentre ADHD Genetics 
(IMAGE) study, recruited in 12 child and adolescent psychiatry clinics representing eight 
countries across Europe. Approval was obtained by the Institutional Review Board of 
SUNY Upstate Medical University and from ethical review boards within each country. 
A detailed description of the study design and assessment procedures has been provided in 
previous publications (Muller et al., 2011a, b). In short, entry criteria for probands were a 
clinical diagnosis of ADHD according to DSM-IV-based structured interviews and access 
to one or both biological parents and one or more full siblings for DNA collection and 
clinical assessment. Exclusion criteria included autism, epilepsy, IQ < 70, brain disorders, 
and any genetic or medical disorder associated with externalizing behaviors that might 
mimic ADHD.
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Measures of aggressiveness
aADHD samples
The adult measure of childhood aggressiveness in the aADHD samples was derived from 
the Wender Utah Rating Scale (WURS) (Ward et al., 1993). The WURS is a questionnaire 
used for retrospective assessment of childhood symptoms of ADHD in adults. An 
exploratory factor analysis (EFA) was run to determine the latent structure of the WURS. 
The EFA consisted of a principal component analysis with Varimax rotation and yielded 
three factors with Eigen values above one. From the main factor explaining the greatest 
amount of variance in responses to the WURS (30.7%), the top six items with the highest 
loadings (0.74-0.82) all represented prototypical elements of aggressiveness: “temper 
outburst/tantrums”, “angry”, “hot- or short-tempered/low boiling point”, “disobedient 
with parents/rebellious/sassy”, “losing control of myself” and “irritable”. For each item, 
the participant was asked to evaluate if she/he as a child was (or had) a specific symptom 
and to rate it according to the following four response categories: “not at all/very slightly” 
(0),  “mildly” (1), “moderately” (2), quite a bit” (3) or “very much” (4). The arithmetic 
sum of the responses of the aforementioned items was adopted as a continuous measure of 
aggressiveness, ranging from 0 to 24. Supplementary Figure 1 shows the distribution of this 
measure across genders in the three aADHD datasets. 
cADHD sample
The dimensions of oppositionality were assessed using the long form of the revised Conners 
Parent Rating Scale (CPRS-R:L) (Conners et al., 1998). The defiant/vindictive and irritable 
dimensions of ODD were defined on theoretical grounds as described elsewhere (Aebi et 
al., 2015), and reflect two previously described dimensions of ODD (Aebi et al., 2013; 
Stringaris et al., 2012).
Genotype data
Genotyping of each sample was performed by each of the four participating groups, 
individually. To maximize available genetic information among examined datasets, genetic 
imputation was carried out independently at each site. 
 aADHD samples
German sample: Genotyping of participants was performed on Illumina’s PsychChip array 
(Illumina, San Diego, CA, USA) at the Broad Institute (Cambridge, MA, USA) using the 
PsychChip 15048346 B manifest. Genotypes were assigned in Illumina’s GenomeStudio 
v2010.3, using the calling algorithm/genotyping module version 1.8.4. Quality control 
procedures were performed as described previously, with lightly modified exclusion criteria 
(SNPs exhibiting missingness above 98%; minor allele frequency below 5%; failing 
Hardy-Weinberg equilibrium test (p<10-4)) (Zayats et al., 2015). Genotype imputation 
was performed with SHAPEIT/IMPUTE2 pipeline as described elsewhere, using 1000 
Genomes Phase 3 data as a reference (Cross-Disorder Group of the Psychiatric Genomics, 
2013; Howie et al., 2009; Marchini et al., 2007).
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Norwegian sample: Participants were genotyped on Human OmniExpress-12v1-1_B 
(Illumina, San Diego, CA, USA) platform at the deCODE Genetics facility (Reykjavik, 
Iceland). Genotyping and quality control procedures are described elsewhere (Zayats et 
al., 2015). Imputation was performed utilizing IMPUTE software as previously detailed 
(Cross-Disorder Group of the Psychiatric Genomics, 2013; Howie et al., 2009; Marchini 
et al., 2007).
Spanish sample: Genome-wide genotyping was performed with the Illumina HumanOmni1-
Quad BeadChip platform. Quality control was implemented at the individual and SNP 
level using PLINK and included filtering subjects with low call rate (<98%) or gender 
discrepancy followed by filtering SNPs with minor allele frequency (MAF) < 0.01, Hardy–
Weinberg equilibrium test P-values <1e-06 or call rate < 0.99 in either cases or controls. 
Imputation was performed using BEAGLE software (Browning and Browning, 2007).
cADHD sample
Sample collection and DNA isolation has been described previously (Brookes et al., 2006). 
Genome-wide genotyping and quality control was performed as part of the GAIN study using 
the Perlegen 600K genotyping platform, as previously described (Neale et al., 2008). The 
imputation was performed using MACH and the Hapmap 2 (Release 22 Build 36) reference 
data set (Li et al., 2010). Quality control was performed on the imputed data, and SNPs with 
imputation quality scores lower than 0.30, a minor allele frequency lower than 0.01, and those 
failing the Hardy-Weinberg equilibrium test at a threshold of p≤10–5 were excluded. SNPs and 
subjects with missingness rates higher than 0.05 were removed from the data.
Statistical analyses
The age and gender distributions between the aADHD and cADHD samples were assessed 
using chi-square for gender and ANOVA for age.
Genome-wide association (GWA) of aggressiveness 
In the aADHD sample, single nucleotide polymorphisms (SNPs) were tested for association 
with the WURS-derived measure of aggressiveness in the form of linear regression carried 
out in PLINK using post-imputation dosage data (Purcell et al., 2007). Regression models 
were adjusted for age and sex. Genotype data of each site were first processed individually. 
The results were then combined with the use of fixed-effects inverse variance meta-analysis 
in METAL (Willer et al., 2010). Only SNPs with minor allele frequency (MAF) equal to 
or above 1% and imputation INFO measure equal to or above 0.6 were included in the 
analyses. Genomic control, QQ plotting and regional plotting of top loci was applied to 
check the integrity of test statistics (Cuellar-Partida et al., 2015; Devlin and Roeder, 1999). 
The genomic inflation factor was calculated using METAL (Willer et al., 2010). A genome-
wide significance threshold of 5.00E-08 was adopted to correct for multiple testing. 
GWA analyses of irritable and defiant/vindictive dimensions of ODD in cADHD sample 
was performed in PLINK software in the form of linear regression adjusted for sex and age 
(Purcell et al., 2007). Details of the analyses are described elsewhere (Aebi et al., 2015).
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Gene-based and Gene-Set association of aggressiveness in the aADHD meta-analysed sample
Gene-based and gene-set pathway analysis were performed in the aADHD sample carried 
out in MAGMA software (de Leeuw et al., 2015). First, a degree of association was calculated 
for each gene based on METAL-derived individual SNPs’ p-values, using 1000 Genomes 
CEU dataset as a reference panel to correct for linkage disequilibrium (LD) (Genomes 
Project et al., 2012). To evaluate each gene’s contribution to examined gene-sets (gene-
set pathway analysis), the p-value of each gene was converted to a Z-value and used as an 
outcome variable in a regression model with gene-set membership as a predictor. Gene size 
and gene-sets’ gene density were added as covariates to adjust for possible confounding 
effects and prevent spurious association. 
For gene-based tests, we assessed the association with both protein and non-protein-
coding genes. The protein-coding gene list was curated from the catalog of known genes 
downloaded from the Genome Browser of the University of California Santa Cruz (UCSC, 
California, USA). The non-protein-coding genes were examined in the form of long non-
coding RNA (lncRNA) genes detailed in the aforementioned catalog. For gene-set pathway 
analysis, we examined structural categories of gene ontology (GO, http://geneontology.org), 
with respect to cellular function, biological process and cellular compartments. To achieve 
meaningful statistics and interpretation of the results, we restricted our pathway analysis 
to those GO terms that contained SNPs in at least 10 genes per term in our aADHD data.
Genome-wide enrichment analyses between GWA results in aADHD and cADHD samples
Prior to performing enrichment analyses, the genetic data in both aADHD and cADHD 
samples were pruned to remove correlated loci in linkage disequilibrium (LD) with each 
other. A pairwise correlation coefficient (r2) threshold of 0.2 and the 1000 Genomes CEU 
reference dataset were used to identify independent SNPs, as previously described (Genomes 
Project et al., 2012; Lindgren et al., 2009). 
Enrichment was examined by means of Fisher’s test performed in R software, assessing 
the difference in proportion of SNPs revealing association p-values below 0.05 in cADHD 
sample according to suggestive association in aADHD sample (p-value below or equal 
to 1.00E-03 versus p-value above 1.00E-03) (Rahmioglu et al., 2015). Consistency in 
directionality of SNP effects with indication of enrichment between aADHD and cADHD 
samples was tested as linear regression on the effect (beta) of each SNP for aADHD as 
an outcome and for cADHD (either irritable or defiant/vindictive dimensions of ODD, 
respectively) as predictor variables (Do et al., 2013). 
Examination of previously reported aggressiveness-related candidate GWA loci 
We assembled a list of previously reported candidate GWA loci associated with aggressive 
behavior by systematic literature search the catalog of published genome-wide association 
studies provided by National Human Genome Research Institute (NHGRI) (https://www.
genome.gov/26525384), using key words of “aggression”, “anger”, “violence” as well as 
“conduct disorder” and “antisocial personality disorder”.  Each identified candidate GWA 
locus was then looked up in meta-analysed aADHD sample.
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RESULTS
Subjects, measure of aggressiveness and GWA analyses
In total, 1060 adult patients as well as 750 children and adolescents with ADHD were 
available for the analyses. The age ranges in the aADHD samples were 17 – 75 in the 
German sample, 18 – 57 in the Norwegian sample and 17 – 60 in the Spanish sample. In 
the cADHD sample, the age range was 5 – 17. Details of the final samples are summarized 
in Table 1. Supplementary Figure 1 presents the distribution of the selected measures of 
aggressiveness in each aADHD dataset.
After quality control of imputed SNPs in the adult samples, 9.301.568 SNPs were available 
for the analyses in the German sample, 8.910.491 SNPs in the Norwegian sample and 
6.683.176 SNPs in the Spanish sample. Among these three datasets, 7.576.458 autosomal 
SNPs were present in at least two and, thus, were meta-analyzed to assess genetic architecture 
of childhood aggressiveness in aADHD. In cADHD sample, 1.871.025 autosomal SNPs 
were available for the analyses.
Individual GWA analyses revealed no genome-wide significant hits (p ≤ 5.00E-08) in 
either aADHD sample (not shown) nor in the cADHD sample (Supplementary Table 1; 
Supplementary Figure 2). None of the variants in the meta-analysis reached the Bonferroni-
corrected genome-wide significance level (p ≤ 5.00E-08) either. The strongest signal 
was observed at rs10826548 on chromosome 10 located within the transcript of a long 
noncoding RNA (lncRNA) (beta = -1.66, standard error (SE) = 0.34, p-value = 1.07E-06) 
(Figure 1), closely followed by rs35974940 in the neurotrimin (NTM) gene (beta = 3.23, 
SE = 0.67, p-value = 1.26E-06) (Figure 2). Top associated markers (p ≤ 1.00E-05) are 
summarized in Supplementary Table 2. The genomic inflation factor was close to one for all 
individual and meta-GWA analyses in aADHD. QQ plots of GWA analyses in aADHD 
are presented in Supplementary Figure 3. 
Table 1: Details of the ADHD patient samples.
aADHD samples
IMpACT site
Number of  
participants Females (%) Age (mean ± SD)
Aggressiveness score 
(mean ± SD)
Germany 368 53 35.18 ± 10.53 11.33 ± 5.17
Norway 293 52.6 32.61 ± 11.00 12.10 ± 6.39
Spain 399 32.3 31.31 ± 12.39 10.19 ± 6.15
Total 1,060 45.1 33.01 ± 11.51 11.11 ± 5.94
cADHD sample
      ODD scores (mean ± SD)
Number of 
participants Females a (%) Age b (mean ± SD) Irritable Defiant/vindictive
IMAGE 750 12.3 10.67 ± 2.77 7.75 ± 3.06 8.95 ± 4.18
Aggressiveness score was derived from WURS in the aADHD sample. In the cADHD sample, dimensions of 
oppositionality (irritable and defiant/vindictive dimensions) were examined (Aebi et al., 2015). SD, standard 
deviation.
aDifference in the proportion of females between the aADHD and cADHD samples: P < 2.2E‐16 (χ2 test).
bDifference in age between the aADHD and cADHD samples: P < 2.2E‐16 (ANOVA).
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Figure 1: Plot of the locus surrounding rs10826548. 
SNPs are plotted by position on chromosome 10 against GWA p-values for aggressive behaviour measure in 
aADHD. Estimated recombination rates from HapMap are plotted in bright red to reflect local LD structure. 
The SNPs surrounding rs10826548 are color-coded to reflect their LD with it (according to pair-wise r2 val-
ues from the HapMap CEU database). SNPs with LD r2≥0.2 are plotted at the bottom of the graph with LD 
color-coding specified in the top right corner. “Genes” refers to protein-coding genes in the presented region. 
“lincRNAsAllCellTypeTopView” reflects the data from lncRNA USCS track in brain tissue. “tfbsConsSites” 
reflects the TFBS UCSC track.
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Gene-based and Gene-Set association of aggressiveness in the aADHD meta-analyz-
ed sample
Among annotated protein-coding genes, 17.595 had more than one SNP present in the 
aADHD data. The strongest signal was noted for the WD repeat domain 62 (WDR62) 
gene (p-value = 4.84E-05). Supplementary Table 3 summarizes the top protein-coding 
genes (p≤1.00E-03) observed in aADHD sample. None of the protein-coding gene-based 
tests survived the correction for multiple testing.
Figure 2: Plot of the locus surrounding rs35974940.  
SNPs are plotted by position on chromosome 11 against GWA p-values for aggressive behaviour measure in 
aADHD. Estimated recombination rates from HapMap are plotted in bright red to reflect local LD structure. 
The SNPs surrounding rs35974940 are color-coded to reflect their LD with it (according to pair-wise r2 val-
ues from the HapMap CEU database). SNPs with LD r2≥0.2 are plotted at the bottom of the graph with LD 
color-coding specified in the top right corner. “Genes” refers to protein-coding genes in the presented region. 
“lincRNAsAllCellTypeTopView” reflects the data from lncRNA USCS track in brain tissue. “tfbsConsSites” 
reflects the TFBS UCSC track.
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Among lncRNA genes, 22.696 had more than one SNP present in our aADHD data. The 
strongest association was observed for ENST00000427806 (p-value = 3.04E-05). The top 
lncRNA genes (p≤1.00E-03) detected in this study are reported in Supplementary Table 
4. None of the non-protein-coding gene-based tests survived the correction for multiple 
testing.
Among GO pathways, 1.945 terms contained SNPs in at least 10 genes per term in the 
aADHD data. The most prominent association was observed for negative regulation of 
I-kappaB kinase/NF-kappaB signaling pathway (GO:0043124 term, p-value = 7.26E-04). 
Supplementary Table 5 reports top GO terms (p≤0.01) recognized in this study. None of 
the GO pathways survived the correction for multiple testing.
Genome-wide enrichment analyses between GWA results in aADHD and cADHD 
samples
To assess potential genome-wide overlap of association signals between measures of 
childhood aggressiveness in aADHD and cADHD, we investigated the independent (r2 
< 0.2) GWA signals of suggestive significance (p≤1.00E-03) in aADHD for enrichment 
in GWA signals of either defiant/vindictive or irritable dimensions in cADHD. Given our 
modest sample size, only those SNPs were considered in cADHD results that revealed a 
p-value below or equal to 0.05 to avoid the examination of effects with a wide confidence 
interval. The top GWA SNPs of WURS-derived childhood aggressiveness in aADHD 
showed significant enrichment of signals from both the defiant/vindictive dimension 
(Fisher’s p-value = 2.28E-06) and the irritable dimension in cADHD GWA analysis 
(Fisher’s p-value = 0.0061) (Figure 3A).
Next, we examined the directionality of effects of variants with association signals in 
both aADHD and cADHD samples (p≤1.00E-03 in aADHD and p<0.05 in cADHD). 
Significant correlation between betas was observed in assessment of both oppositional 
dimensions in cADHD and childhood aggressiveness in aADHD (p=0.0053 and p=0.0045 
for defiant/vindictive and irritable dimensions respectively), but the direction of the 
relationship was negative (Figure 3B and 3C). Supplementary Table 7 summarizes the top 
hits (p≤1-00E-05) observed in GWA meta-analysis of childhood aggressiveness in aADHD 
and their corresponding statistics observed in cADHD.
Examination of previously reported aggressiveness-related candidate genes and 
GWA loci 
Among previously reported aggressiveness-related GWA loci, several SNPs noted to be 
associated with anger, conduct disorder and adult anti-social personality disorder revealed 
p-values below 0.05 in our study (Supplementary Table 8). The strongest signal in the 
GWA analysis of childhood aggressiveness in aADHD among the aforementioned loci was 
observed for rs4889240 in the PKD1L2 (polycystic kidney disease 1-like 2) gene (beta = 
-0.73, SE =0.25, p-value = 0.0039), previously reported to be associated with CD symptom 
count in ADHD patients. The same SNP also revealed nominally significant association in 
the same direction with the defiant/vindictive dimension (beta = -0.54, SE = 0.21, p-value 
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= 0.0094), but not with the irritable dimension in cADHD. In this result, one should keep 
in mind that the cADHD described here is a subsample of the sample in which the original 
finding for rs4889240 was described (Aebi et al., 2015). Full results of our literature search 
are presented in Supplementary Table 8.
DISCUSSION
In this study, we performed a genome-wide exploration of childhood aggressiveness 
as reported retrospectively by adult patients with ADHD (aADHD), examining both 
conventional protein-coding and lncRNA genes. We also explored the overlap with parent-
Figure 3: Enrichment and direction of effect among GWA signals of oppositional dimensions in cADHD 
and WURS-derived childhood aggressiveness in aADHD. 
Panel A reflects the proportion of SNPs nominally associated (p<0.05) with each examined oppositional 
dimension in cADHD (defiant/vindictive and irritable) among suggestive signals (p≤1.00E-03) of association 
with childhood aggressiveness in aADHD. Reported p-values are those of Fisher’s exact test.  
Panels B and C reflect directions of effect of 24 independent nominally significant loci in GWA analyses 
of defiant/vindictive dimension in cADHD and childhood aggressiveness in aADHD (panel B) as well as 
17 independent nominally significant loci in GWA analyses of irritable dimension in cADHD and childhood 
aggressiveness in aADHD (Panel C). Linear regression r2 measures and p-values are shown.
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reported oppositional behavior in youth with ADHD (cADHD) and evaluated previously 
reported aggression-related GWA loci. Given our modest sample size (1060 aADHD 
patients) and the anticipated small effect of common polymorphisms in complex traits, it 
is not surprising that we did not observe any genome-wide significant SNPs (p<5.00E-08). 
Nonetheless, we were able to identify several nominally significant variants (p≤1.00E-05) 
in biologically interesting genes for follow-up studies of aggressiveness in ADHD, a feature 
of the disorder that has received little attention so far.
The strongest signal in the performed single-point GWA tests of childhood aggressiveness 
in aADHD was noted for rs10826548 (beta=-1.16, SE=0.34, p=1.07E-06, Supplementary 
Table 1). This variant resides in the transcript of a lncRNA with uncertain coding potential 
(TCONS_00018147) (Figure 1). Non-protein coding RNAs play a critical role in the 
regulation of gene expression and have been previously associated with neuropsychiatric 
disorders, including ADHD (Gonzalez-Giraldo et al., 2015; Perkins et al., 2005; Zayats et 
al., 2015). In addition, it has recently been observed that SNPs previously associated with 
neurological and psychiatric conditions may be highly concentrated in the regions of long 
non-protein coding RNA genes (Ning et al., 2014). 
The second most significant locus identified in this study is located within the neurotrimin 
(NTM) gene (intronic rs35974940, p=1.26E-06, Supplementary Table 1, Figure 2). NTM is 
a protein-coding gene, encoding a member of glycosylphosphatidylinositol (GPI)-anchored 
cell adhesion molecules, containing immunoglobulin (Ig) domain. These proteins are 
predominantly expressed in the central nervous system (CNS) (Struyk et al., 1995). 
Among the association signals observed in NTM gene, several have the potential to alter 
its expression. As determined in the TRANSFAC database implemented in the SNPinfo 
server of the National Institute of Environmental Health Sciences (http://snpinfo.niehs.nih.
gov), rs34588147 and rs35665773 (GWA p-values of 3.59E-06 and 3.25E-06 respectively, 
Supplementary Table 1) are transcription factor binding sites (TFBS) (Figure 2). Moreover, 
two other SNPs in high linkage disequilibrium with the aforementioned ones (rs12804059 
and rs7119590, r2=1 in CEU population) also represent TFBS. Notably, differential 
expression of NTM between two major brain regions linked to aggression subtypes – 
prefrontal cortex and amygdala – was observed in early prenatal stage of human brain 
development (p=0.015, http://www.brainspan.org). 
Gene expression regulation during neuronal development as one of the possible 
mechanisms behind aggressiveness in aADHD was further affirmed by our top associated 
lncRNA gene - ENST00000427806 (p=3.04E-05, Supplementary Table 4). The target 
gene of this lncRNA has been predicted to be the protein-coding ST6 (alpha-N-acetyl-
neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 
(ST6GALNAC5) gene (Vucicevic et al., 2015). The protein encoded by ST6GALNAC5 is a 
member of sialyltransferases, with reported function in cell adhesion through cell-cell and 
cell-extracellular matrix interactions (Tsuchida et al., 2003). Intriguingly, ST6GALNAC5, 
similarly to NTM, also revealed differential expression in the aggression-related structures 
of prefrontal cortex and amygdala in early prenatal stages of human brain development 
(p=0.013, http://www.brainspan.org). 
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As the adult measure of aggressiveness was derived from self-reported experiences in 
childhood, we examined the possibility of overlap of its GWA signals with those from 
GWA analyses of two oppositional dimensions in a cADHD sample. We observed a slight 
enrichment of association signals between the nominally associated loci in aADHD and 
those observed in the GWA of both the defiant/vindictive and the irritable ODD dimensions 
examined in cADHD (Figure 3). However, it is noteworthy that the aADHD and cADHD 
samples were imputed using different reference panels with disparate genomic coverage. 
Surprisingly, the correlation between the direction of effects of the aforementioned SNPs 
was negative (Figure 3B and 3C). Such an inverse relationship in effect directionality 
between parent-reported ODD dimensions and adult retrospective report of childhood 
aggressiveness is most likely a chance finding due to our study being under-powered or it 
might also be related to phenotypic and genetic heterogeneity of the examined samples. 
There were considerable differences in the percentage of females between the aADHD and 
the cADHD samples (Table 1), which could indicate such mechanisms. It has been shown 
that both age and sex are important factors in genetic influences in ADHD and aggression 
(Faraone et al., 2015; Lyons et al., 1995; Miles and Carey, 1997; Tuvblad and Baker, 2011). 
In addition, the aggressiveness in cADHD sample was determined by parent-report, while 
in the aADHD sample it was based on retrospective self-report. The correlation between 
parent-report and self-report has been shown to be generally poor (Achenbach et al., 1987), 
as also discussed in a recent study that found little overlap between samples of cADHD and 
aADHD (Moffitt et al., 2015). Therefore, the measures of aggressiveness in aADHD and 
cADHD samples are different. Furthermore, the youth and adult ADHD samples may also 
be heterogeneous because childhood ADHD does not always persist into adulthood (Faraone 
et al., 2006; Moffitt et al., 2015). Thus, to gain better understanding of the genetic overlap 
between childhood aggression in aADHD and oppositional dimensions in cADHD, this 
relationship should be examined in larger sample using more rigorous statistical methods, 
such as those developed to test specifically for genetic correlation among various traits 
(Bulik-Sullivan et al., 2015a; Bulik-Sullivan et al., 2015b; Yang et al., 2011). This was not 
possible to implement in the current study due to our modest sample size.
Examination of previously reported aggressiveness-related GWA loci revealed modest 
commonality in genetic architecture between the childhood measures of aggressiveness 
in both cADHD and aADHD, as well as in CD and anti-social personality disorder 
(Supplementary Table 8). This observation may be in line with formerly reported phenotypic 
overlap between these conditions, although to which extent this overlap can be transmitted 
to various subtypes of aggressiveness remains to be determined (Storebo and Simonsen, 
2013). 
This study should be viewed in light of its limitations. One explanation for not observing 
any genome-wide significant loci (p<5.00E-08) could be our relatively modest sample 
size and examination of common variants only (MAF>1%). This study had 63% power 
to detect common variants with small effect size of explaining 0.5% of variability under 
an additive model and an alpha level of 0.05 (http://genome.sph.umich.edu/wiki/Power_
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Calculations: Quantitative_Traits). This may also be observed in the distribution of the QQ 
plots (Supplementary Figure 3). 
Another explanation for the lack of significant findings may lay in phenotypic variability. 
Clinical heterogeneity may weaken true association signals due to the use of different 
assessment protocols or real genetic heterogeneity among subtypes of ADHD (McClellan 
and King, 2010). There are several methodological caveats to assessing aggressiveness 
(Moffitt et al., 2015). As our samples consist of outpatients, we investigate a broader and 
perhaps “softer” aspect of aggressiveness than say, for example, if we were to study prison 
inmates and/or juvenile offenders. However, this approach provides us with access to the 
vast majority of aggressive behaviors, which may not come to be written in official records 
(Moffitt, 2005). Further, we lack assessment of different subtypes of aggressive behaviour 
that may be related to different genotypes.
Considering the different direction of effects and different measures of aggression in the 
cADHD and the aADHD samples, analysing the adult samples and the youth sample 
together could potentially have obscured the genetic association signal. This is why we 
refrained from performing meta-analysis across all samples. Nonetheless, the WURS 
includes a host of symptoms related to various elements of aggressiveness, which, based 
on our factor analysis as well as previous research (Ward et al., 1993) seem to be of key 
importance to the phenotype of aADHD, and the ODD measures have also been validated 
in previous studies of cADHD (Aebi et al., 2013; Stringaris et al., 2012). Our approach 
may add to the discussion of the Negative Valence System in the Research Domain Criteria 
(RDoC) of the National Institute of Mental Health (NIMH) of how to conceptualize and 
operationalize aggressiveness as a dimension across different samples and disorders (Verona 
and Bresin, 2015; Veroude et al., 2015). 
We lacked information on current substance abuse in our aADHD sample. Substance 
abuse is known to be frequently comorbid with ADHD and may confound the relationship 
between ADHD and current aggressiveness. However, we utilized a retrospective measure 
of childhood aggressiveness that is likely to reflect behavior over a longer period of time 
and should, thus, be less affected by volatile environmental influences (Gulberg-Kjär and 
Johansson, 2009). 
Finally, since the genome-wide genotyping arrays consist of SNPs only, we were not able to 
assess the contribution of previously reported variable tandem repeats (e.g. those in MAOA) 
that were noted to be associated with aggressive behaviors and/or ADHD.
Taken together with evidence from previous studies, our results implicate mechanisms 
of cell adhesion as well as regulation of gene expression in the etiology of childhood 
aggressiveness in ADHD. As there is a substantial degree of overlap in aggressiveness among 
neuropsychiatric disorders, it could be beneficial to analyse conditions where aggression 
is present together in order to pinpoint biological processes in dysfunctional forms of 
aggressiveness. Further studies including samples of both children, adolescents and adults, 
adopting multimodal measures and longitudinal designs are warranted. Such studies may 
help our understanding as to which extent various subtypes of aggression are mediated by 
different mechanisms.
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Supplementary Table 1: Top hits (p≤1-00E-05) observed in GWA analyses of oppositional dimensions in 
childhood ADHD.
Defiant/Vindictive Dimension
SNP CHR Gene(nearest gene)
Effect 
Allele BETA SE P-value
rs1330598 13 intergenic C -1.172 0.2402 1.29E-06
rs4075163 9 intergenic (C9orf47) A 1.065 0.2192 1.45E-06
rs7043095 9 C9orf47 T 1.018 0.2156 2.82E-06
rs11791652 9 intergenic (C9orf47) T 1.017 0.2158 2.92E-06
rs3849811 8 intergenic (ST18) C 1.079 0.2291 2.95E-06
rs3892512 8 intergenic (ST18) G 1.079 0.2291 2.95E-06
rs1895885 8 intergenic (ST18) C 1.079 0.2291 2.95E-06
rs9463078 6 SUPT3H A 0.9733 0.2069 3.05E-06
rs10483554 14 intergenic (ATP5G2P2) G -1.482 0.3218 4.86E-06
rs9380938 6 intergenic (EDN1) G 1.036 0.2281 6.53E-06
rs137887 22 TTLL8 G 0.9683 0.2138 6.91E-06
rs9367214 6 SUPT3H G -0.9467 0.2099 7.56E-06
Irritable Dimension
SNP CHR Gene(nearest gene)
Effect 
Allele BETA SE P-value
rs10910623 1 MAP10 A -0.7022 0.1362 3.31E-07
rs12042052 1 intergenic (MAP10) G -0.7052 0.1378 3.97E-07
rs12036759 1 intergenic (MAP10) G -0.7084 0.1392 4.65E-07
rs1278352 10 ADAM12 A 0.2377 0.04806 9.40E-07
rs6892228 5 intergenic (XR_925892.1) C 0.2236 0.04699 2.34E-06
rs10075707 5 intergenic (XR_925892.1) G 0.2236 0.04699 2.34E-06
rs13184157 5 intergenic (XR_925892.1) A 0.2236 0.04699 2.34E-06
rs6869294 5 intergenic (XR_925892.1) A 0.2236 0.04699 2.34E-06
rs3787069 19 MLLT1 G -0.6959 0.1512 4.92E-06
rs6127978 20 BMP7 G -0.2907 0.06339 5.29E-06
rs9559203 13 intergenic C -0.3784 0.08397 7.66E-06
rs2447961 8 intergenic T 0.3281 0.07305 8.20E-06
Association was evaluated in the form of linear regression. “Beta” refers to effect size of each copy of the 
specified allele (“Effect allele”) on the examined oppositional dimension in childhood ADHD. “SE” refers to 
standard error. “P-value” reflects the strength of association signal. “CHR” refers to a chromosome where a SNP 
is located and “Gene” is referring to a gene within which a SNP is located, nearest gene is determined as a gene 
located within ±20Kbp around a SNP.
Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder 
99
C
ha
pt
er
 3
Supplementary Table 2: Top hits (p≤1-00E-05) observed in genome-wide association meta-analysis of 
aggressive behavior in adult ADHD.
SNP CHR
Gene
(nearest gene)
Effect 
Allele Beta SE P-value
Het 
P-value
rs10826548 10 intergenic (LOC101929236) A -1.6612 0.3405 1.07E-06 0.9073
rs35974940 11 NTM T 3.2303 0.6666 1.26E-06 0.1794
rs188370812 10 intergenic A -1.7787 0.3721 1.75E-06 0.9384
rs34807050 11 NTM T -3.176 0.6658 1.84E-06 0.2032
rs78030545 4 intergenic T -3.7706 0.7918 1.91E-06 0.6677
rs192649950 10 Intergenic A 1.7727 0.3727 1.97E-06 0.9371
rs138850252 12 intergenic (NR_110053.1) C -2.9016 0.6101 1.97E-06 0.0579
rs11058510 12 (NR_110053.1) T -2.8978 0.61 2.03E-06 0.05755
rs80113388 8 CSMD1 T -4.3626 0.9284 2.61E-06 0.3371
rs34547019 11 intergenic (NTM) T 3.1449 0.6699 2.67E-06 0.2605
rs76037120 5 intergenic (KRT18P42) C 3.2224 0.6885 2.87E-06 0.06077
rs12600304 16 TEPP T 1.6231 0.3469 2.88E-06 0.3298
rs35042821 11 intergenic (NTM) A -3.1949 0.6859 3.20E-06 0.3432
rs35665773 11 intergenic (NTM) T 3.0938 0.6647 3.25E-06 0.2473
rs34588147 11 NTM A 3.051 0.6584 3.59E-06 0.2745
rs12804059 11 NTM T 3.0437 0.6586 3.81E-06 0.2376
rs77206607 12 intergenic T -2.759 0.5994 4.17E-06 0.04155
rs3893429 3 CPNE4 A -1.5454 0.3361 4.26E-06 0.665
rs10831734 11 intergenic (MICAL2) A -1.336 0.2912 4.47E-06 0.6032
rs7899136 10 LOC101929236 A 1.5467 0.3375 4.59E-06 0.7998
rs77277634 12 intergenic (NR_110053.1) A -2.8197 0.6154 4.61E-06 0.07106
rs11022174 11 intergenic (MICAL2) A -1.3326 0.2912 4.74E-06 0.6097
rs10740790 10 LOC101929236 A -1.5482 0.3387 4.84E-06 0.9025
rs7903633 10 Intergenic (LOC101929236) T -1.5474 0.3388 4.96E-06 0.9311
rs10826546 10 intergenic A 1.5444 0.3388 5.15E-06 0.9306
rs35385808 11 NTM T 3.3222 0.7296 5.28E-06 0.202
rs931200 8 CSMD1 A -4.1975 0.9226 5.38E-06 0.3132
rs117352156 10 intergenic T -1.5494 0.3407 5.41E-06 0.9305
rs4587639 10 LOC101929236 A 1.5419 0.3391 5.43E-06 0.8723
rs10826545 10 intergenic A -1.5399 0.3389 5.51E-06 0.9282
rs11058518 12 LOC101927464 T 2.79 0.6146 5.65E-06 0.078
rs7092115 10 LOC101929236 T -1.5371 0.3387 5.69E-06 0.8871
rs10826543 10 LOC101929236 T -1.5368 0.3387 5.69E-06 0.8878
rs10508740 10 LOC101929236 A 1.5369 0.3387 5.70E-06 0.8872
rs10826542 10 LOC101929236 A -1.5365 0.3387 5.73E-06 0.8874
rs12367682 12 NR_110053.1 A 2.7087 0.5973 5.77E-06 0.04113
rs17760150 10 LOC101929236 A 1.5373 0.3392 5.83E-06 0.8758
rs12411424 10 LOC101929236 T -1.5368 0.3391 5.85E-06 0.8791
rs2887379 10 LOC101929236 T 1.5365 0.3392 5.89E-06 0.8791
rs72664414 1 intergenic C -4.4025 0.9718 5.89E-06 0.7281
rs7119590 11 NTM C 2.9673 0.655 5.89E-06 0.3228
rs72796654 10 intergenic A 3.157 0.6991 6.30E-06 0.02185
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SNP CHR
Gene
(nearest gene)
Effect 
Allele Beta SE P-value
Het 
P-value
rs117970560 12 LOC101927464 A -2.7832 0.6167 6.38E-06 0.0773
rs117169431 12 LOC101927464 A 2.7832 0.6166 6.38E-06 0.07712
rs12737863 1 H3F3A T 2.362 0.5233 6.38E-06 0.09153
rs10763677 10 LOC101929236 A -1.5319 0.3394 6.39E-06 0.896
rs2368966 10 LOC101929236 A -1.5352 0.3405 6.52E-06 0.8802
rs11058488 12 LOC105370057 T 2.7151 0.6023 6.56E-06 0.03986
rs34674354 10 intergenic A -3.1479 0.6992 6.73E-06 0.02519
rs140265971 10 intergenic A 3.1539 0.7011 6.84E-06 0.02184
rs12752329 1 Intergenic (ACBD3) C 2.3339 0.5199 7.16E-06 0.1768
rs10750165 11 LOC101929156 A 1.5241 0.34 7.38E-06 0.5623
rs117063229 10 intergenic (LOC105376469) T 3.5443 0.7913 7.49E-06 0.2038
rs10128443 10 intergenic T 2.6274 0.5874 7.72E-06 0.1408
rs72752681 1 intergenic (LOC105373223) A -3.1736 0.7098 7.78E-06 0.3127
rs9326778 5 intergenic (KRT18P42) T 3.6559 0.8177 7.80E-06 0.1268
rs7894571 10 LOC101929236 A -1.5119 0.3383 7.86E-06 0.764
rs2195588 8 intergenic A 2.7004 0.6043 7.88E-06 0.1006
rs10826544 10 LOC101929236 A -1.5224 0.3409 7.99E-06 0.9107
rs114439515 4 SPINK2 A -3.8041 0.8544 8.50E-06 0.9683
rs692916 18 PHLPP1 T 1.492 0.3351 8.50E-06 0.983
rs61947646 13 UFM1 T -3.4562 0.7785 9.02E-06 0.1763
rs11815470 10 intergenic A 3.0323 0.685 9.58E-06 0.05543
rs11005885 10 intergenic C 2.579 0.5833 9.81E-06 0.1375
rs4387281 10 intergenic A -2.5772 0.5832 9.91E-06 0.1374
“Beta” refers to the effect size of each copy of the specified allele (“Effect allele”) on the childhood aggressive-
ness in adult ADHD. “SE” refers to standard error. “P-value” reflects the strength of association signal, while 
“Het p-value” reflects the level of heterogeneity among the examined samples of IMpACT. “CHR” refers to a 
chromosome where a SNP is located and “Gene” is referring to a gene within which a SNP is located, nearest 
gene is determined as a gene located within ±20Kbp around a SNP.
Genome-wide analyses of aggressiveness in attention-deficit hyperactivity disorder 
101
C
ha
pt
er
 3
Supplementary Table 3: Summary of the top protein-coding genes (p≤1.00E-03) from genome-wide gene-
based association analysis of aggressiveness in aADHD and cADHD respectively.
WURS-derived aggressiveness in aADHD
GENE ID CHR N SNPs P-value
284403 19 130 4.84E-05
100526835 1 591 5.95E-05
10678 2 41 0.00011065
79025 20 7 0.00017479
1155 19 25 0.00017511
115825 13 209 0.00017668
8790 1 33 0.00019857
777 1 761 0.00021359
283554 14 190 0.00021715
127255 1 272 0.00022337
197370 16 94 0.00025686
3762 11 76 0.00032003
51450 9 209 0.00033461
10538 14 58 0.00041025
374739 16 36 0.00043095
167691 6 103 0.00049349
109 2 363 0.00051071
23576 1 755 0.00053187
5438 19 4 0.00054113
90417 15 32 0.00055524
4053 14 262 0.00059176
2880 6 3 0.00073707
199745 19 49 0.00079207
257202 6 28 0.00079486
238 2 2464 0.00083899
84984 3 24 0.00084005
4831 17 15 0.00085045
112609 6 141 0.00089164
3777 2 76 0.00089631
7289 12 183 0.00094173
745 11 57 0.00095995
Defiant/Vindictive Dimension in cADHD
GENE CHR NSNPS P
8464 6 481 0.00018043
374618 15 48 0.00020873
5317 1 38 0.00021958
22846 14 28 0.00028333
6638 15 324 0.00028779
55148 14 12 0.00029561
100132916 5 12 0.00030611
57325 20 35 0.00039792
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Defiant/Vindictive Dimension in cADHD
GENE CHR NSNPS P
4897 7 252 0.00051268
10725 16 3 0.00056183
79644 4 13 0.00063294
55329 15 21 0.00066138
131450 3 37 0.0006674
170482 12 8 0.00070134
54490 4 7 0.00071266
81558 17 28 0.0007647
51643 12 20 0.00083041
860 6 122 0.00085638
83439 2 88 0.00088179
25871 3 4 0.0009544
145497 14 34 0.00097612
245930 20 5 0.00098481
79603 19 5 0.00099264
Irritable Dimension in cADHD
GENE CHR NSNPS P
1004 5 103 1.38E-05
63976 1 169 2.04E-05
3617 6 121 2.79E-05
8038 10 490 8.42E-05
11076 5 29 0.00013628
5317 1 38 0.00015208
83416 1 19 0.00018883
135228 6 54 0.0002044
143425 11 266 0.00023102
115350 1 18 0.0002376
57165 1 5 0.00026708
64359 17 66 0.00033676
5336 16 354 0.00050823
721 6 5 0.00058998
23784 22 25 0.00061831
199223 3 19 0.00077712
129531 2 3 0.00083791
53616 7 144 0.00092337
767 8 81 0.00098055
“Gene ID” reflects that of Entrez Gene nomenclature. “CHR” reflects chromosomal location of a gene. “N 
SNPs” refers to the number of observed SNPs (and, thus, contributing to statistical calculations) in a gene. 
“P-value” reflects cumulative association of all SNPs per gene.
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Supplementary Table 4: Summary of the top lncRNA genes (p≤1.00E-03) from genome-wide gene-based 
association analysis of aggressiveness in aADHD and cADHD respectively.
WURS-derived aggressiveness in aADHD
GENE ID CHR N SNPs P-value
ENST00000427806 1 32 3.04E-05
ENST00000439901 9 308 7.50E-05
ENST00000566854 16 35 0.0001133
ENST00000550680 14 61 0.00014633
ENST00000565060 16 24 0.0001954
ENST00000548631 14 38 0.00025783
ENST00000445660 5 6 0.00027217
ENST00000417409 1 41 0.00031884
ENST00000512838 5 853 0.00035131
ENST00000499939 16 9 0.00038143
ENST00000554814 14 917 0.00042467
ENST00000472514 3 85 0.00048725
ENST00000563475 16 41 0.00056988
ENST00000565633 16 37 0.00057884
ENST00000414538 2 107 0.00058443
ENST00000569710 7 4 0.00062894
ENST00000453798 7 6 0.00063255
ENST00000524252 8 49 0.0006423
ENST00000566535 16 8 0.0006477
ENST00000550470 12 135 0.00069247
ENST00000476130 11 22 0.00074027
ENST00000586962 19 71 0.00074715
ENST00000550118 14 54 0.00080919
ENST00000573772 17 90 0.00091225
ENST00000606866 20 2 0.00092522
ENST00000569786 16 32 0.00093974
ENST00000504773 1 9 0.0009623
ENST00000434635 2 59 0.00097046
Defiant/Vindictive Dimension in cADHD
GENE ID CHR N SNPs P-value
ENST00000422117 15 83 6.93E-05
ENST00000428142 17 5 0.00017532
ENST00000433110 10 3 0.00025754
ENST00000455238 1 2 0.00060977
ENST00000452460 21 23 0.00064512
ENST00000424138 1 4 0.00084691
ENST00000357401 21 148 0.00087883
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Irritable Dimension in cADHD
GENE ID CHR NSNPs P-value
ENST00000433110 10 3 5.15E-06
ENST00000422117 15 83 5.88E-05
ENST00000502568 5 3 0.00029639
ENST00000526206 11 9 0.00034421
ENST00000420845 10 4 0.00051141
ENST00000523584 5 190 0.00052843
ENST00000440090 6 23 0.00054093
ENST00000458633 6 5 0.00058998
ENST00000435946 6 356 0.00063865
ENST00000431422 6 32 0.00068667
ENST00000425914 1 15 0.00071815
ENST00000592607 1 15 0.00071815
ENST00000585367 1 15 0.00071815
ENST00000587839 1 15 0.00071815
ENST00000547794 12 7 0.00079658
ENST00000552469 12 7 0.00079658
ENST00000510225 4 7 0.00086799
ENST00000631169 1 16 0.00090993
ENST00000631064 1 16 0.00090993
“Gene ID” reflects that of Ensembl transcript nomenclature. “CHR” reflects chromosomal location of a gene. 
“N SNPs” refers to the number of observed SNPs in a gene (and, thus, contributing to statistical calculations). 
“P-value” reflects cumulative association of all SNPs per gene.
Supplementary Table 5: Summary of the top GO terms (p≤0.01) from pathway analysis of aggressiveness 
in aADHD.
WURS-derived aggressiveness in aADHD
SET N GENEs P-value
GO:0043124 12 0.00072631
GO:0016571 12 0.0013408
GO:0005520 19 0.0021063
GO:0021987 30 0.0025693
GO:0043046 11 0.0027753
GO:0005905 44 0.0037567
GO:0000786 40 0.003955
GO:0048255 13 0.0056072
GO:0008344 27 0.006711
GO:0030195 10 0.006885
GO:0050840 10 0.0070362
GO:0007283 257 0.0074138
GO:0042953 10 0.0080466
GO:0005537 16 0.0081564
GO:0043691 17 0.0083633
GO:0001975 20 0.0085483
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GO:0007155 511 0.0085612
GO:0000299 17 0.0098109
GO:0005901 49 0.0099714
Defiant/Vindictive Dimension in cADHD
SET N GENEs P-value
GO:0005109 10 0.0026287
GO:0045454 51 0.0033997
GO:0051403 41 0.003553
GO:0008305 26 0.0038064
GO:0018298 14 0.0038912
GO:0014070 77 0.0045464
GO:0001657 34 0.0056237
GO:0070469 33 0.0057444
GO:0008137 32 0.0058441
GO:0048661 27 0.0074798
GO:0006120 31 0.0079751
GO:0005452 16 0.0079799
GO:0050680 23 0.008541
GO:0045987 12 0.0089587
GO:0007204 72 0.0091489
GO:0005747 33 0.0091869
Irritable Dimension in cADHD
SET N GENEs P-value
GO:0015250 11 0.00087038
GO:0043034 10 0.0010436
GO:0017046 19 0.0012288
GO:0001568 27 0.0013583
GO:0045859 10 0.0022
GO:0045669 23 0.0026856
GO:0001569 17 0.0032703
GO:0004860 18 0.0032923
GO:0005743 197 0.0048677
GO:0015631 19 0.0051031
GO:0001508 14 0.0059176
GO:0045597 11 0.0059883
GO:0071564 10 0.0060913
GO:0007588 34 0.0068517
GO:0005488 399 0.007008
GO:0031124 26 0.0071667
GO:0016192 155 0.0076797
GO:0005921 14 0.0077692
GO:0007126 53 0.0083275
“SET” reflects the name of the GO term (http://geneontology.org). “N GENEs” refers to the number genes in a 
term with observed SNP data (and, thus, contributing to statistical calculations). “P-value” reflects cumulative 
association of all genes per term after adjustment for genome-wide linkage disequilibrium, gene size and gene 
density per term.
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Supplementary Table 6: Most Significant SNPs reaching p≤1.00E-03 in GWA analysis of WURS-derived 
childhood aggressiveness in aADHD and p<0.05 in GWA analyses of oppositional dimensions in cADHD.
Defiant/Vindictive Dimension in cADHD WURS-derived childhood aggressiveness in aADHD
SNP
Effect 
Allele BETA SE P-value
Effect 
Allele Beta SE P-value HetPVal
rs7229460 C -0.819 0.2189 0.0001969 T 0.8889 0.267 0.000872 0.3573
rs7093307 T -2.738 0.7449 0.0002556 T 2.5782 0.7582 0.000672 0.4968
rs1053561 A 0.6693 0.2246 0.00298 A 0.8478 0.253 0.000807 0.01241
rs889061 T 0.6828 0.2367 0.004032 T -0.9092 0.2662 0.000635 0.0088
rs11776310 C -1.715 0.6387 0.007414 T -2.2554 0.6855 0.001 0.1026
rs6980667 T 2.064 0.7882 0.00901 A -3.7482 1.045 0.000334 0.08916
rs6903040 C -0.7367 0.2854 0.01003 T 1.1071 0.3333 0.000894 0.437
rs17073719 C 1.111 0.4355 0.01094 T -1.9961 0.5601 0.000365 0.7926
rs1352368 A 0.5662 0.2222 0.01105 A -1.0398 0.2808 0.000212 0.01185
rs12614111 G -0.5629 0.2263 0.0131 C -0.8823 0.2675 0.000974 0.1418
rs17593647 T 1.137 0.4761 0.0172 T -2.6038 0.7267 0.000339 0.6409
rs2115436 T -0.5809 0.2485 0.01968 A -1.0502 0.3137 0.000814 0.7213
rs11546303 G -0.4922 0.2186 0.02464 T 1.1777 0.3537 0.000870 0.6717
rs11716177 T -0.8679 0.3998 0.03025 T -1.8976 0.5746 0.000958 0.2187
rs4077679 C 0.4783 0.2211 0.03082 T 0.8838 0.2679 0.000972 0.349
rs4954579 A 0.577 0.2672 0.03111 A -1.3845 0.3974 0.000493 0.996
rs2636639 A 0.4785 0.2226 0.03191 A -0.9456 0.2642 0.000344 0.1768
rs17129503 G -0.8676 0.4039 0.03202 A 2.0724 0.613 0.000722 0.4513
rs2141484 G 0.4335 0.2106 0.03993 T -1.108 0.3333 0.000887 0.6132
rs6694431 T 0.7897 0.3869 0.04162 T -1.9851 0.4792 3.44E-05 0.8448
rs7130044 C 0.4571 0.2262 0.04368 T -0.9435 0.2665 0.0004 0.2033
rs2722013 G 0.4693 0.2345 0.04571 A -1.0683 0.3078 0.000519 0.8164
rs12827088 T 0.5743 0.2871 0.04588 T 1.12 0.3341 0.000801 0.9039
rs9347083 A 0.4698 0.2379 0.04866 A -1.0248 0.3038 0.000743 0.5482
Irritable dimension in cADHD WURS-derived childhood aggressiveness in aADHD
SNP
Effect 
Allele BETA SE P-value
Effect 
Allele Beta SE P-value HetPVal
rs7229460 C -0.1414 0.05015 0.004931 T 0.8889 0.267 0.000872 0.3573
rs11776310 C -0.396 0.1459 0.006812 T -2.2554 0.6855 0.001 0.1026
rs6980667 T 0.4707 0.1801 0.009167 A -3.7482 1.045 0.000334 0.08916
rs4954579 A 0.152 0.06085 0.01269 A -1.3845 0.3974 0.000493 0.996
rs10761445 G 0.1544 0.06285 0.01423 A -1.5704 0.4241 0.000213 0.4467
rs1053561 A 0.1205 0.05166 0.01989 A 0.8478 0.253 0.000807 0.01241
rs7115584 C 0.1266 0.05437 0.02013 C -0.9034 0.2718 0.000887 0.09245
rs2636639 A 0.116 0.05067 0.02231 A -0.9456 0.2642 0.000344 0.1768
rs4389996 C -0.4417 0.2065 0.03278 T 2.6511 0.7911 0.000805 0.08657
rs2141484 G 0.1017 0.04809 0.0347 T -1.108 0.3333 0.000887 0.6132
rs16923279 G -0.1929 0.09214 0.03661 T 1.763 0.4891 0.000312 0.1707
rs3893429 G -0.1024 0.04908 0.03719 A 1.5454 0.3361 4.26E-06 0.665
rs6049571 T 0.4013 0.193 0.03788 A -2.1148 0.5412 9.32E-05 0.3955
rs655145 G -0.1007 0.04936 0.04167 A -0.8996 0.2598 0.000535 0.07896
rs12284766 G 0.16 0.07873 0.04244 C -1.393 0.4047 0.000578 0.05734
rs9347083 A 0.1092 0.05434 0.04484 A -1.0248 0.3038 0.000743 0.5482
rs6959073 G 0.1043 0.05221 0.04608 T -0.9876 0.2698 0.000252 0.2959
“Beta” refers to effect size of each copy of the specified allele (“Effect allele”) on the measure of aggressiveness in 
ADHD. “SE” refers to standard error. “P-value” reflects the strength of association signal. “Het p-value” reflects 
the level of heterogeneity among the examined aADHD samples of IMpACT.
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Supplementary Table 7:  Top hits (p≤1-00E-05) observed in genome-wide association meta-analysis of 
childhood aggressiveness in aADHD and their corresponding statistics observed in cADHD.
Supplementary Table 7 is available upon request (61 pages).
“Beta” refers to the effect size of each copy of the specified allele (“Effect allele”) on the measure of aggressive-
ness in aADHD or cADHD. “SE” refers to standard error. “P-value” reflects the strength of association signal. 
“Het p-value” reflects the level of heterogeneity among the examined aADHD samples of IMpACT. “CHR” 
refers to a chromosome where a SNP is located and “Gene” is referring to a gene within which a SNP is located, 
nearest gene is determined as a gene located within ±20Kbp around a SNP.
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Supplementary Figure 1: Distribution of WURS derived aggression measure in the examined datasets.
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Supplementary Figure 2: QQ plots of GWA analysis of oppositional dimensions in cADHD.
Supplementary Figure 3: QQ plots of the GWA analysis of aggressiveness in aADHD.
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ABSTRACT
Investigating phenotypic heterogeneity in aggression and understanding the molecular 
biological basis of aggression subtypes may lead to new prevention and treatment options. 
In the current study, we evaluated the taxonomy of aggression and examined specific genetic 
mechanisms underlying aggression subtypes in healthy males and females. Confirmatory 
Factor Analysis (CFA) was used to replicate a recently reported three-factor model of the 
Reactive Proactive Questionnaire (RPQ) in healthy adults (n=661; median age 24.0 years; 
41% male). Gene-set association analysis, aggregating common genetic variants within 
(a combination of) three molecular pathways previously implicated in aggression, i.e. 
serotonergic, dopaminergic, and neuroendocrine signaling, was conducted with MAGMA 
software in males and females separately (total n=395) for aggression subtypes. We replicate 
the three-factor CFA model of the RPQ, and found males to score significantly higher 
on one of these factors compared to females: proactive aggression. The genetic association 
analysis showed a female-specific association of genetic variation in the combined gene-set 
with a different factor of the RPQ; reactive aggression due to internal frustration. Both 
the neuroendocrine and serotonergic gene-sets contributed significantly to this association. 
Our genetic findings are subtype- and sex-specific, stressing the value of efforts to reduce 
heterogeneity in research of aggression etiology. Importantly, subtype- and sex-differences 
in the underlying pathophysiology of aggression suggest that optimal treatment options 
will have to be tailored to the individual patient. Male and female needs of intervention 
might differ, stressing the need for sex-specific further research of aggression. Our work 
highlights opportunities for sample size maximization offered by population-based studies 
of aggression.
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INTRODUCTION
Aggression has been defined as any behavior directed toward the goal of causing harm or 
injury to others (Baron and Richardson, 1994). From an evolutionary perspective, aggressive 
behaviors can be adaptive and have an important role in survival and competition for resources 
(Georgiev et al., 2013). In modern societies, aggression often is maladaptive and associated 
with negative consequences, causing psychological and somatic burden to victims as well as 
to aggressive individuals themselves (Fergusson et al., 2005; Reef et al., 2010). Aggression 
poses a substantial financial burden on society, for example caused by increased legal costs 
and work absence (WHO, 2007). A better understanding of the subtypes and etiology of 
aggression is needed to facilitate prevention and to improve treatment options (Fergusson et 
al., 2005). Given that about half of the variance in aggressive behaviors may be explained by 
genetic influences (Tuvblad and Baker, 2011; Veroude et al., 2016), studying the molecular 
genetics underlying these behaviors can provide important mechanistic insights. Research 
into aggression etiology is, however, complicated by several factors, including considerable 
phenotypic as well as genetic heterogeneity and the existence of sex differences in aggressive 
behaviors (Baker et al., 2008; Georgiev et al., 2013).
Subtypes of aggression
Heterogeneity in the etiology of aggression may be parsed by considering subtypes. 
Different classification systems have been proposed; one based on biological hypotheses 
is the distinction of proactive and reactive aggression (Dodge and Coie, 1987). Proactive 
aggression, also referred to as instrumental aggression, is goal-oriented, organized behavior 
often associated with low autonomic arousal and affect. Reactive aggression on the other 
hand, is also known as impulsive or affective aggression, and occurs in response to provocation 
or a negative emotional state (Raine et al., 2006; Stanford et al., 2003). Importantly, 
the subtypes have been associated with distinct behavioral, neurocognitive, and neural 
characteristics. For example, proactive aggression has been related to psychopathic traits and 
delinquent behavior (Cima and Raine, 2009; Cima et al., 2013), while the reactive subtype 
of aggression has been associated with impulsivity, anxiety, and hostile interpretation bias 
(Brugman et al., 2015; Bubier and Drabick, 2009). Twin studies showed slightly higher 
heritability estimates for proactive than reactive aggression (Baker et al., 2008; Brendgen 
et al., 2005; Tuvblad et al., 2009). The two aggression subtypes may have partially distinct 
genetic contributions. Serotonergic and dopaminergic neurotransmission may regulate both 
reactive and proactive aggression, whereas endocrine signaling seems to be more involved in 
the regulation of reactive aggression, e.g. through modulation of impulsivity and the stress 
response (Waltes et al., 2015). Recently, a further subdivision of reactive aggression has been 
proposed based on an exploratory factor analysis of the Reactive Proactive Questionnaire 
(RPQ). This analysis was conducted in a sample of adolescents (71.6% male), who were 
referred to clinical services for externalizing behavior problems (Smeets et al., 2016). Besides 
a proactive factor, reactive aggression was further subdivided into a subtype associated with 
external provocation or threat and another one associated with internal frustration. Improved 
fit indices for this three-factor model compared to the original two-factor model were also 
Chapter 4
120
reported based on an adult, males-only sample recruited partly in forensic psychiatric in- 
and outpatient clinics and partly from the general population. (Brugman et al., 2016). The 
reactive subtypes differed in their associated behavioral correlates, which suggests that the 
three-factor model may further reduce phenotypic heterogeneity and facilitate the search for 
genes involved in the etiology of aggression. 
Sex differences in aggression
The most convincing observation supporting the existence of sex differences in aggression 
is the difference in crime rate statistics between males and females. Females are vastly 
less likely to commit serious offenses than males, and males are more likely to display 
antisocial behavior than females (Stephenson et al., 2014). Males are also overrepresented 
in aggression-related disorders such as conduct disorder (CD), where the gender ratio is 
approximately 2.5 (Hill, 2002). Importantly, sex differences are also found in the type of 
aggressive behavior displayed (Collett et al., 2003). The clear gender-specificity of aggression 
is thought to have evolved by sexual selection, and to reflect differences in optimal strategies 
in the competition for resources for males and females (Georgiev et al., 2013). Sex differences 
in heritability estimates have been observed in some but not all of the aggression twin 
studies conducted to date, with higher heritability estimates for boys than girls, when self-
report measures were assessed (Baker et al., 2008; Wang et al., 2013). Incorporation of sex 
in aggression studies may be essential to identify the underlying biological mechanisms of 
aggressive behaviors.
Biological systems
The biological systems most investigated in the context of aggression phenotypes (as 
well as related traits such as mood disturbances and impulsivity) are the monoaminergic 
neurotransmitter systems related to serotonin and dopamine and the neuroendocrine 
system. Multiple reviews to date discuss these systems in the context of aggression and list 
the candidate genes that have been investigated for association with aggressive behaviors 
(Pavlov et al., 2012; Veroude et al., 2016; Waltes et al., 2015). 
The serotonergic system is hypothesized to play a key role in aggression due to its influence 
on functions including social cognition, emotional regulation, and cognitive control 
(Lesch et al., 2012). Both human and animal studies link genes within these systems to 
aggressive behavior. For example, the serotonin transporter gene (SLC6A4) is one of the 
most investigated candidate genes for aggression. Variation in the serotonin receptor 2B 
gene (5-HT2B) has been associated with violent impulsivity in a Finnish population, and 
5-HT2B and 5-HT1B knockout studies in mice implicate these genes in aggression and/
or impulsivity (Bevilacqua et al., 2010; Nautiyal et al., 2015). While candidate genetic 
association studies have often produced equivocal results, investigations measuring levels of 
the serotonin metabolite 5-HIAA in cerebrospinal fluid, e.g. (Brown et al., 1979; Coccaro 
and Lee, 2010), or manipulating central serotonin function through tryptophan depletion/
loading, e.g. (Bjork, 2000), have revealed a highly significant relationship between 
serotonin availability and aggression (Rosell and Siever, 2015). Dopamine is relevant for 
understanding aggression because of its effects on reward, motivated behavior, and decision 
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making (Costa et al., 2012). While studies of dopamine manipulation have mostly been 
conducted in animals, the involvement of dopamine in aggression is also evidenced by the 
fact that in humans, D2-receptor antagonists have been used effectively to treat aggressive 
behavior (Nelson and Trainor, 2007). Additional evidence linking the serotonergic and 
dopaminergic neurotransmitter systems comes from genetic association studies of the 
MAOA gene. This X-linked gene encodes the enzyme monoamine oxidase A, which breaks 
down both serotonin and dopamine, and has been robustly associated with aggression, 
especially in the context of stress and maltreatment (Brunner et al., 1993; Caspi et al., 2002; 
Byrd and Manuck, 2014). The third system implicated in aggression is the neuroendocrine 
system, including both stress-related hypothalamic-pituitary-adrenal (HPA) axis signaling 
and sex-hormone-related hypothalamo-pituitary-gonadal (HPG) axis signaling. As early 
life stress is known to increase risk for the development of mood and aggression-related 
disorders (Agid et al., 1999; Éthier et al., 2004; Fonagy, 2006; Heim et al., 2001), the 
neuroendocrine stress response with its genetic components is a major candidate system 
for the development of aggressive behaviors. The relation of the HPA axis to aggression has 
been well established, especially through animal studies (Veenema, 2009). Also in humans, 
cortisol levels have been related to aggression repeatedly (Alink et al., 2012; Loney et al., 
2006; Popma et al., 2007; Shirtcliff et al., 2005; van Bokhoven et al., 2004). The HPG axis 
involves signaling between hypothalamus, pituitary, and the gonadal glands, which produce 
estrogen and testosterone. Testosterone levels have been related to human aggression (Book 
et al., 2001; Brown et al., 2008; Chichinadze et al., 2010; Yu and Shi, 2009) and it has been 
hypothesized that especially the interplay between cortisol and sex steroids is important in 
determining aggression liability (Pavlov et al., 2012; Terburg et al., 2009).
Extensive reviews of aggression candidate gene studies have recently been published 
(Fernandez-Castillo and Cormand, 2016; Pavlov et al., 2012; Veroude et al., 2016; Waltes 
et al., 2015). Although a moderate number of studies has been conducted, a meta-analysis 
of individual candidate variants did not reveal any significant associations with aggressive 
behavior (Vassos et al., 2014). One reason for this may be the complex genetic background 
of aggression in most people. While a few monogenic aggression disorders caused by rare 
genetic variations with a high effect size exist (Brunner et al., 1993; Zhang-James et al., 
2016), aggression in the population has a complex and polygenic genetic background, 
which can be aggravated by environmental factors (Veroude et al., 2016).
In the current study, we assessed the genetic mechanisms underlying aggression subtypes in 
the general population. Firstly, we aimed to verify the existence of three aggression subtypes 
in adult males and females from the general population based on the RPQ. Second, we 
aimed to assess the association of common genetic variants in the three biological systems 
with most evidence for a role in aggression, i.e. the serotonergic system, the dopaminergic 
system, and the neuroendocrine system with the different subtypes. We aimed to maximize 
power for finding genetic associations by (1) parsing phenotypic heterogeneity through 
differentiating between subtypes, (2) by assessing males and females separately, and (3) by 
combining genetic variants in a gene-set analysis (Bralten et al., 2011; Bralten et al., 2013; 
Naaijen et al., 2017).
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METHODS
Sample
The investigated sample consisted of participants of the Brain Imaging Genetics (BIG) 
study conducted at the Donders Institute for Brain, Cognition and Behaviour (Franke 
et al., 2010). The BIG study consists of self-reported healthy adults, who participated in 
smaller-scale imaging studies at the institute and gave consent to be included in the BIG 
study. Saliva samples for genetic testing were collected, and an internet-based test-battery 
of questionnaires was applied. The Reactive Proactive Questionnaire (RPQ; Raine et al., 
2006) was available for 661 participants (age range 18-45 years). Of those, 395 participants 
had genome-wide genotyping data available.
All participants were of Caucasian descent and were screened using a self-report 
questionnaire for the following exclusion criteria before study participation: a history of 
somatic disease potentially affecting the brain, current or past psychiatric or neurological 
disorder, medication (except hormonal contraceptives) or illicit drug use during the past 
6 months, history of substance abuse, current or past alcohol dependence, pregnancy, 
lactation, menopause, and magnetic resonance imaging contraindications (Gerritsen et al., 
2012). All participants gave written informed consent, and the study was approved by the 
regional ethics committee.
Aggression Questionnaire
The Reactive Proactive Questionnaire (RPQ) was used to assess subtypes of aggression 
(Raine et al., 2006). The RPQ is a self-report questionnaire consisting of 23 items. For 
each item, subjects are asked to indicate, how often they have engaged in a given type of 
behavior. Items are rated on a three-point Likert scale (‘never’ =0, ‘sometimes’ =1, ‘often’ 
=2). Responses were summed to yield the three factors that best described the RPQ in 
an earlier exploratory factor analysis (Smeets et al., 2016): ‘proactive aggression’, ‘reactive 
aggression due to internal frustration’, and ‘reactive aggression due to external provocation’. 
Items relating to each subtype can be found in Supplementary Table 1. 
Factor analysis 
Confirmatory factor analysis (CFA) was conducted using Mplus (version 6.11; https://www.
statmodel.com/). Results were considered acceptable, when both the Comparative Fit Index 
(CFI) and the Tucker-Lewis Index (TLI) exceeded .90 (with values closer to 1 indicating 
better fit), and the Root Mean Squared Error of Approximation (RMSEA) was below .06 
(with values closer to 0 indicating better fit) (Hu and Bentler, 1999; Smeets et al., 2016). 
Genotyping and imputation
Genetic analyses were carried out at the Department of Human Genetics of the Radboud 
University Medical Center. Saliva samples were collected using Oragene kits (DNA Genotek, 
Kanata, Canada), and genomic DNA was extracted as specified by the manufacturer. 
Genome-wide genotyping was performed on two different platforms, Affymetrix 
Genome-Wide Human SNP Array 6.0 (Affymetrix Inc., Santa Clara, CA, USA) (n=243) 
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and the Infinium PsychArray-24 v1.1 BeadChip  (http://www.illumina.com/products/
psycharray.html) (n=152). Genotype calling and quality control steps are described in 
the Supplementary Information. MACH software was used for haplotype phasing and 
minimac for the final imputation (Howie et al., 2012; Li et al., 2010), with 1000 Genomes 
Phase 1.v3 reference data (Abecasis et al., 2012).
Gene-set selection and construction 
Gene selection for aggression candidate gene-sets involved in neuroendocrine signaling, 
dopamine neurotransmission, and serotonin neurotransmission was performed using the 
Ingenuity Pathway Analysis (IPA) software (http://www.ingenuity.com). Ingenuity draws 
on the Ingenuity Knowledge Base which is based on information from published literature 
as well as on various other sources including gene expression and gene annotation databases. 
The serotonergic gene-set contained genes involved in serotonergic receptor signaling and 
de dopaminergic gene-set contained genes involved in dopaminergic receptor signaling. 
The neuroendocrine gene-set contained genes involved in corticotropin-releasing hormone, 
glucocorticoid, androgen, and estrogen signaling. An overview of selected genes can be 
found in Table 1. All single nucleotide polymorphisms (SNPs) in or within 100kb flanking 
regions of the genes (also capturing regulatory sequences; Veyrieras et al., 2008) were 
selected for analysis.
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Gene-set analyses 
Genome-wide association analyses for the three subtypes of aggression were performed 
using Mach2qtl/Mach2dat (Li et al., 2010), adjusting for age, age2, and four population 
components derived from multidimensional scaling analysis. For RPQ proactive aggression 
scores only, scores were dichotomized into high- and low-scoring (score ≥ 2 and score ≤ 1, 
respectively), because of a highly positively skewed distribution (Supplementary Table 2). 
Separate analyses were run for males and females, and for subjects genotyped on the two 
different genotyping arrays. SNPs with low imputation quality (R2 <0.6) and minor allele 
frequency of less than 1%  were filtered out. Resulting SNP p-values for each of the traits 
were used to run gene-set analysis using MAGMA v1.04 (de Leeuw et al., 2015). SNPs were 
mapped onto genes using 1000 Genomes Phase 1.v3 reference data followed by computation 
of gene p-values. Fixed-effects meta-analysis of the output of the two genotyping arrays 
was run using the weighted Stouffer’s Z method as implemented in MAGMA. We first 
assessed association of all three gene-sets combined on the three aggression subtypes. The 
MAGMA competitive gene-set analysis was used to assess association, which will correct 
for confounding due to gene-size, gene density, differential sample size and the log of those 
values. Results of the self-contained test option in MAGMA, which tests whether a signal 
is present in the aggregated set of SNPs compared with a signal being present by random 
chance, are also reported for comparability with previously used methods in literature. 
This association method does not take into account gene-size and gene density, or whether 
the association of the gene-set is greater than that of other genes. Results were considered 
significant if they reached the Bonferroni-corrected P‐value-threshold for testing of three 
aggression subtypes and two sexes (P‐value threshold =0.05/6 =0.0088). For significant 
associations observed in the competitive test, we performed post-hoc tests to localize effects 
amongst the three separate gene-sets and individual genes within the sets. An additional 
post-hoc analysis assessed association of all three gene-sets combined using the two-factor 
classification of reactive and proactive aggression (Supplementary Information).
RESULTS
The general characteristics of our sample of 661 participants and the genotyped sample of 
n=395 are shown in Table 2. The tree factor model of the RPQ, consisting of a proactive 
factor, a reactive factor due to internal frustration, and a reactive factor due to external 
provocation or threat, showed a good model fit in the healthy adults (RMSEA 90% CI: 
.041-.051, RMSEA: .046, CFI: .915, TLI: .905), Cronbach’s alpha = 0.687 (proactive), 
0.663 (reactive internal frustration), 0.684 (reactive external provocation). An overview of 
fit-measures for one-, two-, and three-factor models are provided in Supplementary Table 
3. In line with earlier studies, inter-correlations between the three investigated aggression 
subtypes were moderate and significant in our investigated sample (.436 ≥ r ≤ .574), marking 
them as distinguishing but correlated dimensions of aggression. 
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Table 2: Sample characteristics for phenotypic and genetic analyses.
Phenotypic 
sample 
(n=661)
Pheno-
typed 
females 
(n=391)
Pheno-
typed 
males 
(n=270)
Genotyped 
sample 
(n=395)
Genotyped 
females 
(n=227)
Genotyped 
males 
(n=168)
Sex (% male) 41% - - 43% - -
Mean age 
(SD)
25.45 
(4.56)
25.60 
(4.88)
25.24 
(4.07)
25.60 
(4.70)
25.85 
(5.08) 25.30 (4.11)
Mean 
proactive 
score (SD; 
range)
1.38 
(1.81;0-12)
1.00 
(1.38;0-8)
1.92 
(2.19;0-12)
1.45 
(1.91;0-12)
0.97* 
(1.40;0-8)
2.09* 
(2.3;0-12)
Mean reac-
tive internal 
frustration 
score (SD; 
range)
3.01 
(1.76;0-9)
2.96 
(1.75;0-9)
3.10 
(1.79;0-9)
3.02 
(1.82; 0-9)
2.89 
(1.78;0-9)
3.20 
(1.85;0-9)
Mean 
reactive 
external 
provocation 
score (SD; 
range)
2.39 
(1.89;0-11)
2.29 
(1.86;0-11)
2.55 
(1.92;0-9)
2.37 
(1.91;0-11)
2.24 
(1.86;0-11)
2.54 
(1.98;0-9)
* RPQ proactive aggression scores were dichotomized into high- and low-scoring (score ≥ 2 and score ≤ 1, 
respectively), because of a highly positively skewed distribution in both males and females.
Gene-set association analysis with aggression subtypes was conducted in the 395 subjects 
with genotyping information available. Males scored significantly higher on proactive 
aggression than females in the genotyped (t(393) =5.97, P <0.001) as well as the phenotyped 
cohort (t(659) =6.59, P<0.001). A total of 483 unique autosomal genes were selected for 
the combined dopaminergic, serotonergic, and neuroendocrine gene-set. Twenty additional 
genes, either located on the X- and Y-chromosome or not captured by the array, could not 
be included in the analysis (Table 1).
Association analysis of all three gene-sets combined with each of the three aggression 
subtypes was performed for males and females separately (Table 3). In females, the combined 
gene-set was significantly associated with frustration-based reactive aggression, but not 
with reactive aggression due to external provocation/threat or with proactive aggression 
scores. The significant association of the combined set with reactive aggression due to 
internal frustration as measured by competitive testing was observed for both genotyping 
arrays (PAffymetrix_competitive =1.397e-03 and PInfinium_competitive =2.175e-04, respectively), showing 
replicability of the finding. In males, the combined gene-set was not associated with any of 
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the aggression subtypes using competitive tests.  Post-hoc analysis results, comparing our 
main association results with associations based on the two-factor model of reactive and 
proactive aggression, can be found in the Supplementary Information. Self-contained test 
results were highly significant for proactive aggression scores in both males and females. 
Table 3: Results for the association of the serotonergic, dopaminergic and neuroendocrine gene-sets com-
bined with three aggression subtypes.
Females Males
Pcompetitive Pself-contained Pcompetitive Pself-contained
Proactive aggression 0.316 1.12E-17 0.043 3.20E-28
Reactive internal frustration 2.275E-5* 5.51E-07 0.337 0.525
Reactive external provocation 0.438 0.014 0.273 0.159
* Indicates significance after Bonferroni correction for testing 3 subtypes and 2 sexes (Pthreshold = 0.0088).
For the significant finding for reactive aggression due to internal frustration in females, 
we subsequently explored contributions of the three separate gene-sets and of individual 
genes within these sets. As shown in Table 4, these post-hoc analyses showed that the 
neuroendocrine and the serotonergic gene-set were independently contributing to 
the association. Separate tests of each of the subsets of the neuroendocrine pathway 
(corticotropin-releasing hormone, glucocorticoid, estrogen, and androgen signaling 
cascades) provided evidence for contributions of each of these cascades to the association, 
with lowest p-values for glucocorticoid and androgen signaling (Table 4). No single 
genes showed significant associations after Bonferroni correction for 40 (serotonin), 73 
(dopamine) and 411 (neuroendocrine) genes tested (Supplementary Table 4). The gene with 
the strongest association in the serotonergic set was the serotonin transporter (SLC6A4, P 
=0.0098), and the gene with the strongest association in the neuroendocrine set was Cyclin-
Dependent Kinase-Activating Kinase Complex Subunit (CCNH, P =0.0004).
Table 4: Results for the association of the serotonergic, dopaminergic, and neuroendocrine gene-sets with 
reactive aggression due to internal frustration in females.
Ngenes Pcompetitive
Serotonin 40 0.016*
Dopamine 73 0.059
Neuroendocrine 411 1.147E-4*
     Glucocorticoid 264 8.49E-04
     Corticotropin-releasing hormone 107 0.012
     Androgen 110 6.46E-03
     Estrogen 123 0.023
* Indicates significance after Bonferroni correction  for multiple testing (3 sets; Pthreshold = 0.0167).
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DISCUSSION
In the current study, we investigated genetic mechanisms underlying aggression subtypes 
in the healthy population. Factor analysis confirmed that three correlated but separate 
dimensions of aggression can be distinguished in healthy adults, using the self-report scale 
RPQ (‘proactive aggression’, ‘reactive aggression due to internal frustration’, and ‘reactive 
aggression due to external provocation’). Aggregated analysis of common variants within 
monoaminergic and neuroendocrine systems confirmed association of these systems with 
reactive aggression due to internal frustration in females.
Our results confirming the existence of three distinguishable dimensions of aggression in 
healthy adults are in line with the previous study investigating alternative factor solutions 
for the RPQ in adults (Brugman et al., 2016). These authors reported improved fit-indices 
in exploratory factor analysis for the three-factor model compared to the original two-factor 
model in a males-only sample, recruited partly in forensic psychiatric in- and outpatient 
clinics and partly from the general population. The first study to find the three-factor 
structure of the RPQ investigated a younger sample of adolescents, all from clinical samples 
(Smeets et al., 2016). The current study extends these findings further by showing them 
to be valid in a highly educated healthy population sample. The specificity of our genetic 
finding for one of the subtypes, underscores the biological meaningfulness of the observed 
three-factor structure.
The scores for both reactive subtypes showed a normal distribution in our general population 
sample; proactive aggression scores were heavily skewed towards the lower end, reflecting 
the fact that proactive aggression includes more severe behaviors less prevalent in the general 
population. Proactive aggression scores were significantly higher for males compared to 
females in our sample of healthy adults. In general, males and females have been shown to 
differ markedly, both in terms of prevalence and type of aggression displayed. Males are at 
increased risk of showing overt/physical aggression (Baillargeon et al., 2007; Côté, 2007; 
Hill et al., 2006), while females may show slightly more indirect aggression (also termed 
social aggression, relational aggression) compared to males (Card et al., 2008). As proactive 
aggression is often displayed in a covert manner, and reactive aggressive behavior is more 
overt, it has been suggested that girls show more proactive aggression and boys show more 
reactive aggression (Kempes et al., 2005). However, prior studies that have investigated 
gender-differences in rates of proactive and reactive aggression in children do not confirm 
this idea. A study of the prevalence of proactive and reactive aggression in a sample of 
clinically referred children and adolescents did not find gender differences for either of 
the subtypes (Connor et al., 2003). Studies in non-referred children did find differences, 
and reported higher rates of both reactive and proactive aggression in boys (Salmivalli & 
Nieminen, 2002; Baker et al., 2008). It has been suggested that gender-differences may 
be more pronounced in non-clinical samples (Connor et al., 2003). In our current study 
of healthy adults, we only find higher proactive (not reactive) aggression scores in males, 
suggesting that an age effect may also be at play. It has been hypothesized that proactive 
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aggression may become more pronounced at a later age, when cognitive abilities are fully 
developed and aggressive behaviour may become more calculative in nature (Kempes et al., 
2005), a hypothesis that warrants further investigation in future studies. 
Our identified association of candidate genetic systems with reactive aggression due to 
internal frustration in females was driven by variation in serotonergic  and neuroendocrine 
signaling. This finding is in line with literature describing specific effects of serotonin, 
cortisol, and the sex steroids on aggressive behavior. Indeed, the reported associations of 
these molecules with aggression often differ as a function of sex and type of aggression 
studied (reviewed in Rosell and Siever, 2015). For example, higher cortisol reactivity 
was reported for reactive aggression compared to proactive aggression (Lopez-Duran 
et al., 2008). One influential theory hypothesizes that a high testosterone/cortisol ratio 
predisposes to increased aggression, with serotonin modulating the balance between 
impulsive and instrumental aggression. Specifically, the high testosterone/cortisol ratio is 
thought to facilitate the fight-flight response by acting on the amygdala-hypothalamus-
periaqueductal gray network, while low serotonin reduces inhibitory control by the 
prefrontal cortex, together leading to increased impulsive, reactive aggression (Montoya et 
al., 2012). It is interesting to mention that, although not significant after correcting for the 
number of genes tested, the gene with the strongest association in our serotonergic set was 
the serotonin transporter (SLC6A4). This is one of the most investigated candidate genes 
for aggression (Veroude et al., 2016) and has been associated with antisocial behavior in 
meta-analysis (Ficks and Waldman, 2014). 
Our finding for neuroendocrine and serotonergic signaling was specific to one of the two 
reactive aggression subtypes, i.e. the frustration-based reactive subtype. Although gene-
set association of reactive aggression as defined by the two-factor classification was also 
significant (Supplementary Information), providing evidence for the usefulness of the two-
factor model in research of aggression etiology, our analysis using three subtypes shows 
that the association was strongly driven by frustration-based reactive aggression and not 
by threat-based reactive aggression, underscoring the biological meaningfulness of the 
three-factor structure. This highlights the value of the further reduction of phenotypic 
heterogeneity for the identification of underlying biological mechanisms of aggression. One 
of the characteristics of the frustration-based subtype is thought to be an inflexibility to 
changes in the environment (Smeets et al., 2016). Our specific finding of strong association 
of frustration-based reactive aggression with neuroendocrine and serotonergic genes may 
thus arise (partly) from the function of these genes in stress modulation. However, more 
research is needed to assess the complex interactions and mechanisms through which the 
investigated systems lead to aggression-related phenotypes. In this context it will be useful 
to investigate the effects of early environment on the epigenome and the genetic factors 
moderating these effects (Provencal et al., 2015). Additionally, imaging genetics studies will 
be instrumental in investigating the modulation of aggression brain circuitry by aggression 
risk genes (Bogdan et al., 2017; Thompson et al., 2014).
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Our findings were female-specific, a possible explanation for which lies in the idea that the 
signaling and interaction of the endocrine HPA and HPG axes is different between the 
sexes. For example, the two axes contribute to androgen production in different proportions 
in the different sexes (Burger, 2002; Montoya et al., 2012). In general, males and females 
probably developed different aggression strategies during evolution as a result of sex-specific 
sex hormone signaling (Georgiev et al., 2013). When using self-contained tests, we found 
a highly significant association of the gene-set with proactive aggression scores in both 
sexes. While no biological inferences can be made regarding the tested systems based on 
self-contained tests, nominally significant competitive association results for proactive 
aggression in males might nevertheless potentially point towards a role of the investigated 
systems in proactive aggression risk in males. The sex-specificity of at least some of our 
findings forms an important starting point into genetic differences in aggressive behavior 
between males and females. With most studies to date including male subjects only, the 
aggression phenotype in females specifically has been understudied and deserves more 
attention. 
This study provides new information on the underlying mechanisms of aggression, 
thereby facilitating the search for diagnostic, preventive, and treatment options based 
on understanding biology. Importantly, from a clinical perspective, the sex and subtype 
specificity of our findings emphasizes the need for individually tailored treatment options. 
For example, our genetic association results suggest there is a biological aspect to sexual 
dimorphism. Fundamental differences in underlying pathophysiology may have important 
consequences for therapeutic interventions, suggesting that male and female needs for 
intervention might differ markedly. 
Our study should be viewed in the context of specific strengths and limitations. One 
strength of the current study is the large sample size used to verify the factor structure of 
the RPQ. Moreover, the study addresses three different types of heterogeneity, tackling 
issues with phenotypic, sex-related, and allelic heterogeneity. By aggregating the effect 
of multiple genetic variants relating to the biological processes implicated in aggressive 
behavior, we were able to boost statistical power for finding genetic association (Naaijen et 
al., 2017). Nevertheless, power of the study provided limited opportunity for an expansion 
of the number of variables investigated. Future studies should further investigate correlates 
of female reactive aggression that could serve to explain our main association results. 
Possible variables of interest are provided by a study by Connor and coworkers (2003), 
who specifically investigated the correlates of proactive and reactive aggression in males 
and females separately. They showed that while a large amount of variance in male reactive 
aggression was mediated by hyperactive/impulsive behaviors, a large amount of explained 
variance in female reactive aggression was mediated by early traumatic stress (Connor et 
al., 2003). X- and Y-linked genetic variation could not be taken into account in our study, 
and we were thus unable to include genetic variation in the well-known MAOA gene in the 
analysis. Including this variation may further improve power of genetic studies, however, 
the assumed underlying polygenic risk model (many genetic variants, each with small effect 
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size, are assumed to contribute to the phenotype) was sufficiently captured in the current 
analysis. Our study of aggression was performed in healthy individuals. In doing so, we 
assumed a model in which patients diagnosed with aggression disorders can be seen as the 
extremes in a distribution of aggressive traits. Several lines of research have already shown 
that this model is relevant in other psychiatric traits such as attention-deficit/hyperactivity 
disorder and autism spectrum disorders (Martin et al., 2014; Middeldorp et al., 2016; 
Riglin et al., 2016; Robinson et al., 2016). We selected genes based on their implication 
in aggression disorders, and indeed, were able to find association with aggressive traits 
in the general population. Showing that common genetic variants underlying aggression 
phenotypes are similar in typical and psychiatric populations, this offers many possibilities 
for future research. While recruitment of large clinical cohorts often proves challenging, 
large population-based samples are much easier to investigate, offering important 
opportunities for sample size maximization. 
We provide evidence for the existence of three correlated but separate dimensions of 
aggression in healthy adults, and identify variation in neuroendocrine and serotonergic 
signaling as a biological risk factor involved in the etiology of frustration-based reactive 
aggression in females. To our knowledge, this is the first study investigating the combined 
effect of common genetic variants related to monoaminergic and neuroendocrine signaling 
on aggression subtypes. The findings stress the value of reducing phenotypic and sex-
related heterogeneity in research of aggression etiology, and the opportunities offered by 
population-based studies of aggression.
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SUPPLEMENTARY MATERIAL
Genotyping and quality control
Genotyping and imputation for the Affymetrix Genome-Wide Human SNP Array 6.0 are 
described in Guadalupe et al. (Guadalupe et al., 2015). Shortly, genotype calls were made 
using the Birdseed algorithm. Samples with call rates lower than 90% and/or deviant values 
of genome-wide heterozygosity (Purcell et al., 2007) were excluded, as well as SNPs with a 
minor allele frequency below 1% or that failed the Hardy–Weinberg equilibrium test at a 
threshold of p ≤ 10–6.
For the Infinium PsychArray-24 v1.1 data, genotypes were called using Illumina 
GenomeStudio software. Samples with a call rate <0.994 were excluded. Clustering was 
performed using GeneTrain 2.0 (no-call threshold 0.15) after which samples with call rate 
<0.98 were excluded. Quality control steps performed prior to imputation included removal 
of SNPs with a call rate below 98%, removal of SNPs with a minor allele frequency of less 
than 1% or failing the Hardy-Weinberg equilibrium test at a threshold of p≤10–6, and 
removal of individuals with a call rate below 98% or heterozygosity rate of more than 3 
standard deviations from the mean. For both platforms, MACH software was used for 
haplotype phasing and minimac for the final imputation (Howie et al., 2012; Li et al., 
2010), with 1000 Genomes Phase 1.v3 reference data (Abecasis et al., 2012).
Post-hoc association analysis based on the two-factor model
To compare our main gene-set association result based on the (best fit) Reactive Proactive 
Questionnaire three-factor model (‘proactive aggression’, ‘reactive aggression due to 
internal frustration’, and ‘reactive aggression due to external provocation’) with the two-
factor classification of aggression (‘proactive aggression’, ‘reactive aggression’), we assessed 
association of the combined dopaminergic, serotonergic, and neuroendocrine gene-sets 
with reactive aggression as defined by the two-factor model. As our main results (i.e. using 
the three-factor model), showed significant association of the combined gene-set with 
frustration-based reactive aggression in females only, this post-hoc analysis was conducted 
in females. Responses of the Reactive Proactive Questionnaire were summed to yield 
the reactive aggression score based on the two-factor model (mean reactive score (SD) 
=5.13 (3.25); range 0-20; n=227). The combined gene-set showed association significance 
with reactive aggression as defined by the two-factor classification in females (p=0.01). 
Although this provides evidence for the usefulness of the two-factor model, our analysis 
using three subtypes shows that the association was strongly driven by frustration-based (P 
=2.27E-5) and not threat-based (P =0.438) reactive aggression, underscoring the biological 
meaningfulness of the three-factor structure.
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Supplementary Table 1: Reactive Proactive Questionnaire items relating to each of the aggression sub-
types.
Proactive aggression
2: Had fights with others to show who was on top
4: Taken things from other students
6: Vandalized something for fun
9: Had a gang fight to be cool
10: Hurt others to win a game
12: Used physical force to get others to do what you want
15: Used force to obtain money or things from others
17: Threatened and bullied someone
18: Made obscene phone calls for fun
20: Gotten others to gang up on someone else
21: Carried a weapon to use in a fight
23: Yelled at others so they would do things for you
Reactive internal frustration
1: Yelled at others when they have annoyed you
5: Gotten angry when frustrated
8: Damaged things because you felt mad
11: Become angry or mad when you do not get your way
13: Gotten angry or mad when you lost a game
Reactive external provocation
3: Reacted angrily when provoked by others
7: Had temper tantrums
14: Gotten angry when others threatened you
16: Felt better after hitting or yelling at someone
19: Hit others to defend yourself
22: Gotten angry or mad or hit others when teased
Supplementary Table 2: Confirmatory Factor Analysis results for the Reactive Proactive Questionnaire; 
overview of fit-measures for different models. 
Model RMSEA estimate RMSEA 90% CI CFI TLI 
Single-factor .053 .048 - .057 .888 .877 
Two-factor .048 .043 - .053 .908 .899 
Three-factor .046 .041 - .051 .915 .905 
Supplementary Table 3: Association results for individual genes with aggression due to internal frustration 
in females.
Supplementary Table 3 is available upon request (11 pages).
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Supplementary Figure 1: Distribution of Reactive Proactive Questionnaire proactive aggression scores in 
males and females. Dotted line represents the cut-off for dichotomized high- and low-scores.
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ABSTRACT
Neurodevelopmental disorders are defined by highly heritable problems during 
development and brain growth. Attention-deficit/hyperactivity disorder (ADHD), autism 
spectrum disorders (ASDs), oppositional defiant disorder (ODD), conduct disorder (CD), 
and intellectual disability (ID) are frequent neurodevelopmental disorders, with common 
comorbidity among them. Imaging genetics studies on the role of disease-linked genetic 
variants on brain structure and function have been performed to unravel the etiology of these 
disorders. Here, we reviewed imaging genetics literature on these disorders attempting to 
understand the mechanisms of individual disorders and their clinical overlap. For ADHD, 
ASD, and ODD/CD, we selected replicated candidate genes implicated through common 
genetic variants. For ID, which is mainly caused by rare variants, we included genes for 
relatively frequent forms of ID occurring comorbid with ADHD, ASD, or ODD/CD. We 
reviewed case-control studies and studies of risk variants in healthy individuals. Imaging 
genetics studies for ADHD were retrieved for SLC6A3/DAT1, DRD2, DRD4, NOS1, 
and SLC6A4/5HTT. For ASD, studies on CNTNAP2, MET, OXTR, and SLC6A4/5HTT 
were found. While no reports on case-control imaging genetics studies were retrieved for 
ODD/CD, studies of the effects of well-known risk variants from aggression literature, in 
the MAOA, AVPR1A, and SLC6A4/5HTT genes, on the brain of healthy individuals are 
reviewed here. For ID, we reviewed the genes FMR1, TSC1 and TSC2, NF1, and MECP2. 
Alterations in brain volume, activity, and connectivity were observed. Several findings were 
consistent across studies, implicating e.g. SLC6A4/5HTT in brain activation and functional 
connectivity related to emotion regulation. However, many studies had small sample sizes, 
and hypothesis-based, brain region-specific studies were common. Results from available 
studies confirm that imaging genetics can provide insight into the link between genes, 
disease-related behavior, and the brain. However, the field is still in its early stages, and 
conclusions about shared mechanisms cannot yet be drawn. 
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INTRODUCTION
Neurodevelopmental disorders are broadly defined as disorders in the development and 
growth of the brain (Goldstein and Reynolds, 1999), but this term is largely used to describe 
neurological and psychiatric disorders that have their onset prior to adulthood. Most 
neurodevelopmental disorders are highly heritable, either caused by single genetic defects, 
like many of the intellectual disability (ID) disorders (Deciphering Developmental Disorders 
Study, 2015), or with a more multifactorial background, in which several to multiple less 
penetrant genetic variants cause the disease in combination with environmental factors, 
like in many cases of autism spectrum disorders (ASDs; (Gaugler et al., 2014; Iossifov et 
al., 2014), as well as in attention-deficit/hyperactivity disorder (ADHD; (Faraone et al., 
2015; Franke et al., 2012), oppositional defiant disorder, and conduct disorder (Salvatore 
and Dick, 2016). 
While technological advances in the last decade, especially genome-wide association studies 
(GWASs) and next generation sequencing, have enabled the identification of many genetic 
factors involved, the biological mechanisms contributing to the neurodevelopmental 
disorders are still largely unknown. It is thought that gene variation/mutation will alter 
molecular and cellular processes, which leads to altered brain development, be it structurally 
and/or functionally, and subsequently to altered behavior and disease symptoms (Franke 
et al., 2009). Measures that mediate the effects of genes on behavioral/disease phenotypes 
have been termed endophenotypes or intermediate phenotypes (Gottesman and Gould, 
2003; Kendler and Neale, 2010).
Much research into the consequences of gene aberrations is performed in animal 
models. However, brain imaging methods like magnetic resonance imaging (MRI), 
electroencephalography (EEG), and magnetoencephalography (MEG) offer excellent ways 
to investigate the effects of genetic variation on brain structure, function, and connectivity 
directly in humans in vivo. Such ‘imaging genetics’ approaches can unveil the brain-
biological consequences of molecular changes induced by genetic variants – both common 
and rare – linked to neurodevelopmental disorders. In that way they can help to understand 
the mechanisms through which differences in behavior arise. It has been argued that the 
effects of disease-linked (common) genetic variation on the brain would be larger than those 
on behavior and clinical phenotypes (Gottesman and Gould, 2003; Rose and Donohoe, 
2013)), although more recent work using hypothesis-free imaging genetics approaches 
argues against this – at least for brain structural phenotypes (Franke et al., 2016).
Different neuroimaging methods can be used in imaging genetics studies, including 
different forms of structural and functional MRI as well as EEG and MEG. They have 
complementary characteristics enabling information to be gathered on different aspects of 
(gene effects on) brain anatomy and function, like location (especially MRI-based methods) 
and timing (especially EEG and MEG). In this review, we concentrated on those methods 
that have most frequently been used in imaging genetics studies of neurodevelopmental 
disorders, i.e. MRI-based methods evaluating gene effects on brain structure, function, 
and connectivity.
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With structural magnetic resonance imaging (sMRI) it is possible to noninvasively 
characterize the structure of the human brain. Thereby, the different magnetic properties 
of brain tissues are used to map the spatial distribution of these structural properties of 
the brain. In this way, the different brain tissues (grey and white matter) and cortical and 
subcortical structures of the brain can be mapped. By adapting scanning parameters, 
different weighting techniques of the signal can be used, such as T1-weighted imaging (used 
to visualise anatomy) and T2-weighted imaging (which is useful for demonstrating lesions 
and pathology). Different aspects of brain structure can be used for quantitative analyses. 
To investigate whether volumetric differences are global or regional, specific brain regions 
of interest (ROIs) can be selected a priori and studied individually. In contrast, global 
changes in grey or white matter intensity can be detected by using voxel-based morphometry 
(VBM) analyses. Next to volumetric differences observed in grey matter, structural 
differences of white matter connectivity can also be quantified. With the help of diffusion 
tensor imaging (DTI), it is possible to non-invasively investigate the macrostructural 
integrity and orientation of white matter fibre bundles. Thereby, the directional diffusion 
of water molecules along neuronal membranes is measured, allowing to map white matter 
connection within the brain. Multiple measures can be derived from DTI. A frequently 
measured parameter is fractional anisotropy (FA). Basically, anisotropy indicates that 
diffusion takes place in a directional manner, whereas isotropy indicates diffusion in all 
directions. Additional DTI-derived parameters include mean diffusivity (MD; average of 
axial diffusivity (AD) and perpendicular diffusivities), and radial diffusivity (RD; average 
of perpendicular diffusivities), the mode of anisotropy (sensitive to crossing fibres), and the 
apparent diffusion coefficient (indicating the magnitude of diffusion) (Le Bihan, 2003; Le 
Bihan et al., 2001; Yoncheva et al., 2016).
Resting state functional MRI (rs-fMRI), allows to analyse the temporal correlations of 
neural activity across anatomically disparate brain regions and thereby to examine the 
functional connectivity based on spontaneous brain activity, neural organization, and 
circuit architecture.
To investigate potential changes in brain activity, functional magnetic resonance imaging 
(fMRI) can be used. Since fMRI is sensitive to the oxygenation of the blood, the so-called 
blood-oxygen-level-dependent (BOLD) signal can be measured. Thereby brain function 
is measured, based on the premise that active cells consume oxygen, thus causing changes 
in blood oxygenation, and subsequently leading to increased blood flow. However, the 
exact link between cell activation, oxygen saturation, and cerebral blood flow changes is 
debatable (Hillman, 2014). Generally in fMRI, alterations in blood flow after e.g. a task-
induced stimulus or during a resting condition are measured.
Here, we systematically reviewed the imaging genetics literature for five frequent 
neurodevelopmental disorders, ADHD, ASDs, ODD and CD, and selected intellectual 
disability (ID) disorders. The choice for those neurodevelopmental disorders was based 
on their frequent comorbidity (Bailey et al., 2008; Connor and Doerfler, 2008; Hill et 
al., 2014; Vorstman and Ophoff, 2013) and robustly established associations with specific 
genetic variants. The aim of this work was to extract core brain mechanisms affected by 
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disease-linked genetic factors related to the individual disorders as well as their clinical 
overlap.
ADHD is one of the most common neurodevelopmental disorders, with a prevalence of 5-6% 
in childhood (American Psychiatric Association, 2013; Polanczyk et al., 2007). ADHD can 
be clinically characterized by two core symptom domains: inattention and hyperactivity/
impulsivity (American Psychiatric Association, 2013; Faraone et al., 2015). Up to 60% of 
all patients diagnosed in childhood show ADHD symptoms and/or meet formal diagnostic 
criteria for the disorder in adulthood, and prevalence rates of persistent ADHD in adults 
range between 2.5 and 4.9% (Simon et al., 2009). ASD affects approximately 0.6% to 1% 
of the children, making it one of the most prevalent disorders in childhood (Elsabbagh 
et al., 2012). Although there are some important differences in core symptom definition, 
the co-occurrence between ADHD and ASD is supported by clinical (Craig et al., 2015), 
common biological (Rommelse et al., 2010), and non-biological risk factors (Kroger et al., 
2011). Moreover, several studies identified that symptoms of autism or autistic traits appear 
in 20% to 30% of children with ADHD (Grzadzinski et al., 2011; Kochhar et al., 2011). 
Additionally, ADHD is a common comorbid disorder in children with ID, and the risk 
increases with increasing severity of ID (Voigt et al., 2006). Studies of children with mild 
and borderline ID have identified ADHD in 8% to 39% of the cases (Baker et al., 2010; 
Dekker and Koot, 2003; Emerson, 2003). ADHD is highly heritable (heritability 70-80%) 
(Burt, 2009; Faraone et al., 2005). However, identification of ADHD risk genes has been 
difficult (Franke et al., 2009; Gizer et al., 2009), mainly due to ADHD’s complex genetic 
background (Faraone et al., 2015; Franke et al., 2012). Mostly genetic variants, which occur 
quite frequent in the population and have generally small effects on disease risk have been 
investigated for their role in ADHD until today, either through candidate gene studies or 
hypothesis-free GWASs. Only a few of the candidate genes have been confirmed through 
meta-analysis (Gizer et al., 2009). However, none of the eleven GWAS (Hinney et al., 2011; 
Lasky-Su et al., 2008a; Lasky-Su et al., 2008b; Lesch et al., 2008; Mick et al., 2010; Neale 
et al., 2008; Neale et al., 2010a; Sanchez-Mora et al., 2014; Sonuga-Barke et al., 2008; 
Stergiakouli et al., 2012; Yang et al., 2013) nor a meta-analysis of many of them (Neale et 
al., 2010b) published to date, reported any genome-wide significant risk variant. 
ASDs refer to a heterogeneous group of neurodevelopmental disorders diagnosed in 
approximately 1 of 88 children (Autism and Developmental Disabilities Monitoring 
Network Surveillance Year 2008 Principal Incestigators and Centers for Disease Control 
and Prevention, 2012). It is characterized by deficits in social behavior and language 
development, as well as restricted or stereotypic interests (American Psychiatric Association, 
2013). About 70% of individuals with ASDs have some level of ID while the remaining 
30% have some disability (speech, behavior) other than cognitive dysfunction (Mefford et 
al., 2012). Whereas early reports estimated ASD heritability to be higher than 90% (Bailey 
et al., 1995; Folstein and Rutter, 1977; Ritvo et al., 1985; Steffenburg et al., 1989), recent 
population-based studies provided an estimate of ~50% heritability (Gaugler et al., 2014; 
Sandin et al., 2014). ASDs are genetically highly complex, as part of the cases has oligogenic 
or even monogenic causes (with an important role for de novo mutations (Iossifov et al., 
2014)), whereas the concerted action of common genetic variants of individually small 
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effect sizes and environmental factors is likely to cause most of the disease burden of ASDs 
(Iossifov et al., 2014) (Gaugler et al., 2014; Zhao et al., 2007). Several of those common 
variants contributing to ASD risk have been identified through hypothesis-driven studies. 
Until now, three GWASs have been performed for ASDs (Anney et al., 2010; Wang et al., 
2009; Weiss et al., 2009), which identified a single locus on chromosome 5p14, in-between 
CDH10 and CDH9 (Wang et al., 2009). Association with this locus might be driven by 
markers located within the MSNP1AS pseudogene (Ma et al., 2009).
CD and ODD are disruptive behavior disorders that tend to co-occur during development 
(Rowe et al, 2002). CD is defined as a repetitive and persistent pattern of behavior, in 
which the basic rights of others or major age-appropriate societal norms or rules are violated 
(Hill, 2002). ODD is defined by a pattern of angry and irritable mood, argumentative and 
defiant behavior, or vindictiveness (APA, 2013). As ODD and CD are the two most typical 
categorically defined aggression disorders, we discuss their overlap with the other disorders 
investigated in this paper both disorder specifically and in the general context of aggressive 
behavior. Genetics of these disorders are also discussed in the broader context of aggressive 
behavior. Co-morbid presence of ODD/CD is a clinically important dimension of ADHD 
heterogeneity, with ODD occuring in up to 60% of individuals with ADHD (Connor 
and Doerfler, 2008). Individuals with ADHD, who show such comorbid aggression-related 
problems, have a considerably worse prognosis than individuals without them. A defiant/
vindictive behavioral pattern is associated with an increased risk for criminal outcomes later 
in life (Aebi et al., 2013), and irritable mood is thought to underlie the developmental link 
between ODD and later affective disorders (Loeber et al., 2000; Stringaris et al., 2009). 
Aggressive behavior – not necessarily in the context of ODD or CD - is also highly prevalent 
in ASDs. Children with ASD are at higher risk for displaying aggressive and oppositional 
behavior compared to other populations, with prevalence estimates of up to 68% (Hill et 
al., 2014). The same is true for IDs. For example, for one of the most common forms of 
inherited ID, Fragile X syndrome (Hagerman and Hagerman, 2002; Loesch et al., 2004), 
it has been estimated that 38% of males and 14% of females engage in aggressive behaviors 
(Bailey et al., 2008). Like in ADHD, disruptive behaviors in ASD and ID are risk factors 
for later poor outcomes, family stress and greater functional impairment (Lecavalier, 2006). 
This emphasizes the need to identify risk factors for comorbid aggression in these disorders. 
Little is known yet about the etiological basis of the described comorbidities, but shared 
and unique genetic influences between disorders have been postulated to play a role (Dick 
et al., 2005; Faraone et al., 1991). Heritability of aggression-related disorders, including 
ODD and CD, has been estimated at about 50% (Veroude et al., 2016). However, like 
in ADHD, identification of risk genes has been difficult, because of the complex genetic 
background of aggression. Many common genetic variants with small effect sizes as well 
as the environment are assumed to contribute to disease etiology (Tielbeek et al., 2017; 
Veroude et al., 2016). However, rare genetic variations identified in Mendelien disorders 
with documented aggressive symptoms, often in the context of intellectual disability, also 
point at genes involved in aggression etiology (Zhang-James and Faraone, 2016). Only two 
of the common candidate variants for aggression investigated to date have been confirmed 
through meta-analysis (Ficks and Waldman, 2014). GWAS have been small, with the 
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exception of a recent GWAS by the early genetics and lifecourse epidemiology (EAGLE) 
consortium, which included a large cohort of children and adolescents (N=18,988) from 
the general population. Aggressive behavior was assessed in nine population-based studies 
using parent-report questionnaires and combined in meta-analysis. The GWAS meta-
analysis of the total cohort identified a region reaching near genome-wide significance. 
A candidate gene-based association test using the summary statistics of the total sample 
showed association of the AVPR1A gene with childhood aggression after correcting for 21 
candidate genes tested .
ID refers to a highly heterogeneous group of disorders characterized by below average 
intellectual functioning (IQ < 70) in conjunction with significant limitations in adaptive 
functioning with onset during development. ID may occur as an isolated phenomenon or 
accompanied with malformations, neurological signs, impairment of the special senses, 
seizures and behavioral disturbances (van Bokhoven, 2011). ID has an estimated prevalence 
of approximately 2% to 3%, and approximately 0.3% to 0.5% of the population is severely 
handicapped (Perou et al., 2013). Comorbidity with ADHD and ASDs is frequently 
observed (Vorstman and Ophoff, 2013). Disease etiology of ID is thought to be largely 
monogenic, but with many different genetic anomalies implicated (van Bokhoven, 2011). 
Genetic causes of ID range from large cytogenetically visible chromosomal aberrations, 
such as trisomy 21, to translocations, subchromosomal abnormalities (such as Prader-
Willi syndrome (15q11.2-q13)), copy number variations, and to single gene defects. We 
concentrated only on the latter in our review, based on the assumption that we can learn 
most from understanding effects of specific genes/variants on brain structure, function and 
connectivity. While in many ID disorders, a defect in a single gene can be identified as the 
cause of the disorder, only a few genes are hit more frequently and cause relatively common 
ID disorders. To prevent bias of our review by single case reports, we concentrated on 
those common forms of ID, especially selecting those, in which comorbidity with ADHD, 
ASD, and aggression is common. This resulted in five ID disorders included in this review: 
fragile X syndrome, tuberous sclerosis, neurofibromatosis type 1, Rett syndrome, and 
Timothy syndrome. Fragile X syndrome (FXS), caused by genetic defects in the FMR1 
gene, is associated with a variable clinical phenotype, including intellectual disabilities with 
a broad range of severities. IQ is 40 on average for affected men (Merenstein et al., 1996) 
and normal or borderline in females (de Vries et al., 1996), who show a milder phenotype 
because the disorder is X-chromosome-linked. High rates of autism and autistic behaviors 
are seen in individuals with FXS (Hagerman et al., 2009), and 59% of FXS subjects shows 
ADHD symptoms (Sullivan et al., 2006). It has been estimated that 38% of males and 
14% of females with the full mutation engage in aggressive behavior (Bailey et al., 2008). 
Neurofibromatosis type 1 (NF1), caused by mutations in NF1, is associated with the 
presence of usually benign neurofibromas. While IQ in general is average to low average, 
up to 8% of children with NF1 have an IQ below 70. Learning difficulties, internalizing 
and externalizing behavior problems, and neuropsychological deficits are common. The 
core cognitive impairments are in visual spatial function, attention, executive function, and 
language skills. About 38% of children with NF1 meet diagnostic criteria for ADHD, and 
a substantial proportion of subjects show social deficits related to ASD (Hyman et al., 2005; 
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Walsh et al., 2013). Tuberous sclerosis complex (TSC) is caused primarily by mutations in 
the genes TSC1 and TSC2 and is characterized by benign hamartomas in multiple organ 
systems, including the brain. Intellectual ability in TSC ranges from normal to profoundly 
impaired, and neurobehavioral abnormalities and epilepsy are common. ASD, ADHD, as 
well as aggression are all reported in about 50% of individuals with TSC, with an even higher 
number of diagnoses in intellectually impaired individuals (Eden et al., 2014; Prather and 
de Vries, 2004). Rett syndrome, caused by mutations in the MECP2 gene, primarily affects 
females. Language problems and cognitive and motor deficits start to become obvious 
around the age of 6 months in the patients. Testing of cognitive dysfunction is difficult 
because of a characteristic absence of speech, but ASD-related features, such as avoidance of 
eye contact, are common (Armstrong, 2005). Timothy syndrome is a multisystem disorder 
caused by missense mutations in the CACNA1C gene. Neurodevelopmental features include 
global developmental delays and ASDs. Average age of death is 2.5 years, usually caused 
by ventricular tachyarrhythmia, infection, or complications of hypoglycemia (Splawski et 
al., 1993).
With this review, we aimed at providing a comprehensive overview on the imaging genetics 
literature for the neurodevelopmental disorders. To prevent bias, we excluded reports 
including less than 10 cases and focused on specific genetic variants, which for ADHD, 
aggression and ASDs resulted in a focus on genes/loci implicated through variants that 
are common in the population, and for ID, we restricted the review to the genes causing 
the single-gene ID disorders described above. While imaging genetics studies have been 
performed in patients, the underlying candidate genes and their common genetic variants 
are also frequently studied in healthy individuals. This allows analysis of effects of common 
genetic variation in candidate genes on imaging correlates in the general population and 
offers the opportunity to study brains not influenced by chronic disease and medication. 
Previous studies showed that neuroimaging correlates of common genetic variants are likely 
to be similar in typical and psychiatric populations (Hibar et al., 2015b). As such studies of 
healthy individuals may also be informative regarding the biological mechanisms leading 
to the diseases of interest, they were also included in this review. 
METHODS
Search terms
Pubmed was searched for research articles describing imaging genetics studies (April, 14th, 
2015; http://www.ncbi.nlm.nih.gov/pubmed). Only studies using magnetic resonance 
imaging (MRI) were reviewed, specifically structural MRI (sMRI), functional MRI 
(fMRI), resting-state functional MRI (rs-fMRI), and diffusion tensor imaging (DTI). A 
general search term was created and was extended by adding the disorder (for ADHD, 
ASD, and ODD/CD (investigated and described combined)) or syndrome name and gene 
(for ID) of interest. The following search term shows an example for ADHD (for [Title/
Abstract]): ((((ADHD OR Attention-Deficit Hyperactivity Disorder) AND (gene* OR 
genetic* OR imaging genetic OR imaging genetics OR genotype OR polymorphism OR 
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SNP OR single nucleotide polymorphism OR meta-analysis OR genome wide association 
OR GWA OR GWAS)) AND (structural magnetic resonance imaging OR volume 
OR sMRI OR voxel-based morphometry OR brain morphometry OR brain volumetry 
OR VBM OR functional magnetic resonance imaging OR fMRI OR diffusion tensor 
imaging OR diffusion imaging OR connectivity OR tractography OR DTI OR resting-
state functional magnetic resonance imaging OR voxel-wise analysis OR rsfMRI)) NOT 
“review”[Publication Type]). For ID syndromes, the search term did not include (gene* OR 
genetic* OR imaging genetic OR imaging genetics OR genotype OR polymorphism OR 
SNP OR single nucleotide polymorphism OR meta-analysis OR genome wide association 
OR GWA OR GWAS), as the genes of interest were added specifically. Titles and abstracts 
of the retrieved records were evaluated for relevant publications. Case-reports and reports 
describing less than 10 cases were excluded to prevent bias, and review articles, medical 
hypotheses, non-English articles, and studies on animal models were not considered (for a 
graphical summary of the selection procedure, please see Figure 1). 
Candidate gene selection for ADHD, ASD, ODD, CD and ID studies 
Taking into account the differences in the genetic architecture of the neurodevelopmental 
disorders of interest, we defined selection criteria for the genes to be included in this review 
as similar as possible. The restriction to studies with 10 or more cases and single genetic 
variants/single-gene mutations largely defined our search strategy, which resulted in a focus 
on common genetic variants for ADHD, aggression and ASDs (minor allele frequency ≥ 1%); 
for ID disorders, this lead to the selection of relatively common forms of the disorder. For 
ADHD, aggression and ASDs, we selected the most promising genes containing common 
variants associated with the disorder based on meta-analyses, successful replication studies, 
and/or significant findings from hypothesis-free (genome-wide) studies. 
For ADHD, we included all genes and genetic variants mentioned in Table 1 of the meta-
analytic study by Gizer and coworkers (2009) that had reached a significant result at P ≤ 
0.05 for association with ADHD. In addition to this, we also included genes with reported 
and replicated evidence for association with ADHD from more recent studies. These 
included two meta-analytic studies (Pan et al., 2015; Wu et al., 2012), a research article 
(Ribases et al., 2011), and the more recently observed replicated candidate genes NOS1 and 
SLC9A9 (Stergiakouli et al., 2012; Weber et al., 2015) (total number of candidate genes = 
10; Table I). A recent overview of these ADHD candidate genes has been published by 
Hawi and colleagues (2015).
For the ASD genes, we based our selection on the review of the most consistently replicated 
genes harboring common variants associated with autism by Persico and Napolioni (2013). 
Additionally, the CDH9/CDH10 locus was included, because it has shown genome-wide 
significant association with ASD (Prandini et al., 2012; Wang et al., 2009). Selection of 
the candidate polymorphisms in the selected genes was based on recent research articles, as 
meta-analyses were only available for the OXTR and RELN gene (total number of candidate 
genes = 11; Table II).
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For ODD/CD, we included the genes that have been most consistently associated with 
aggression-related phenotypes, thus using a braoder phenotypic definition for gene 
selection. The two most investigated genes in this context are the serotonin related 
genes SLC6A4/5HTT and MAOA. While a first meta-analysis, taking into account 12 
polymorphisms in aggression candidate genes, did not provide any meta-analytic evidence 
for association (Vassos et al., 2014), a later meta-analysis of 5HTTLPR and MAOA-uVNTR 
variants specifically (described in more detail below) confirmed association with antisocial 
behaviour (Ficks and Waldman, 2014). Hence, these polymorphisms were selected for 
the current study. Additionally, we included the AVPR1A gene, which showed gene-wide 
Figure 1: Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) flowchart of the 
literature search and study selection for qualitative analysis.
Note: see http://www.prismastatement.org/ for more information on this reporting system. ADHD = At-
tention-Deficit/Hyperactivity Disorder, ASD = Autism Spectrum Disorder, ID = Intellectual Disability. 
Records excluded for ID contain unrelated records identified by screening as well as records describing non-
ID samples. *The number of studies for ADHD candidate genes also include the records up to April 2015 for 
SLC6A4 (5-HTTLPR), which is also a candidate gene for ODD/CD and ASD.
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association significance in the largest aggression GWAS to date, after correcting for 21 
candidate gene tests (Pappa et al., 2015). Selection of risk polymorphisms in this gene was 
based on earlier candidate studies for aggression-related phenotypes (anger and altruistic 
tendency) (Table III; total number of ODD/CD candidate genes = 3). 
For the ID, the restrictions to relatively common forms of the disorder resulting from single 
gene mutations (as opposed to structural genetic variants involving several to many genes) 
as well as our aim to study potential brain mechanisms contributing to comorbidity among 
the disorders lead to the inclusion of the following 5 syndromes: fragile X syndrome (FMR1), 
tuberous sclerosis (TSC1 and TSC2), neurofibromatosis type 1 (NF1), Rett syndrome 
(MECP2), and Timothy syndrome (CACNA1C) (Table IV). For our selection, we used 
Table 1 from Vorstman and Ophoff (2013), describing genetic anomalies associated with 
ID. We included all disorders with known genetic cause including a single gene (FMR1, 
TSC1 and TSC2, NF1, and CACNA1C). Patients with these disorders also show a high rate 
of ASD, aggressive behaviors, and/or ADHD phenotypes (Bailey et al., 2008; Connor and 
Doerfler, 2008; Hill et al., 2014; Vorstman and Ophoff, 2013). Additionally, we included 
the Rett syndrome (MECP2), because of its known ASD- and ADHD-related features 
(Armstrong, 2005; Rose et al., 2016; Suter et al., 2014). 
RESULTS
Imaging genetics of ADHD candidate genes 
A total of 76 records were retrieved for the ADHD search term, and a total of 16 research 
articles describing case-control studies were eligible for review according to our criteria. 
To those, we added three more recent papers from our own group ((Onnink et al., 2016; 
Sokolova et al., 2015; van der Meer et al., 2015); Figure 1). Most of the studies investigated 
a single gene (all in Caucasians), and three studies investigated multiple genes (2 in 
Caucasians, 1 in Asians). In addition, we obtained 295 records for the ADHD candidate 
gene studies in healthy population samples, of which 98 were eligible (Figure 1). Of 
those, 73 studies investigated a single gene (68 in Caucasians, 5 in Asians), and 25 studies 
tested more than one gene (1 Asian). The ADHD case-control samples consisted of both 
childhood/adolescent and adult samples, whereas the studies in the healthy population were 
largely restricted to samples of (young) adults. Single-gene findings of ADHD case-control 
studies and studies in the healthy population of both Caucasian and Asian ethnicities 
can be found in Table V, multi-locus studies are shown in Table VII. Most of the genes 
investigated in brain imaging genetics studies in ADHD are from the dopaminergic and 
serotonergic neurotransmitter systems (SLC6A3/DAT1, DRD2, DRD4, SLC6A4/5-HTT/
SERT ). SNAP25, DRD5, HTR1B, and LPHN3 had also been selected for this study, but 
for these genes no imaging genetics studies using MRI were found with our search terms. 
The dopamine transporter gene DAT1 (official name SLC6A3) codes for a solute 
carrier protein, responsible for the reuptake of dopamine from the synaptic cleft into the 
presynaptic neuron, representing a primary mechanism of dopamine regulation in the 
striatum (Ciliax et al., 1999). The most widely studied polymorphism in SLC6A3/DAT1 
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is a variable number of tandem repeat (VNTR) sequence in the 3’ untranslated region 
(3’UTR) that is 40 base pairs (bp) in length. Most common alleles are those with 9 and 10 
repeats. Additionally, a 30 bp VNTR in intron 8 of the gene (most common alleles with 
5 and 6 repeats), is sometimes studied together with the 3’UTR VNTR as a haplotype. 
The 10R/10R genotype of the 3’UTR VNTR and the 10-6 haplotype of the two VNTRs 
are thought to be risk factors for ADHD in children (Asherson et al., 2007; Brookes et al., 
2006; Faraone et al., 2005). In contrast, the 9R/9R genotype and the 9-6 haplotype are 
associated with persistent ADHD (Franke et al., 2010). The sMRI and fMRI studies for 
SLC6A3/DAT1, the latter investigating several cognitive domains known to be impaired in 
ADHD, i.e. reward processing, working memory, and response inhibition, are summarized 
in Table V and VII. The main focus of the studies for this gene has clearly been on the 
striatum, which shows highest gene expression. 
The two sMRI case-control studies were performed in children, and both reported a 
smaller volume of the caudate nucleus in homozygotes for the 10R allele as compared to 
children with the 9R/10R genotype (Durston et al., 2005; Shook et al., 2011). A third 
study, including a large sample of children and adults with and without ADHD, showed 
that only in the adult ADHD case-control cohort, carriers of the DAT1 adult ADHD risk 
haplotype 9-6 had a 5.9% larger striatum volume relative to participants not carrying this 
haplotype. The effect was depended on diagnostic status, since the risk haplotype affected 
striatal volume only in patients with ADHD (Onnink et al., 2016). 
Two fMRI studies in case-control design investigated the SLC6A3/DAT1 haplotype using 
reward paradigms. Independent of the genotype, a recent meta-analysis has shown that in 
reward-processing paradigms, most studies report lower activation of the ventral striatum 
in patients with ADHD in anticipation of reward than controls (Plichta and Scheres, 2014). 
Consistent with this, a study in adolescents (including only males) found the activation of 
the caudate nucleus to be reduced in the ADHD group as the number of 10-6-haplotype 
copies increased (Paloyelis et al., 2012). The other study, in adult ADHD cases and controls 
(in whom the 9-6 allele is the ADHD risk allele), found no effect of DAT1 haplotype 
on striatal activity (Hoogman et al., 2013). Studies in healthy adult individuals point in 
different directions. One found higher activation during reward anticipation in 9R-carriers 
(Dreher et al., 2009). Another also found increased striatal activation in 9R-carriers in a 
rewarded task-switching task, especially in high reward conditions (Aarts et al., 2010). A 
third study in healthy adults suggested that a link between reward sensitivity and striatal 
activation during reward anticipation is only present in 10R/10R individuals, and is lost in 
9R-carriers (Hahn et al., 2011). In studies of response inhibition in children/adolescents, 
the 10R/10R genotype was found linked to lower (Durston et al., 2008) but also higher 
(Bedard et al., 2010) striatal activation. Methylphenidate was able to increase activity 
in the caudate nucleus (as well as a thalamocortical network and inferior frontal gyrus) 
during successful inhibition in healthy adult male 9R-carriers, but decreased activity in 
10R/10R individuals (Kasparbauer et al., 2015). A working memory task in healthy adults 
elicited more activation in fronto-striatal-parietal regions in 9R/10R individuals under high 
memory load (Stollstorff et al., 2010). Additionally, a resting-state fMRI study in healthy 
adults showed stronger connectivity between midbrain (mainly striatal) and prefrontal 
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regions in 9R/10R heterozygotes compared with 10R/10R homozygotes (Gordon et al., 
2015).
Beyond striatum, SLC6A3/DAT1 genotype effects have also been observed in fMRI studies 
of cortical regions, especially (pre)frontal, medial (pre-SMA, dorsal ACC), and (temporo)
parietal regions (Bedard et al., 2010; Braet et al., 2011) (Table V and VII). As expression of 
DAT is limited outside of striatum and cerebellum, these effects are likely due to direct or 
indirect connections between the regions of gene expression and the rest of the brain. This is 
in line with the fact that no effect of SLC6A3/DAT1 genotype on cortical development has 
been observed in a longitudinal study (Shaw et al., 2007). Of particular interest might be 
studies showing effects of SLC6A3/DAT1 genotype on amygdala reactivity upon exposure 
to threatening faces (Bergman et al., 2014) as well as on cerebellar activation during 
response inhibition (Durston et al., 2008). These regions are currently understudied in 
ADHD. A first study using DTI did not suggest a strong effect of SLC6A3/DAT1 genotype 
on structural brain connectivity (Hong et al., 2015) (Table V). 
In summary, although SLC6A3/DAT1 is one of the best-studied genes in imaging genetics 
literature covered in this review, existing studies do not yet clarify sufficiently the role of 
ADHD-linked genetic variation in brain activity and connectivity related to symptoms/
cognitive deficits or their structural brain correlates. A complicating matter for this gene is 
the switch in ADHD risk allele from childhood to adulthood. Furthermore, interactions 
between genotype and diagnosis are observed in some studies, which suggest that studying 
effects of SLC6A3/DAT1 in healthy individuals will not suffice to fully understand the 
brain mechanisms linking this gene to ADHD.
The dopamine D2 receptor gene (DRD2) codes for a G protein-coupled receptor, which 
inhibits adenylate cyclase (Andersen et al., 1990). Consistent with its broad expression 
in the brain being highest in striatum, DRD2 plays a key role in regulating mesolimbic 
reward processing pathways (Usiello et al., 2000) and is also implicated in other cognitive 
domains, such as cognitive flexibility and learning (Puig et al., 2014). The gene has been 
implicated in many different psychiatric disorders, including schizophrenia and substance 
use disorders (Patriquin et al., 2015; Schizophrenia Working Group of the Psychiatric 
Genomics, 2014) and is the target of several antipsychotics (Moore et al., 2014). The risk 
factor for ADHD is the most frequently investigated common genetic variant of DRD2 
rs1800497 (also known as Taq1A restriction fragment length polymorphism). This SNP 
actually lies downstream of DRD2 in an exon of a neighboring gene, ANKK1 (Neville et 
al., 2004). It affects dopamine D2 receptor expression and striatal dopamine metabolism, 
with the A1-allele (the ADHD risk allele) reducing the number of DRD2 receptors (Laakso 
et al., 2005). No studies in ADHD case-control design are yet available for DRD2. The risk 
SNP has, however, been investigated in healthy individuals using structural and functional 
MRI covering the cognitive domains of reward processing, task-switching and reversal 
learning, working memory, emotion recognition, and language (Table V and VII). 
Structural MRI showed that the SNP affects the volume of midbrain structures, with 
A1-allele carriers having smaller volumes of substantia nigra (Cerasa et al., 2009), cerebellum 
(Wiener et al., 2014), and ACC (in interaction with BDNF; (Montag et al., 2010)). 
Functional MRI during reversal learning tasks revealed that A1-allele carriers showed 
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reduced response of the rostral cingulate to negative feedback and had a reduced recruitment 
of the right ventral striatum and right lateral occipital frontal cortex (OFC) during reversals 
(Jocham et al., 2009). Pharmacological fMRI in a reversal learning task showed that 
cabergoline (D2 receptor agonist) administration induced an allele-specific response, where 
A1-allele carriers showed increased neural reward responses in medial OFC, cingulate 
cortex, and striatum (consistent with increased D2-mediated dopamine signaling); this 
was coupled, however, to worse task performance and lower fronto-striatal functional 
connectivity (Cohen et al., 2007). The reward-related paradigms showed that A1-allele 
carriers exhibited increased anterior insula (Richter et al., 2013) and increased nucleus 
accumbens activation, the latter observed only in a three-way interaction analysis looking 
for differences between a placebo and bromocriptine (D2 receptor agonist) administration 
condition (Kirsch et al., 2006). Two multi-locus studies including the DRD2 Taq1A variant 
suggested higher activation during reward anticipation, but blunted activity during reward 
receipt with increasing number of risk factors (Table VII).
In summary, the effects of the ADHD risk factor in DRD2 in fMRI appear to be relatively 
consistent across most of the studies currently available, with stronger brain activity in parts 
of the wider reward processing and memory/learning circuits. It seems that this stronger 
activity is linked to worse functional connectivity and/or performance, thus potentially 
reflecting compensatory processes. Currently, no data from patients with ADHD are 
available.
The dopamine D4 receptor (encoded by the DRD4 gene) is another G protein-coupled 
receptor and belongs to the dopamine D2-like receptor family (Oldenhof et al., 1998). The 
most widely studied DRD4 polymorphism in ADHD has been the 48 bp VNTR in exon 3, 
with the 2-, 4-, and 7-repeat alleles being the most common alleles. Allele frequencies vary 
significantly across ethnic groups (Chang et al., 1996; Van Tol et al., 1992), and the ADHD 
risk allele in the Caucasian population (7R) seems to be a different one from that in Asians 
(Nikolaidis and Gray, 2010; Wang et al., 2004). 
Structural MRI suggested that patients with ADHD carrying the 7R-allele have smaller 
volumes of the superior frontal and cerebellar cortex (Monuteaux et al., 2008), while no 
differences were found in another study (Castellanos et al., 1998) (Table V). Interestingly, 
carriership of the DRD4 7R-allele seemed to affect cortical development in a longitudinal 
study, with 7R-carriers showing thinner prefrontal and parietal cortex and ADHD 
patients with this allele having a distinct trajectory of cortical development characterized 
by normalization of parietal cortical regions (Shaw et al., 2007) (Table VII). Structural 
connectivity was investigated in two studies in Asians using DTI, and while one did not 
find effects for 4R homozygotes (Hong et al., 2015), a very large recent study reported 
widespread increases in mean diffusivity in 5R-carriers (Takeuchi et al., 2015) (Table V). 
With the role of the D4 dopamine receptor in cognition not sufficiently characterized 
yet, and DRD4 being expressed in large parts of the cortex (predominantly in frontal 
lobe regions, such as the OFC and ACC (Floresco and Tse, 2007; Noain et al., 2006)), 
fMRI studies have investigated the DRD4 gene in healthy Caucasians covering different 
cognitive domains, i.e. emotion processing, response inhibition, reward, stimulus-response 
incompatibility, and time discrimination tasks, as summarized in Table V. Depending on 
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the type of paradigm used in the fMRI studies, DRD4 genotype was found to modulate 
brain activity in prefrontal and temporal, but also in striatal and cerebellar brain regions in 
the healthy adults (Table V). 
Thus, though existing evidence does not support firm conclusions, DRD4 may mark a 
particular developmental trajectory in cortical brain structure related to adult outcome of 
ADHD, and plays a role in structural connectivity. With only one fMRI study per cognitive 
domain published to date, no clear picture of DRD4 action on brain activity emerges, but 
those studies do clearly indicate that DRD4 (like DAT1) influences brain activity beyond 
its regions of expression, possibly due to its effects on white matter connectivity (Takeuchi 
et al., 2015).
The serotonin transporter gene (SLC6A4, 5HTT, SERT ) codes for a solute carrier protein 
responsible for the reuptake of serotonin from the synaptic cleft back into the presynaptic 
neuron, which is the primary mechanism for regulation of serotonergic activity in the brain 
(Lesch et al., 1996). A functional polymorphism in the promoter region of the gene (referred 
to as 5HTTLPR) is a 44-bp insertion/deletion yielding short (S) and long (L) alleles. The 
long variant is associated with more rapid serotonin reuptake, resulting in lower levels of 
active serotonin (Lesch et al., 1996). However, allele frequencies vary across different ethnic 
groups (Haberstick et al., 2015). A SNP in the long allele, rs25531, can modify the activity 
of this allele (Lesch et al., 1996). SLC6A4/5HTT has been implicated in emotion regulation 
as well as (emotional) memory and learning processes (Araragi and Lesch, 2013; Barzman 
et al., 2015; Meneses and Liy-Salmeron, 2012). Expression of the transporter is observed 
in regions implicated in attention, memory, and motor activities, such as the amygdala, 
hippocampus, thalamus, putamen, and ACC (Frankle et al., 2004; Oquendo et al., 2007). 
Only one recent imaging genetics study in patients with ADHD has been performed for 
the 5HTTLPR, showing that stress exposure, which is associated with increased ADHD 
severity in S-allele carriers, was associated with reduced cortical gray matter volume in 
precentral gyrus, middle and superior frontal gyri, frontal pole, and cingulate gyrus in these 
individuals. Interestingly, this paper showed that only some of these regions, the frontal pole 
and the ACC, actually mediated the effects of the gene-environment interaction on ADHD 
severity. In sMRI studies in healthy individuals, the 5HTTLPR has been associated with 
volume of the ACC and amygdala as well as hippocampus, though the direction of effect 
seemed to differ with gender and/or in interaction with environmental factors (Table V). 
Few studies have looked at effects of the 5HTTLPR on structural connectivity (Table V). A 
large study observed reduced connectivity of amygdala with PFC in S-allele carriers (Long 
et al., 2013), while another reported increased hippocampus-putamen connectivity for this 
genotype group (Favaro et al., 2014). 
Brain activation patterns in task-based fMRI have been studied extensively for the 
5HTTLPR following hallmark studies by the Weinberger lab (Hariri et al., 2005; Hariri 
et al., 2002). They were the first to report increased activation of the amygdala in S-allele 
carriers in response to negative-emotional faces. Since then, increased amygdala activation 
has been observed in S-allele carriers in many tasks activating the amygdala (Table V and 
VII). In 2013, 34 studies investigating effects of the 5HTTLPR on amygdala activation 
were meta-analyzed, confirming the increased activation in S-allele carriers (although only 
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borderline significant) (Murphy et al., 2013). However, this meta-analysis also showed 
strong heterogeneity between studies and a potential publication bias (towards studies 
reporting significant associations). Linked to the increased activation seems to be a reduced 
functional connectivity of the amygdala, as first observed by Pezawas and colleagues (2005) 
and subsequently also seen in additional studies (Table V). Not only the amygdala, but 
also other cortical and subcortical brain regions (forming the ‘threat circuit’) seem to be 
influenced by 5HTTLPR genotype. A recent, replicated fMRI study, for example, also 
showed stronger activity in dorsomedial prefrontal cortex (dmPFC), insula, thalamus, and 
regions of the midbrain, in reaction to threat in S-allele carriers (Klumpers et al., 2014); 
interestingly, also in this study (like in the one by van der Meer and coworkers (2015)) only 
some of the activated regions actually mediated the genotype effects on psychophysiological 
responsivity to pending threats (in this case the dmPFC activation, Table V).
 Increasing evidence suggests that S-allele carriers are hypervigilant to environmental stimuli 
(Homberg and Lesch, 2011). Potential sustained effects of environmental factors have not 
sufficiently been addressed in imaging genetics studies published to date. Several studies 
have taken stressful life events into account, and these studies suggested effects on both 
brain volume and activation. Only one study to date has directly looked at methylation of 
the promoter of the SLC6A4/5HTT gene, and found correlations with the volume of several 
regions in the ‘threat circuit’ of the brain, though these appeared genotype-independent 
(Dannlowski et al., 2014). Also a combined PET, sMRI plus fMRI study indicated that 
5HTTLPR genotype did not influence current (midbrain) serotonin transporter availability 
(Kobiella et al., 2011), suggesting that other factors (like environmental ones) might overrule 
this effect. Taking into account epigenetic effects on the SLC6A4/5HTT gene might thus 
help explain the strong heterogeneity observed in the meta-analysis of amygdala reactivity 
studies (Murphy et al., 2013). 
In summary, functional genetic variation in the SLC6A4/5HTT gene is clearly linked to 
emotion regulation through effects on brain activation in the amygdala and the wider ‘threat 
circuit’, with those carrying the risk factor for emotional dysregulation showing increased 
activation in tasks related to emotion processing and learning. Those experiments link 
reduced availability of the transporter (at some point in development) - and thus increased 
serotonin signaling capacity - to increased brain activation. This increased activation seems 
to be linked to functional dysconnectivity, however. Whether brain volume and structural 
integrity are influenced by the 5HTTLPR, remains to be clarified. Importantly, genotype 
effects are likely to be sensitive to environmental factors.
The nitric oxide synthase 1 (encoded by the NOS1 gene) is an enzyme which synthesizes 
nitric oxide from L-arginine. Nitric oxide is a reactive free radical, which acts as a biological 
mediator in several processes, including dopaminergic and serotonergic neurotransmission 
(Kiss and Vizi, 2001). The NOS1 gene has a complex structure, including 12 alternative 
untranslated first exons (exon 1a-1l). In exon 1f, a functional VNTR that affects gene 
expression has been linked to hyperactive and impulsive behavior in humans (Reif et 
al., 2009; Weber et al., 2015), with the short allele being the risk factor for ADHD. In 
addition, a recent Nos1 knock-out mouse model showed dysregulation of rhythmic activities 
mimicking ADHD-like behaviors (Gao and Heldt, 2015).
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So far, only one case-control study investigated the effect of the VNTR polymorphism on 
the brain, in his case on reward-related ventral striatal activity (Hoogman et al., 2011) (Table 
V). The study revealed that homozygous carriers of the short allele of NOS1 demonstrated 
higher ventral striatal activity than carriers of the other NOS1 VNTR genotypes (Hoogman 
et al., 2011). This effect was comparable for both patients and healthy individuals. Similar 
effects of the genotype were also observed for behavioral impulsivity, with those carrying 
the ADHD risk factor acting more impulsive than other participants. 
Imaging genetics of candidate genes for autism spectrum disorders
A total of 193 records were retrieved for the ASD search terms, and a total of six research 
articles were eligible for review according to our criteria. All studies investigated a single 
gene and were performed in Caucasian populations. For studies in the healthy population, 
we obtained 120 records, and 17 were included in the review (Figure 1). Twelve of those 
investigated a single gene in a Caucasian study sample, and five studies used Asian samples 
(studies for SLC6A4/5HTT are included in the ADHD section above). Generally, the ASD 
case/control samples included mainly childhood and adolescent study samples, whereas 
the studies in healthy population samples mostly used samples of (young) adults. From 
the eleven genes selected and listed in Table VI, imaging genetics studies could only be 
retrieved for genetic variants in CNTNAP2, MET, OXTR, and the SLC6A4/5HTT gene.
The contactin-associated protein-like 2 (CASPR2), encoded by the gene CNTNAP2 (the 
largest gene in the human genome), is a neural transmembrane protein involved in neuronal-
glial interactions and in clustering K+-channels in myelinated axons; as such, it is involved 
in neuronal cell adhesion, migration, and the formation of neuronal networks (Rodenas-
Cuadrado et al., 2014). Several single nucleotide polymorphisms (SNPs) in CNTNAP2 
have been associated with ASDs. During human brain development, CNTNAP2 expression 
is broad, with highest levels in frontal and anterior lobes, striatum, and dorsal thalamus. 
This cortico-striato-thalamic circuitry is important for higher order cognitive functions, 
including speech and language, reward, and frontal executive function (Rodenas-Cuadrado 
et al., 2014). This is reflected in the imaging genetics studies having been performed for 
CNTNAP2, which cover studies of brain volume and structural connectivity as well as 
brain activity and functional connectivity during tasks related to rewarded learning and 
language (Table VI). 
Two studies performed DTI in healthy individuals. For the SNP rs2710102 it was found 
that carriers of the CC risk genotype showed reduced overall path length and increased 
small-worldness of brain-wide structural connectivity, which appeared to be a general 
phenomenon rather than being localized to individual tracts (Dennis et al., 2011). A large 
study in healthy individuals combining sMRI with DTI for the SNP rs7794745 showed 
that carriers of the ASD risk genotype exhibited reduced gray and white matter volume 
as well as reduced white matter integrity in the cerebellum, fusiform gyrus, occipital and 
frontal cortices; distribution of reductions was found to be sex-specific (Tan et al., 2010). 
In a case-control study, an association between the SNP rs2710102 and medial prefrontal 
cortex activation during a rewarded implicit learning task was found, when collapsing 
patients and controls into one group. The non-risk allele was linked to reduced activation. 
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Furthermore, the risk carriers had more widespread and bilateral connectivity throughout 
the frontal cortex and anterior temporal poles. The latter finding was confirmed in an 
independent healthy sample (Scott-Van Zeeland et al., 2010). An additional fMRI study 
using a sentence completion paradigm showed that carriers of the risk genotype for one of 
two SNPs had increased activation of the IFG (Broca’s area), the lateral temporal cortex, or 
right middle temporal gyrus (Whalley et al., 2011).
The Met proto-oncogene encoded by the MET gene is a cell surface receptor with tyrosine-
kinase activity. In the forebrain, MET gene and protein expression is regulated in excitatory 
projection neurons during synaptogenesis (Judson et al., 2011) and is restricted to regions 
of temporal, occipital, and medial parietal cortex in humans. These regions are known to 
be of relevance to the processing of socially relevant information (Rudie et al., 2012). The 
effects of the ASD risk variant rs1858830 have been studied in two imaging genetics studies 
(Table VI). 
A case-control study combining fMRI (emotional face task), resting-state fMRI, and 
DTI modalities showed that the ASD risk genotype predicted wide-spread atypical brain 
activity patterns to social stimuli, with increased activation in amygdala and striatum, 
and impaired deactivation patterns in part of the default mode network (DMN) in the 
posterior cingulate cortex. In addition, reduced functional and structural connectivity 
was observed in temporo-parietal regions belonging to the DMN suggesting altered white 
matter integrity. In general, the effects were more pronounced in the ASD group (Rudie 
et al., 2012). An sMRI study in a large sample of healthy individuals revealed that cortical 
thickness in temporal, pre- and postcentral gyri, anterior cingulate, and frontopolar cortex 
was reduced in risk-allele carriers, with reductions increasing with increasing number of 
risk alleles (Hedrick et al., 2012). 
The oxytocin receptor (OXTR) gene encodes the receptor protein for oxytocin, which has 
an important role in the regulation of social cognition and behavior (Meyer-Lindenberg et 
al., 2011). So far, no imaging genetic studies were performed for risk variants in the OXTR 
gene in ASD case-control samples, but twelve studies in healthy samples were found (Table 
VI). Various different SNPs and combinations of those were investigated, not all related to 
ASD risk. 
Two sMRI studies showed that adolescents homozygous for the rs2254298 risk factor 
for psychopathology displayed an overall increased gray matter volume, but a decreased 
amygdala volume (Furman et al., 2011); for carriers of the rs53576 SNP, a risk factor for 
disorders associated with social impairment, a smaller hypothalamus gray matter volume 
was reported in healthy adults (Tost et al., 2010). 
Functional MRI paradigms used to study OXTR all covered the cognitive domains of 
emotion processing and reward (Table VI). In a face matching task, adult carriers of the 
rs53576 risk allele showed increased functional correlation of hypothalamus and amygdala 
during perceptual processing of facial emotion (Tost et al., 2010). Investigating a large 
group of 1445 healthy adolescents in a passive face viewing task for effects of 23 SNPs 
across OXTR, the IMAGEN Consortium found significant effects of one SNP on ventral 
striatal activity in a region of interest analysis. In the presence of stressful life events, this 
SNP modulated the occurrence of emotional problems in the participants, linking more 
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emotional problems to reduced striatal activation; no effects of the risk variants for ASD 
were observed (Loth et al., 2014). A study of brain regions related to processing of social 
stimuli observed increased functional connectivity between such regions in adult carriers 
of the risk genotype for rs53576 (Verbeke et al., 2013). Functional MRI of mesolimbic 
structures during reward processing was modulated by the rs2268493 risk factor for ASD: 
young adult carriers of the risk genotype showed reduced activation in mesolimbic reward 
circuitry (nucleus accumbens, amygdala, insula, thalamus, and prefrontal cortical regions) 
during the anticipation of rewards but not during reward receipt (Damiano et al., 2014). 
Using a mother-child interaction task, Michalska and coworkers (2014) showed that 
females carrying the ASD risk genotypes for rs53576 or rs1042778 had lower brain activity 
in OFC, ACC, and hippocampus in response to child stimuli. When healthy adult females 
were tested for empathic response and associated brain activation, carriers of the rs2254298 
risk factor for psychopathology showed increased responsiveness of the superior temporal 
sulcus to observed pain (Laursen et al., 2014). In a pharmacologic imaging genetics study 
in adult males, one of three SNPs modulated the response of the amygdala (only) after 
oxytocin inhalation, with increased activation to directed gaze and decreased activation to 
averted gaze under oxytocin in the carriers of the variant allele (Montag et al., 2013). This 
study did not find any effects of rs2254298 on brain activation.
In summary, genetic variation in the OXTR gene has been linked to brain activation during 
emotional processing. Risk factors for ASD/psychopathology appear to reduce activation 
during most relevant paradigms, but may increase functional connectivity during those 
tasks.
Four ASD case-control imaging genetics studies investigated the gene encoding the 
serotonin transporter gene (SLC6A4, 5HTT ) in addition to those in healthy individuals 
(and ADHD case-control samples) described in the section on ADHD candidate genes. 
Structural MRI, fMRI, and rs-fMRI were used to study the effect of either only the 
5HTTLPR or the combination of this variant with rs25531 (Table VI). 
Whereas a VBM study did not reveal an association between total gray or white matter 
volume and genotype in adult patients (Raznahan et al., 2009), another sMRI study showed 
that in 2-4 year old boys with ASD, carriers of the 5HTTLPR S-allele had increased total 
cortical and frontal lobe gray matter volume (Wassink et al., 2007), suggesting an age-
dependent effect of the variant. 
The fMRI and rs-fMRI study, performed in overlapping samples of adolescent patients 
and controls, showed that carriers of alleles that mark low gene expression had increased 
amygdala activation during an emotional face task, an effect that was observed only in 
the patients (Wiggins et al., 2014b), and increased posterior-anterior connectivity during 
a resting-state condition in patients, where the converse was observed in the healthy group 
(Wiggins et al., 2012). 
The findings of those case-control studies are not easily reconciled with those observed 
in healthy individuals (Table V and VII), and indeed the latter two studies suggest the 
existence of differential effects in patients and healthy individuals.
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Imaging genetics of candidate genes in oppositional defiant disorder and conduct 
disorder
A total of 158 records were retrieved for the ODD and CD search terms. No case-control 
studies were identified. For studies in the healthy population, we obtained 38 records, 
of which 15 were eligible for review (Figure 1). This search included imaging genetics 
studies for AVPR1A and MAOA, updated up to October 1th, 2017. Studies investigating 
SLC6A4/5HTT in healthy individuals are included in the ADHD section above (Table V). 
Imaging genetics studies for genetic variants in AVPR1A and MAOA in healthy individuals 
are summarized in Table VIII. Most of these studies investigated Caucasian adolescents 
or (young) adults.
The Arginine Vasopressin Receptor 1A (AVPR1A) gene encodes the primary receptor of 
arginine vasopressin (AVP) in the brain. This is a neuropeptide, which is strongly implicated 
in emotional and complex social behaviors, including aggressive behaviors (Ebstein et al., 
2010). Two repeat polymorphisms (RS1 and RS3) exist in the promoter region of the gene, 
with shorter alleles of RS3 and the 320 bp allele of RS1 marked as risk alleles (Knafo et 
al., 2008; Moons et al., 2014). While no imaging genetics studies have been performed 
so far in case-control samples for ODD or CD, two studies investigated the effect of 
microsatellite variants RS1 and RS3 on the brain in healthy individuals (Table VIII). One 
study investigated brain activation during a face-matching task in a Caucasian population, 
and found a significant increase in left amygdala activation in carriers of the 334 bp risk 
allele of RS3 compared to all other alleles. The 320 bp risk allele of RS1 was associated with 
decreased left amygdala activity compared to other alleles (Meyer-Lindenberg et al., 2009). 
The second study investigated effects of RS3 on grey matter volume in a Chinese Han 
population. Smaller grey matter volume of the right fusiform face area (FFA) was found 
in male subjects with shorter repeats, representing risk for (decreased) altruistic decision 
making (Wang et al., 2016). Although more information is necessary, these first studies 
suggest an association of AVPR1A risk factors for psychopathology with the structure and 
function of brain areas involved in processing socially relevant information (amygdala 
and FFA).
The monoamine oxidase A gene (MAOA), located on the X-chromosome, encodes a key-
enzyme in the metabolism of monoamine neurotransmitters. The 30 base pair variable 
number of tandem repeats of the gene (MAOA-uVNTR) is the most commonly studied 
polymorphism in the context of human antisocial behaviors. Transcription of short repeats 
(2 or 3 repeated copies) of this VNTR results in reduced MAOA activity (MAOA-L), while 
long repeats (3.5 or 4 copies) result in increased activity (MAOA-H). Low activity variants, 
leading to increased serotonin in the synapse, are positively associated with antisocial 
behaviors in meta-analysis (Ficks and Waldman, 2014). 
Only one study investigated the effect of MAOA genotype group on brain structure, and 
found pronounced limbic grey matter volume reductions, including structures like amygdala 
and ACC, in individuals homo-/hemizygous for MAOA-L compared to MAOA-H alleles 
(Meyer-Lindenberg et al., 2006). Ten additional studies investigated brain function, and 
several confirm differential task-related activation of the structurally affected limbic brain 
regions for subjects with MAOA-L compared to MAOA-H genotypes (Table VIII). Studies 
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using face-matching tasks detected increased activity in the amygdala as well as increased 
amygdala connectivity with the ventromedial PFC, which was male-specific (Buckholtz 
et al., 2008; Meyer-Lindenberg et al., 2006). Sex-specificity of brain function differences 
during face-matching was also highlighted by a later study, where a three-way interaction 
of MAOA genotype group, sex, and stressful life events on brain activity was found: male 
MAOA-L subjects with a high exposure to life stress showed increased amygdala and 
hippocampal activity, while a decrease was seen in male MAOA-H subjects. Interestingly, 
females showed the opposite pattern (Holz et al., 2016). Other fMRI studies using tasks 
related to emotion processing confirmed increased amygdala activation in male MAOA-L 
carriers. Adverse emotional memory retrieval (Meyer-Lindenberg et al., 2006), response to 
the word ‘no’ in subjects with high anger reactivity (Alia-Klein et al., 2009), and response 
to anger provocation (Denson et al., 2014) all elicited increased amygdala activation in 
male MAOA-L carriers. While the same activity increase has been found for female carriers 
of MAOA-L alleles during passive viewing of sad faces (Lee and Ham, 2008), results are 
more variable for women (e.g. (Holz et al., 2016)). One report, studying females only, found 
increased amygdala activation during a rejection-themed emotional Stroop paradigm in 
MAOA-L adults, but decreased activation in MAOA-L adolescents (Sebastian et al., 2010), 
suggesting that functional development of the circuitry underlying the processing of social 
rejection continues throughout adolescence into adulthood. Hence, the effects of MAOA 
genotype on emotional or social neural responses may vary not only with sex, but also 
with age.
Functional imaging genetics studies for MAOA have also probed cognitive inhibitory 
control. Studies using a Flanker task show that male MAOA-L carriers have decreased 
activation in dorsal ACC during response inhibition (Holz et al., 2016; Meyer-Lindenberg 
et al., 2006). Another study, investigating how MAOA affects brain activity within resting-
state networks, confirms reduced activity in brain areas related to inhibitory and executive 
control for MAOA-L subjects (Clemens et al., 2015).
In summary, available imaging genetics studies in healthy individuals confirm that genetic 
variation in the MAOA gene is linked to brain activation during emotion and inhibitory 
processing. Increased amygdala activation during emotion processing and reduced 
activation in regions regulating inhibitory control might be intermediate phenotypes for 
aggressive behaviour, suggesting a possible mechanism of susceptibility for ODD/CD and 
other aggression-related phenotypes.
Imaging genetics in selected intellectual disability disorders
A total of 579 records were retrieved for the ID syndromes of interest. Eighty research 
articles were eligible for review according to our criteria, 30 for fragile X syndrome, 24 for 
neurofibromatosis type 1, 22 for tuberous sclerosis complex, and four for Rett syndrome 
(Figure 1). No imaging studies of Timothy syndrome patients were uncovered by our search 
term. The reviewed imaging genetics studies in ID syndromes are presented in Table IX.
The fragile X mental retardation 1 gene (FMR1) is located on the X chromosome and 
codes for fragile X mental retardation protein. Large expansions of a CGG repeat (>200 
repeats) in the 5’- untranslated (5’UTR) region of the gene, leading to protein deficiency, 
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are the cause of fragile X syndrome (FXS). FMR1 has a prominent role in synaptic plasticity 
and maturation (Saldarriaga et al., 2014). In studies including participants with the FMR1 
full mutation, brain structure was most often investigated, followed by task-based brain 
activation (Table IX). A few studies investigated brain structural integrity and resting-state 
functional connectivity. Several studies compared individuals with FXS with and without 
ASD or included an idiopathic autism or IQ-matched group (Table IX). 
The most robust finding in investigations of brain structure in FXS is an increased caudate 
nucleus volume. This enlargement was observed early in development (Hazlett et al., 2009), 
throughout adolescence (Bray et al., 2011; Hall et al., 2013; Lee et al., 2007) as well as in 
adult samples (Hallahan et al., 2011; Molnar and Keri, 2014; Wilson et al., 2009). Studies 
comparing individuals with FXS and with ASD found increased caudate volumes in 
children and adults with FXS compared to children/adults with idiopathic autism (Hazlett 
et al., 2009; Wilson et al., 2009). Consistent volumetric abnormalities have also been found 
for cerebellar regions in FXS; a reduction in the volume was observed in both children 
and adults with FXS (Hazlett et al., 2012; Hoeft et al., 2008; Wilson et al., 2009). Several 
studies found cerebellar volumes to be larger in children and adults with FXS relative to 
individuals with autism, in whom reduced volume of cerebellar regions compared to control 
subjects is often seen as well (Hazlett et al., 2012; Wilson et al., 2009). Few studies have 
investigated white matter integrity in people with the full FMR1 mutation, and deficits seem 
most prominent in fronto-striatal connections. Increased density of fibers was found in the 
left ventral fronto-striatal pathway in boys with FXS compared to typically developing 
and developmentally delayed controls (Haas et al., 2009), and differences in white matter 
in frontal-caudate circuits were found in females with FXS compared to controls (Barnea-
Goraly et al., 2003). More widespread reductions in white matter integrity have also been 
observed (Villalon-Reina et al., 2013). 
Cognitive and psychiatric characteristics associated with FXS include poor eye contact, 
repetitive motor behavior, language deficits, inattention, hyperactivity, inhibition, and 
anxiety (Saldarriaga et al., 2014). Functional neuroimaging studies have focused on these 
deficits, with a main focus on poor eye contact and behavioral inhibition. Several fMRI 
studies have investigated the circuitry underlying face/gaze processing in subjects with FXS, 
as eye-gaze avoidance is common in this population. Abnormal activation was found in 
several regions, including superior temporal gyrus and fusiform gyrus (Garrett et al., 2004), 
amygdala and insula (Watson et al., 2008), regions within the ventrolateral prefrontal cortex 
(vlPFC) (Holsen et al., 2008), and frontal cortex and cingulate and fusiform gyri (Bruno 
et al., 2014). These regions are associated with visual processing, social cognition, emotion 
processing, and executive functioning, indicating that eye-gaze avoidance in FXS may be 
linked to social anxiety. Investigating attention and inhibition, a study using a Go/No-go 
task found that boys with FXS show reduced activation in the right vlPFC and caudate 
head. The authors suggested that defective fronto-striatal signaling is a key feature of FXS, 
leading to impairments in executive functioning (Hoeft et al., 2007), which is in line with 
the altered white matter connectivity in fronto-striatal connections, described above. 
The neurofibromin 1 gene (NF1) located on chromosome 17q11.2 codes for neurofibromin, 
a protein which is thought to be a regulator of the RAS signal transduction pathway 
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and necessary for embryonic development. Neurofibromatosis type 1 (NF1) is caused 
by mutations in the gene, often leading to the synthesis of truncated or otherwise non-
functional proteins. We found 14 studies investigating effects of NF1 on brain structure 
and four investigating brain function. Additional studies of brain structural and functional 
connectivity have been conducted. While most studies included children and adolescents, 
a few studies have included adults as well (Duarte et al., 2014; Karlsgodt et al., 2012; Pride 
et al., 2014; Violante et al., 2012; Wignall et al., 2010; Zamboni et al., 2007) (Table IX). 
The structural brain abnormalities most commonly seen in subjects with NF1 are T2 
hyperintensities and an increased brain volume. T2 hyperintensities are areas of high 
signal intensity on T2-weighted MR images also referred to as ‘unidentified bright objects’ 
(UBOs). Although their association with cognitive and intellectual deficits remains 
controversial, thalamic hyperintensities have repeatedly been associated with cognitive 
impairments (Payne et al., 2010). Multiple studies have investigated the characteristics of 
UBOs. UBOs are found in almost all children with NF1, but reports on whether their 
volume and number increases or decreases with age are inconsistent (Gill et al., 2006; 
Griffiths et al., 1999; Kraut et al., 2004). A few studies have used diffusion tensor imaging 
(DTI) to characterize white matter microstructure and integrity of UBOs by measuring 
the degree and directionality of diffusivity. Higher apparent diffusion coefficient (ADC) 
and (radial) diffusivity values and lower fractional anisotropy (FA) values have been found 
in UBOs compared to normal appearing white matter (Ertan et al., 2014; van Engelen 
et al., 2008). These findings can be explained by myelin deficiency and axonal damage. 
An increase in brain volume is observed in children with NF1, which was found to be 
due to increases in white matter volume (Said et al., 1996; Steen et al., 2001), gray matter 
volume (with an increased gray to white matter ratio especially in younger subjects (Moore 
et al., 2000)), or both gray and white matter volume (Karlsgodt et al., 2012). These volume 
increases involve temporal, parietal, occipital, and frontal regions (Duarte et al., 2014; 
Greenwood et al., 2005; Pride et al., 2014). In addition, the corpus callosum seems larger 
in cases compared to controls, which has been found in children with NF1 as well as adults, 
marking it as a robust finding for NF1 (Duarte et al., 2014; Moore et al., 2000; Violante 
et al., 2013; Wignall et al., 2010). In addition to the investigation of UBOs, DTI studies 
have been used to study microstructural integrity in NF1 more broadly. Increased ADC 
values (Ertan et al., 2014; Nicita et al., 2014; van Engelen et al., 2008) and decreased FA 
values (Ertan et al., 2014; Ferraz-Filho et al., 2012) are found widespread across the brain. 
Karlsgodt et al. also found increased radial diffusion, which may be explained by decreased 
myelination or axonal packing density (2012). Differences in radial diffusivity have also 
been observed at the genu and anterior body of the corpus callosum (Wignall et al., 2010). 
The change in corpus callosum size and connectivity observed in NF1 may have functional 
importance, as they have been associated with academic achievement and visual-spatial and 
motor skills (Moore et al., 2000). 
Three fMRI studies have investigated visual-spatial processing in subjects with NF1, and 
one study investigated phonologic processing (Table IX). During visual-spatial processing, 
decreased activation in the primary visual cortex was found for individuals with NF1 
compared to controls (Clements-Stephens et al., 2008), although an earlier study reported 
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contrasting findings of increased posterior (occipital) cortex activation relative to lateral/
inferior frontal activation (Billingsley et al., 2004). A later study did confirm that both 
children and adults with NF1 showed deficient activation of the low-level visual cortex 
during tasks specifically designed to activate magnocellular and parvocellular pathways 
(Violante et al., 2012). During such magnocellular-biased stimulation, NF1 patients did 
not deactivate regions belonging to the brain default-mode network as would be expected 
during cognitively demanding tasks (Violante et al., 2012).
The tumor growth suppressor genes tuberous sclerosis 1 (TSC1) and tuberous sclerosis 2 
(TSC2) code for the hamartin and tuberin proteins, respectively. Mutations in either TSC1 
or TSC2 disrupt the function of the GTPase-activating protein (GAP) complex formed by 
these proteins that regulates mTOR signaling. The neurocutaneous syndrome tuberous 
sclerosis complex (TSC), characterized by benign hamartomas in multiple organ systems, is 
caused primarily by these mutations. In the brain, the hamartomas manifest as subendymal 
giant cell astrocytomas, subendymal nodules (SEN), and tubers. Tubers show disrupted 
cortical architecture and contain a number of atypical cells. For TSC, structural MRI 
and DTI studies have been conducted investigating both typical neuropathological lesions, 
especially tubers, and normal-appearing brain matter (Table IX). A consistent imaging 
determinant of the cognitive phenotype in TSC has not been established. Findings of an 
inverse correlation of tuber number and cognitive functioning have not been consistent 
(Ridler et al., 2004). Tuber/brain proportion may be a better predictor of IQ than tuber 
load, although the age of seizure onset in patients seemed to predict cognitive functioning 
best (Jansen et al., 2008). However, abnormal brain structure and connectivity unrelated to 
tubers are likely also important factors contributing to the neurobehavioral abnormalities 
in TSC. Decreased white matter volume of major intrahemispheric tracts has been found 
in adults with TSC compared to age-matched controls, as has a decrease of gray matter 
volume in several cortical and subcortical structures (Ridler et al., 2001; Ridler et al., 
2007). Reduced volume in the cerebellum has been associated with tuber-associated loss of 
the underlying parenchyma (Jurkiewicz et al., 2006; Marti-Bonmati et al., 2000). Reduced 
cerebellar volume was observed in all cerebellar regions in a more recent study, with 
strongest volume reductions in patients with a mutation in TSC2 (Weisenfeld et al., 2013). 
The finding of reduced cerebellar volume is in line with mouse models showing cerebellar 
involvement in TSC (Reith et al., 2011). White matter abnormalities are another typical 
finding in TSC. DTI studies generally report increased ADC values and decreased FA 
values in individuals with TSC compared to controls, in tubers and white matter lesions, 
but also in other white matter portions (Table IX). Compared to contralateral white 
matter or white matter in control subjects, increased ADC values were found in cortical 
tubers, and higher ADC and lower FA values were found in white matter lesions (Piao et 
al., 2009). A recent study also found increased radial diffusivity values and decreased FA 
values in cortical tubers and white matter lesions (Dogan et al., 2015). Hypomyelination, 
gliosis, and heterotopic cells may lead to ADC and FA changes observed in such lesions 
(Alexander et al., 2007). Abnormalities have also been reported in normal-appearing white 
matter in individuals with TSC compared to control groups. Decreased FA and increased 
ADC, especially in corpus callosum and internal and external capsules, have been reported 
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repeatedly (Krishnan et al., 2010; Peters et al., 2012; Simao et al., 2010). A recent whole-
brain analysis of white matter connectivity showed that increased radial diffusivity exists 
throughout the brains of TSC patients and that interhemispheric connectivity is decreased 
(Im et al., 2015).
The methyl CpG binding protein 2 gene (MECP2) is located on the short arm of 
chromosome X (Xq28) and codes for the protein MECP2. MECP2 acts as a modifier of 
gene expression and is highly expressed in the brain. Mutations in MECP2 are the cause 
of Rett syndrome, a disorder primarily affecting female patients. Brain weight is reduced 
in Rett syndrome, particularly that of cerebral hemispheres. Although the anatomical 
basis for this reduction is not completely clear, it has been suggested that it is caused by 
defective neuronal maturation for which MECP2 is essential, rather than by atrophy 
(Armstrong, 2005). Only few imaging studies have been conducted in series of patients 
with Rett syndrome (Table IX). All investigated brain structure in girls. These studies 
confirmed a wide-spread reduction in cerebral white and gray matter volumes, the latter 
most pronounced in subcortical nuclei including the caudate nucleus and in prefrontal, 
posterior-frontal, and anterior-temporal (Reiss et al., 1993; Subramaniam et al., 1997) and 
parietal regions (Carter et al., 2008). Using DTI, evidence of reduced white matter integrity 
was found in frontal regions, corpus callosum, and internal capsule. FA was also reduced 
in the superior longitudinal fasciculus, but only in patients who had little or no ability to 
speak (Mahmood et al., 2010).
DISCUSSION
In this review, we set out to summarize the literature on imaging genetics studies in 
neurodevelopmental disorders. This being a very broad field, we focused on five most 
frequent and often comorbid disorder spectra, ADHD, ASDs, ODD, CD and selected forms 
of ID, and we only considered MRI-based imaging genetics studies. Further restriction of 
the search space was achieved by focusing on genes harboring common genetic variants 
with the most consistent evidence for association with ADHD, ASDs, and aggression, and 
by selecting five relatively common ID disorders with frequent ADHD/ASDs/aggression 
comorbidity implicating single genes. The review was driven by the wish to learn more 
about the mechanisms by which genetic factors influence disease-related behavior specific 
to the individual disorders and their clinical overlap. 
At the level of the individual genes, the most extensively studied candidate gene is the 
SLC6A4 (5HTT ) gene encoding the serotonin transporter (associated with ADHD and 
ASDs as well as with ODD and CD). Limitations regarding power of individual studies 
and hypothesis-driven designs aside, the fMRI-based imaging genetics literature on this 
gene does show a remarkably coherent picture of functional genetic variation leading to 
hyperactivation of the amygdala and connected areas in conjunction with functional 
dysconnectivity amongst those areas. Possibly, this finding is linked to availability of 
synaptic serotonin, as imaging genetics studies on the MAOA gene – coding for an enzyme 
that metabolizes monoamine neurotransmitters - reveal a similar picture. However, since 
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much of this research has been performed in healthy individuals only, the link to cognition 
in patients with neurodevelopmental disorders needs further investigation. Findings for 
SLC6A3 (DAT1) and DRD4, which have also been studied quite often already, still lack 
the consistency observed for SLC6A4 (5HTT ), partly due to the much less restricted focus 
on a particular cognitive domain, and thus more ‘patchy’ literature. 
The most consistent findings observed in all of the imaging genetics literature reviewed 
here are for the different genetic variants for ID. This is likely linked to the severity of 
the variants present in the patients, with those for ID being rare and most damaging. 
Consistent are finding for increased caudate volume and reduced cerebellum due to FMR1 
mutations, and for T2 hyperintensities and increased brain volume in patients carrying 
NF1 mutations. However, in terms of finding overlap between different forms of ID, we 
find that conclusiveness of studies still is limited, as most concentrated on a limited set 
of (often non-overlapping) features. Tubers and T2 hyperintensities have received a lot of 
attention in studies of TSC and NF1, for example, although reports on their contribution 
to cognitive deficits are inconsistent. In recent years, DTI studies have produced evidence 
that tissue microstructure and white matter connectivity patterns are affected in all ID 
disorders, and often in widespread brain areas. Effects on brain volumes are also often 
widespread, but can go in opposite directions, with reductions in total brain volume in 
Rett, but increases in NF1. One may conclude that while altered (structural) connectivity 
is likely to play a role in ID etiology, MRI at its current resolution (1.5 – 4 Tesla), does not 
allow a sufficiently detailed view on the brain to understand the neuroanatomical overlap 
between disorders (Williams and Casanova, 2011). 
Similar to the situation amongst the ID disorders, there seems to be little overlap between 
the findings for different genes in ADHD, ASD, and aggression related disorders. This is 
likely to be heavily influenced by the strong focus on regions and cognitive domains of 
interest (consistent with the limited power of many of the studies published to date). Some 
overlap is seen, e.g., for DAT1 and DRD2, both of which have been studied for their effects 
on striatal phenotypes. (Appropriately powered) brain-wide studies and phenome-wide 
association study (PheWAS)/RDoc-like approaches (Cuthbert and Insel, 2013; Pendergrass 
et al., 2011) would help to determine, whether the apparent specificity of brain phenotypes 
for individual genes is real. An important observation is that gene expression does not 
predict/limit the location of effects of a genetic factor ( e.g., SLC6A3/DAT1 shows effects 
outside of its region of gene expression), most likely through effects on structural and/or 
functional connectivity.
Did the reported imaging genetics findings help us understand the comorbidity between 
different neurodevelopmental disorders? This would be expected, since several of the genes 
implicated in ID, ASD, ADHD, ODD and CD, function in the same or overlapping 
molecular networks (Poelmans et al., 2011; Rudie et al., 2012; van Bokhoven, 2011). 
As discussed above, imaging genetics studies of SLC6A4 and MAOA putatively point 
to a similar mechanism for ADHD and aggression symptomatology based on amygdala 
hyperactivity/dysconnectivity. However, the limited availability of genes investigated 
through imaging genetics to date might bias our interpretation of the data. In ID, the genes 
studied thus far are related to mTOR signaling, RAS signaling, and translation repression/
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regulation, thus functioning in very ‘basal’ cell signaling pathways in comparison to the 
genes investigated for ADHD and ODD/CD, which regulate the dopamine and serotonin 
neurotransmitter systems specifically. This could explain the much more widespread cell 
proliferation/migration defects observed in ID, whereas in for example ADHD defects 
seem more specific, e.g. limited to individual neurotransmitter systems and or affecting 
cell-cell communication more acutely. ASD seems to be intermediate between the other 
disorder spectra, but more studies are necessary to substantiate this view. What is already 
very clear from the available studies, is that the associations of genetic factors are with 
behavioral traits, and not with the disorders directly (e.g., (Hoogman et al., 2011). Some 
level of pleiotropy is highly likely, which may also form the basis of comorbidity between 
the neurodevelopmental disorders.
In general, we found the existing imaging genetics literature for the neurodevelopmental 
disorders of our interest lacking in several aspects. Firstly, despite our focus on well-
supported candidate genes, several of the selected genes had not been studied at all 
with MRI in humans. In several additional cases, only single studies were available for 
different MRI modalities (sMRI, DTI, fMRI), thus limiting the conclusiveness of the 
reported findings. And in the case of ODD/CD, no case-control studies were retrieved 
for the selected aggression candidate genes at all. Secondly, most imaging genetics studies, 
especially the earlier ones, suffer from being underpowered. The small sample sizes are 
severely hampering the generalization of findings to the population the samples are meant 
to represent (Button et al., 2013). Although the endophenotype concept postulates that 
measures, which mediate a genetic effect on behavior (including some of those investigated 
in the imaging genetics studies), should have stronger effect sizes for gene effects than the 
behavioral/disease measures (Gottesman and Gould, 2003), the sample size of most studies 
would still have to be considered too small. The problem of limited number of samples 
becomes evident from e.g. a recent review by Strike and coworkers. They showed that at the 
most lenient threshold for significance (α = 0.05) studies with at least 1,566 participants 
would be needed to achieve the canonical 80% power threshold to detect a reasonable effect 
size (0.5% of the phenotypic variance explained) (Strike et al., 2015). Furthermore, recent 
work raises doubts about whether larger effect sizes can really be expected for neuroimaging 
(endo)phenotypes, at least for volumetric MRI measures (Franke et al., 2016; Hibar et 
al., 2015b). Major challenges are the large inconsistency across genetic variants tested and 
genotype groups compared, differences in study designs and imaging modalities, and the 
fact that data acquisition and analysis protocols usually were not standardized across studies. 
Additionally, we observed large inconsistency across studies in the way how genotypic effects 
were reported and recommend a standardized way of reporting results, e.g. including at 
least effect estimates and standard errors. Nevertheless, meta-analyses are strongly needed 
in order to enable definition of robust findings and realistic effect estimates. Therefore, 
meta-analytic studies would be beneficial for those brain measures covered by multiple 
studies, as it was shown for the effect of the serotonin transporter 5HTTLPR on amygdala 
activation (Murphy et al., 2013). Thirdly, to interpret observed links between genes, 
brain, and behavior properly, one needs to determine, whether a brain (endo)phenotype 
is really intermediate between a genetic factor and a behavioral outcome, or if it is only an 
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epiphenomenon unrelated to the behavior of interest (Kendler and Neale, 2010; Preacher 
and Hayes, 2008). Only few studies have really studied this, e.g. by mediation analysis 
including environmental, behavioral, and/or physiological variables (Klumpers et al., 
2014; van der Meer et al., 2015), by applying combinations of different imaging modalities 
(Kobiella et al., 2011; Zhang et al., 2015), or by using causal modeling (Sokolova et al., 
2015). The results of those studies show that only part of the brain regions showing genotype 
effects actually do mediate between genetics and behavior, proving the importance of such 
multilevel investigations. Fourthly, age effects might also be of importance, but have been 
neglected in most studies. Our own work has shown, for example, that the risk factor for 
ADHD in DAT1 differs between children and adults, which resulted in effects of the 9-6 
VNTR haplotype on caudate nucleus volume only in adult patients (Onnink et al., 2016). 
Age effects have also been observed for the 5-HTTLPR variant (Wiggins et al., 2014a) and 
for MAOA (Sebastian et al., 2010). Fifthly, current brain imaging genetics studies often 
suffer from additional limitations, such as the low ethnic diversity, as most studies included 
cohorts of only Caucasian origin, and gender imbalance, especially in studies of childhood 
ADHD and ASD that showed an over-representation of males. 
An important additional aspect is that this review enabled us to look at the overlap between 
studies in healthy individuals and those in patients (case-control designs). An interaction 
between genetic variant and diagnosis was indeed observed in some studies (e.g. (Durston 
et al., 2008; Monuteaux et al., 2008; Wiggins et al., 2012; Wiggins et al., 2014b). With 
the available limited amount of evidence it is hard to judge though, whether this is a true 
difference between patients and healthy individuals, or whether it is simply due to power 
restrictions in the samples investigated. Recent genome-wide studies investigating the 
genetics of brain structure as part of the ENIGMA Consortium (Thompson et al., 2014) 
suggest that effects are largely similar for healthy individuals and those with a psychiatric 
disorder (Hibar et al., 2015b; Stein et al., 2012). This means, that brain imaging genetics 
studies with healthy participants can be very informative in discovering related brain 
correlates and in understanding the biological mechanisms leading to diseases of interest.
Did we overlook important literature through the choices made in our review? We did 
restrict our selection of genes to study. For ASD, we did not include genes harboring rare 
genetic variants, while those might result in stronger effect sizes, as observed for the ID 
genes. However, most of the rare variants linked to ASD have only recently been identified, 
making the availability of imaging genetics studies (with 10 or more cases) unlikely. A 
similar argument holds true for our selection of ID genes, where the imaging genetics 
literature is largely focused on the relatively common disorder subtypes we included in our 
study. We also restricted our search to MRI-based studies, following a first screen of the 
literature showing that this was the predominant method used for imaging genetics studies 
of the neurodevelopmental disorders. Nevertheless, for several genes/variants, also other 
imaging modalities have been employed, which may provide additional insights. EEG 
and MEG offer a much higher time resolution than MRI, and may allow investigation 
of genetic influences on neuronal functioning and oscillation patterns. PET can provide 
information on (acute) protein availability. Especially the integration of modalities in the 
study of individual participants can provide deeper insights into mechanisms (e.g. (Kobiella 
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et al., 2011)). Moreover, future studies might want to investigate additional comorbid 
neurodevelopmental disorders, such as obsessive-compulsive disorder (OCD), once robust 
association of genetic variants with these disorders has been established and investigated in 
imaging genetics studies. 
To summarize, despite the considerable numbers of imaging genetics studies in 
neurodevelopmental disorders available for review, this field of research should still be 
considered in its early stages. More genes need to be studied, and individual genes need to be 
investigated in larger samples, with more hypothesis-generating brain- and phenome-wide 
methods. Gene-environment interactions and age effects should be taken into account. 
While we see consistent findings for single genes and variants, gene-wide and gene-set 
analyses, with polygenic scores explaining more phenotypic variance and thus improving 
study power (Bralten et al., 2011), are likely to take the stage in the future. Several early 
examples reviewed here already show the promise of this work (e.g. (Nikolova et al., 2011; 
Passamonti et al., 2008; Stice et al., 2012). As the genes in such sets often show different 
gene expression patterns, (structural and functional) connectivity patterns are likely the 
best brain phenotypes to be studied with such approaches (see above). In the future, we 
are also likely to see studies approaching imaging genetics in a different way, by asking the 
question, whether genes contributing to brain structure/function observed in hypothesis-
free, genome-wide approaches also contribute to disease-related phenotypes (Franke et al., 
2016). First studies of this kind have been published for schizophrenia (Franke et al., 2016) 
and obsessive compulsive disorder (OCD) (Hibar et al., 2015a), based on results of findings 
from the ENIGMA GWAS of brain structure (Hibar et al., 2015b; Stein et al., 2012). To 
successfully map the biological pathways from gene to disease, imaging genetics studies 
need to be combined with complementary approaches  (Klein et al., in press). Recent 
examples for this are provided by studies by our own group, in which we investigated 
effects of ADHD-associated genes for their effects in the fruit fly Drosophila melanogaster 
(Klein et al., 2015; van der Voet et al., 2016), as well as the study by Jia and coworkers, in 
which the authors identified a genetic variant significantly associated with dysfunctional 
reward, a cognitive and affective deficit frequently observed in ADHD, then verified gene 
function in locomotion in the fruit fly model (Jia et al., 2016). In conclusion, although still 
in its early stages, results from studies available thus far already confirm that the imaging 
genetics approach is suitable to provide more insight into the link between genes, the brain, 
and behavior in neurodevelopmental disorders.
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TABLES CHAPTER 5
To improve readability of the article, tables for chapter 5 have been grouped together in 
this separate section. References for each table can be found directly below it to enable fast 
lookup of information.
Table I: Genes containing common variants most consistently implicated in ADHD, based on (Gizer et al. 
2009) and more recent (meta-) analyses.
Gene Protein Associated 
variant/
polymorphism
Risk allele Location/chr 
position
References for reports of 
association with ADHD 
DRD2/ ANNK1 Dopamine receptor 
D2/ Ankyrin repeat 
and kinase domain 
containing 1
Taq1A (rs1800497) T allele = 
A1-allele
Exon 8/
3’ 
flanking/11q23
(Comings et al. 1991)a;
(Pan et al. 2015)b
DRD4* Dopamine receptor 
D4
48 bp VNTR 7 repeat  
(5 repeat in 
Asians)
Exon 3/11p15 (LaHoste et al. 1996)a; 
(Gizer et al. 2009)b; (Wu et 
al. 2012)b
rs1800955 T allele Promoter/11p15 (Barr et al. 2001)a; (Yang 
et al. 2008)d; (Gizer et al. 
2009)b
DRD5 Dopamine receptor 
D5
148 bp dinucleo-
tide repeats
148 bp allele 5’ 
flanking/4p16
(Daly et al. 1999)a; (Gizer et 
al. 2009)b; (Wu et al. 2012)b
HTR1B Serotonin 
receptor 1B, G 
protein-coupled
rs6296 G allele Exon 1/6q14 (Hawi et al. 2002)a; (Gizer 
et al. 2009)b
LPHN3 Latrophilin 3 rs6551665 
rs6858066 
G allele
G allele
4q13 (Arcos-Burgos et al. 2010)
a; (Hwang et al. 2015)
d; (Ribases et al. 2011)d; 
(Labbe et al. 2012)a
NOS1* Nitric oxide synthase 
1
180-210 bp CA 
repeat
Short allele Exon 1/12q24 (Reif et al. 2009)a; (Franke 
et al. 2009)c; (Weber et al. 
2015)b
SLC6A3/ DAT1*
 
Solute Carrier Family 
6 (Neurotransmitter 
Transporter), Member 
3; Dopamine trans-
porter 1
40 bp VNTR 10 repeat 3’ UTR/5p15 (Cook et al. 1995)a; (Gizer et 
al. 2009)b
rs27072 G allele 3’ UTR/5p15 (Galili-Weisstub and 
Segman 2003)a; (Gizer et 
al. 2009)b
30 bp VNTR 6 repeat Intron 8/5p15 (Brookes et al. 2006)a; 
(Gizer et al. 2009)b
SLC6A4/ 5HTT* 
 
Solute carrier family 
6 (neurotransmit-
ter transporter), 
member 4; serotonin 
transporter
5-HTTLPR Long allele Promoter/17q11 (Manor et al. 2001)a; (Gizer 
et al. 2009)b; (Landaas et 
al. 2010)b
SLC9A9/ NHE9 Solute Carrier Family 
9, Subfamily A, 
Member 9
rs9810857 T allele Region 
3p14-q21
(de Silva et al. 2003)a; (Ster-
giakouli et al. 2012)c; (Mick 
et al. 2010)c
SNAP25 Synaptosomal-associ-
ated protein, 25kDa
rs3746544 T allele 3’ UTR/20p12 (Brophy et al. 2002)a; (Gizer 
et al. 2009)b
Bold text indicates significant result at P < 0.05 in Gizer et al., 2009. aAssociation first reported by. bMeta-anal-
ysis article. cGWAS finding. dAssociation in large sample or validation using animal model. *Gene with at least 
one case-control imaging genetics study; ADHD = Attention deficit/hyperactivity disorder, bp = base pair, chr 
= chromosome, CNV = copy number variation, UTR = untranslated region, VNTR = variable number tandem 
repeat; no imaging genetics studies found.
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Table II: Genes containing common variants most convincingly implicated in ASDs, adapted from Persico 
and Napolioni (2013). We added CDH9, CDH10, and MSNP1AS, because the locus harbouring these genes 
has shown genome-wide significant association with ASDs in GWAS (Prandini et al. 2012; Wang et al. 
2009). Selection of candidate polymorphisms and risk alleles for ASD was based on recent research articles.
Gene Protein Associated 
variant/
polymorphism
Risk allele Location/chr 
position
References for association with 
ASD
CDH9 Cadherin 9 rs4307059 C allele Intergenic/5p14 (Wang et al. 2009)a,c; (Prandini et 
al. 2012)d
CDH10 Cadherin 10 rs4307059 C allele Intergenic/5p14 (Wang et al. 2009)a,c; (Prandini et 
al. 2012)d
MSNP1AS Moesin pseudogene 1, 
antisense
rs4307059 C allele Intergenic/5p14 (Wang et al. 2009)a,c; (Prandini et 
al. 2012)d
CNTNAP2* Contactin associated 
protein-like 2
rs7794745 T allele Intron 2/7q35 (Arking et al. 2008)a; (Li et al. 
2010)d
rs2710102 C allele Exon 8/7q35 (Stein et al. 2011)
EN2 Engrailed homeobox 2 rs1861972 G allele Intron/7q36 (Gharani et al. 2004)a; (Benayed et 
al. 2005)d
rs1861973 T allele Intron/7q36 (Gharani et al. 2004)a; (Benayed et 
al. 2005)d
GABRB3 Gamma-aminobu-
tyric acid (GABA) A 
receptor, beta 3
rs7171512 G allele Intron/15q12 (Warrier et al. 2013)a
rs7180158 (AS) G allele Intron/15q12 (Warrier et al. 2013)a
rs7165604 (AS) T allele Intron/15q12 (Warrier et al. 2013)a
rs12593579 (AS) C allele Intron/15q12 (Warrier et al. 2013)a
rs9806546 (EQ) G allele Intron/15q12 (Warrier et al. 2013)a
rs11636966 (EQ) T allele Intron/15q12 (Warrier et al. 2013)a
ITGB3 Integrin, beta 3 (plate-
let glycoprotein IIIa, 
antigen CD61)
rs12603582 T allele Intron 
11/17q21.32
(Napolioni et al. 2011)a; (Schuch et 
al. 2014)d
rs15908 A allele Exon 9/17q21.32 (Schuch et al. 2014)a
MET* Met proto-oncogene 
(hepatocyte growth 
factor receptor)
rs1858830 C allele Promoter/7q31 (Campbell et al. 2006)a; (Sousa et 
al. 2009)d; (Thanseem et al. 2010)
d; (Zhou et al. 2011)d
OXTR Oxytocin receptor rs7632287 A allele 3’ flanking/3p25 (Tansey et al. 2010)a; (LoParo and 
Waldman 2014)b; (Campbell et 
al. 2011)d
rs237887 A allele Intron3/3p25 (Liu et al. 2010)a; (LoParo and 
Waldman 2014)b
rs2268491 T allele Intron3/3p25 (Liu et al. 2010)a;  (LoParo and 
Waldman 2014)b
rs2254298 A allele Intron3/3p25 (Wu et al. 2005)a; (LoParo and 
Waldman 2014)b; (Liu et al. 2010)
d; (Nyffeler et al. 2014)d
rs2268493 C allele Intron3/3p25 (Yrigollen et al. 2008)a; (Campbell 
et al. 2011)d; (Di Napoli et al. 
2014)d
rs53576 A allele Intron3/3p25 (Wu et al. 2005)a; (Nyffeler et al. 
2014)d
rs2268494 T allele Intron3/3p25 (Lerer et al. 2008)a
RELN Reelin rs362691 Population 
specific?
Exon 22/7q22 (Wang et al. 2014)b
rs362780 G allele Intron 41/7q22 (Holt et al. 2010) a
rs736707 Population 
specific?
Intron 59/7q22 (Sharma et al. 2013)a
rs2073559 T allele Intron 11/7q22 (Ashley-Koch et al. 2007) a
SLC6A4/
5HTT*
Serotonin transporter 5-HTTLPR Long allele Promoter/17q11.2 (Nyffeler et al. 2014)d; (Gadow et 
al. 2013)
aAssociation first reported by. bMeta-analysis article. cGWAS finding. dAssociation in large sample or validation 
using animal model. *Gene with at least one case-control imaging genetics study; ASD = Autism spectrum 
disorder, AS = Asperger’s syndrome, chr = chromosome, EQ = empathy quotient); no imaging genetics studies 
found.
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Table III: Genes containing common variants most consistently implicated in aggressive behaviors, based on 
(Ficks and Waldman, 2014) and (Pappa et al., 2015).
Gene Protein Associated 
variant/poly-
morphism
Risk allele Location/chr 
position
References for reports 
of association with 
ADHD 
AVPR1A Arginine Vasopressin 
Receptor 1A
Gene-wide - 12q14 (Pappa et al., 2015)b
RS1 and RS3 320 allele (RS1); short 
repeats (RS3)
5’ UTR/12q14 (Moons et al., 2014); 
(Knafo et al., 2008)
SLC6A4/ 5HTT 
 
Solute carrier family 
6 (neurotransmitter 
transporter), member 4; 
serotonin transporter
5-HTTLPR Short allele Promoter/17q11 (Ficks and Waldman, 
2014)a
MAOA Monoamine oxidase A 30bp 
uVNTR
Short repeats Promoter/Xp11 (Ficks and Waldman, 
2014)a
aMeta-analysis article. bGWAS finding.; bp = base pair, chr = chromosome, UTR = untranslated region, VNTR 
= variable number tandem repeat; no imaging genetics studies found.
REFERENCES TABLE III
Ficks, C.A., and Waldman, I.D. (2014). Candidate genes for aggression and antisocial behavior: a meta-analysis 
of association studies of the 5HTTLPR and MAOA-uVNTR. Behav Genet 44, 427-444.
Knafo, A., Israel, S., Darvasi, A., Bachner-Melman, R., Uzefovsky, F., Cohen, L., Feldman, E., Lerer, E., Laiba, 
E., Raz, Y., et al. (2008). Individual differences in allocation of funds in the dictator game associated with 
length of the arginine vasopressin 1a receptor RS3 promoter region and correlation between RS3 length 
and hippocampal mRNA. Genes, brain, and behavior 7, 266-275.
Moons, W.G., Way, B.M., and Taylor, S.E. (2014). Oxytocin and vasopressin receptor polymorphisms interact 
with circulating neuropeptides to predict human emotional reactions to stress. Emotion 14, 562-572.
Pappa, I., St Pourcain, B., Benke, K., Cavadino, A., Hakulinen, C., Nivard, M.G., Nolte, I.M., Tiesler, C.M.T., 
Bakermans-Kranenburg, M.J., Davies, G.E., et al. (2015). A genome-wide approach to children’s aggressive 
behavior:The EAGLE consortium. Am J Med Genet 171, 562-572.
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Table IV: Genes causing prevalent and well-studied single-gene ID disorders with behavioral and cognitive 
overlap with ADHD, ASD, and/or aggression.
Gene Protein Chr 
position
Associated ID 
disorder
Reported rate 
of ASD-related 
phenotype
Reported rate of 
ADHD-related 
phenotype
Reported rate of aggres-
sion- related phenotype
FMR1 Fragile X mental 
retardation 
protein
Xq27 Fragile X 
syndrome
30% [Hagerman 
and others 2009]
59% [Sullivan 
and others 2006]
38% (males)/14%(females) 
(Bailey et al., 2008)
NF1 Neurofibromin 17q11 Neurofibroma-
tosis type 1
40% [Walsh and 
others 2013] 
38% [Hyman and 
others 2005]
unknown
TSC1
TSC2
Hamartin
Tuberin
9q34
16p13
Tuberous scle-
rosis complex
50% [Prather and 
de Vries 2004]
30-60% [D’Agati 
and others 2009]
50% (Eden et al., 2014)
MECP2 Methyl-CpG-
binding protein 
2
Xq28 Rett syndrome 42-58% [Wulf-
faert and others 
2009]
unknown unknown
CACNA1C Voltage-de-
pendent L-type 
calcium channel 
subunit alpha-1C
12p13 Timothy 
syndrome
60% [Splawski 
and others 2004]
unknown unknown
Genes causing prevalent and well-studied single-gene ID disorders with behavioral and cognitive overlap with 
ADHD and/or ASD.
Phenotypic overlap as adapted from [Vorstman and Ophoff 2013]; ID= intellectual disability; ASD= Autism 
spectrum disorder; ADHD= Attention deficit/hyperactivity disorder; Chr= chromosome; no imaging genetics 
studies found.
REFERENCES TABLE IV
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 c
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f c
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 c
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l. 
20
06
)
Imaging genetics in neurodevelopmental psychopathology 
221
C
ha
pt
er
 5
D
is
or
de
r
G
en
e
Im
ag
in
g 
m
od
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re
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t o
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l l
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 b
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t p
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 c
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 c
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, d
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 c
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, t
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ABSTRACT
Reactive and proactive subtypes of aggression have been recognized to help parse etiological 
heterogeneity of this complex phenotype. With a heritability of about 50%, genetic factors 
play a role in the development of aggressive behavior. Imaging studies implicate brain 
structures related to social behavior in aggression etiology, most notably the amygdala and 
striatum. This study aimed to gain more insight into the pathways from genetic risk factors 
for aggression to aggression phenotypes.
To this end, we conducted genome-wide gene-based cross-trait meta-analyses of aggression 
with the volumes of amygdala, nucleus accumbens, and caudate nucleus to identify genes 
influencing both aggression and aggression-related brain volumes. We used data of large-
scale genome-wide association studies of a) aggressive behavior in children and adolescents 
(EAGLE, N=18,988) and b) Magnetic Resonance Imaging (MRI)-based volume measures 
of aggression-relevant subcortical brain regions (ENIGMA2, N=13,171). Second, the 
identified genes were further investigated in a sample of healthy adults (mean age (SD)=25.28 
(4.62) years; 43% male) who had genome-wide genotyping data and questionnaire data on 
aggression subtypes available (BIG, N=501) to study their effect on reactive and proactive 
subtypes of aggression.
Our meta-analysis identified two genes, MECOM and AVPR1A, significantly associated 
with both aggression risk and nucleus accumbens (MECOM) and amygdala (AVPR1A) 
brain volume. Subsequent in-depth analysis of these genes in healthy adults (BIG), 
including sex as an interaction term in the model, revealed significant subtype-specific 
gene-wide association of AVPR1A with reactive aggression due to external provocation or 
threat (p=0.016), an association that was driven by males in the sample.
Using cross-trait meta-analysis of brain measures and psychiatric phenotypes, this study 
generated new hypotheses about specific links between genes, the brain, and behavior. 
Results indicate that MECOM and AVPR1A may exert an effect on aggression through 
mechanisms involving nucleus accumbens and amygdala volumes, respectively. Additionally, 
we replicate association of AVPR1A with aggression in an independent sample. We show 
that this association is specific to a threat-/provocation-based reactive subtype of aggression 
in males, which may help explain contradictory findings for this gene. Our subtype- and 
sex-dependent association results highlight the importance of taking into account issues of 
heterogeneity in aggression research.
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INTRODUCTION
Aggression is a common but heterogeneous phenotype often associated with psychiatric 
disorders that may be harmful to others (Baron and Richardson 1994; Miczek et al. 
2002). The term covers a wide range of human behaviors, varying from verbal aggression 
and bullying to physical violence. Together, these behaviors have been associated with a 
large emotional and financial burden on society, while interventions typically still have 
small effects (McGuire 2008; Bakker et al. 2017). To address aggression-related negative 
outcomes more successfully, a better understanding of the genes and neural mechanisms 
that control this behavior is essential.
Twin studies show that about 50% of the variance in aggression can be explained by 
genetic influences, implicating a role for genetics in the development of aggressive behavior 
(Tuvblad and Baker 2011; Veroude et al. 2016). The main focus of candidate gene studies 
of aggression has been on genes related to brain neurotransmitter function, in particular 
to serotonergic and dopaminergic genes, and on genes related to neuroendocrine signaling, 
like sex-steroid receptors and stress-related circuitry (Waltes, Chiocchetti, and Freitag 
2016). Besides these candidate gene studies, several genome-wide association studies 
(GWAS) of aggressive phenotypes have been conducted. Recently, a large-scale GWAS 
meta-analysis was conducted within the framework of the early genetics and lifecourse 
epidemiology (EAGLE) consortium, including nearly 19,000 subjects. The researchers 
combined GWAS data on childhood and adolescent aggression from nine population-based 
cohorts, and found suggestive evidence of association for a region on chromosome 2, near 
a gene involved in the regulation of excitatory synapse development (Pappa et al. 2015). 
While most other GWASs of aggression were relatively small-scaled, these studies together 
with bioinformatics approaches have highlighted the importance of neurodevelopmental 
and synaptic plasticity genes for aggression risk (Fernandez-Castillo and Cormand 2016).
Investigation of the neural correlates of aggression has highlighted the involvement 
of several brain phenotypes in aggression. Imaging studies point towards an important 
role for subcortical brain regions in the neurobiology of aggressive phenotypes (Siever 
2008). Of specific interest in the context of aggression are the amygdala and the striatal 
subregions nucleus accumbens and caudate nucleus (Blair, Veroude, and Buitelaar 2016). 
The amygdala has been strongly linked to aggression through its role in emotion processing 
and threat reactivity (Fusar-Poli et al. 2009; Mobbs et al. 2010). A large number of studies 
have reported differences in the size of the amygdala between aggressive and comparison 
subjects, predominantly volume reductions (Noordermeer, Luman, and Oosterlaan 2016; 
Caldwell et al. 2015; Fairchild et al. 2013; Pardini et al. 2014; Sterzer et al. 2007; Thijssen 
et al. 2015; Wallace et al. 2014; Zhang et al. 2013). The striatum has been associated with 
aggression through its central role in reward sensitivity, processing of punishment, and 
regulation of avoidance behaviors (Crowley et al. 2010; Finger et al. 2008; Finger et al. 
2011; White et al. 2013). Impairments in these functions are thought to be the basis of 
poor decision-making in individuals with aggressive behavior (Fairchild et al. 2009; Blair, 
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Veroude, and Buitelaar 2016). Both volume reductions and volume increases of the striatum 
have been related to aggressive phenotypes, especially for the caudate nucleus and nucleus 
accumbens (Cha et al. 2015; Fairchild et al. 2013; McAlonan et al. 2007; Ducharme et 
al. 2011; Schiffer et al. 2011; Nosarti et al. 2005). Brain volume has been shown to be 
heritable, and the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) 
consortium recently conducted a GWAS meta-analysis on volumes of seven subcortical 
brain structures and intracranial volume, to identify genetic variants that influence brain 
structure (Hibar et al. 2015)). Identification of such genetic variants may help to uncover 
mechanisms underlying neuropsychiatric disorders. 
Since both aggression risk and brain volumes are heritable, one may hypothesize that part 
of the genes contributing to aggression neurobiology do so by influencing aggression-
related brain volumes. Identification of these genes may highlight specific pathways from 
gene to aggressive behavior via the brain. However, research into the underlying genetic 
and neurobiological mechanisms of aggression is complicated by the fact that aggression is 
a behaviorally and etiologically complex phenomenon. Efforts have been made to recognize 
different subtypes of aggressive behavior, presumed to differ in their underlying neurobiology. 
A frequently used system divides aggression into three subtypes; proactive aggression, 
reactive aggression due to external provocation or threat, and reactive aggression due to 
internal frustration (Dodge and Coie 1987; Raine et al. 2006; Smeets et al. 2016; Brugman 
et al. 2016). Proactive aggression has been related to psychopathic traits and delinquent 
behavior (Cima et al. 2013). In this subtype, dysfunction in neural circuitry involving 
(venteromedial) prefrontal and striatal areas is thought to underlie observed difficulties 
with decision making and reinforcement learning, while a decreased responsiveness of the 
amygdala to distress cues is thought to reflect deficits in emotional empathy (Blair 2013). 
Reactive subtypes of aggression, on the other hand, have been associated with impulsivity, 
anxiety, and hostile interpretation bias (Brugman et al. 2015; Bubier and Drabick 2009). It 
has been suggested that reactive forms of aggression are mediated by an overly responsive 
amygdala-related threat response circuitry, which is dependent on regulation by cortical 
brain regions (Blair 2013). Hence, different pathways to the maladaptive behavior are 
thought to exist. An added complication for the identification of genetic and neurobiological 
mechanisms underlying aggression are the marked sex-differences in aggressive behaviors. 
Sex-differences in aggression are pronounced with respect to prevalence and with respect 
to type of aggression displayed (Stephenson, Woodhams, and Cooke 2014; Hill 2002; 
Collett, Ohan, and Myers 2003). For example, males are overrepresented among patients 
with aggression-related disorders such as conduct disorder (Hill 2002), and are more prone 
to display physical aggression compared to females (Baillargeon et al. 2007). Identification 
of subtype- and sex-dependent genetic association may help in elucidating specific links 
from gene to brain to behavior.
Based on the above, the aim of the current study was two-fold. First, we sought to identify 
genes influencing both aggression and aggression-related brain volumes. To this end, we 
conducted genome-wide gene-based cross-trait meta-analyses of aggression and amygdala, 
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nucleus accumbens, and caudate nucleus volume, using GWAS meta-analysis data of two 
large-scale consortia (EAGLE, N=18,988; ENIGMA2, N=13,171). Second, we aimed to 
assess subtype- and sex-specificity of association for identified genes. For this, we conducted 
gene-wide association analyses with aggression subtypes for these genes in a population 
sample of healthy adults with available genome-wide genotyping and questionnaire data on 
aggression subtypes (BIG, N=501).
MATERIALS AND METHODS
Samples
EAGLE
GWAS-MA data on aggression were obtained from the EAGLE consortium which 
investigated childhood aggressive behavior using nine population-based studies with a total 
of 18,988 subjects (mean age = 8.44 years, SD = 4.16) (Pappa et al. 2015). Different well-
validated parent-report questionnaires were used to assess aggressive behavior. Depending 
on study sample, aggressive behavior was assessed with the aggression scale of the Childhood 
Behavioral Checklist (CBCL), the conduct problem scale of the Strengths and Difficulties 
Questionnaire (SDQ), or comparable items in general questionnaires. Scores derived from 
SDQ and CBCL questionnaires were shown to be highly correlated and interchangeable 
for the assessment of children’s behavior problems (Goodman and Scott 1999). Genomic 
data were imputed to the HapMap reference panel (release 22) and comprised only samples 
of European ancestry. GWAS was performed for each cohort, followed by filtering of SNPs 
with low minor allele frequency (<0.05) and imputation quality (RSQ <0.3 or INFO >0.4). 
Results were combined using the sample-size weighted z-score method as implemented in 
METAL (Willer, Li, and Abecasis 2010), controlling for genomic inflation. Access to the 
summary statistics was requested through http://www.tweelingenregister.org/EAGLE. All 
sites involved in this study obtained approval from local research ethics committees, and 
written parental consent was obtained for all participants.
ENIGMA2
GWAS Meta-Analysis (GWAS-MA) data on the aggression-related subcortical volumes 
of nucleus accumbens, amygdala, and caudate nucleus were obtained from the ENIGMA 
consortium. The ENIGMA consortium conducted GWAS-MA on intracranial volume 
(ICV) and seven subcortical brain volumes, to identify common genetic variants 
contributing to volume differences. They used MRI brain scans and genome-wide genotype 
data of 13,171 subjects of European ancestry from 28 cohorts (discovery sample). Brain scans 
were examined and processed at each site following a standardized protocol. Subcortical 
volumes had been adjusted for ICV to identify specific genetic contributions to individual 
volumes. Genomic data comprised only European samples and were imputed to the 1000 
Genomes, v3 phase1 reference panel using MaCH for phasing and minimac for imputation 
(Fuchsberger, Abecasis, and Hinds 2015). GWAS was performed at each site, and SNPs 
with an imputation score of RSQ <0.5 and minor allele count <10 were removed. Results 
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were combined using an inverse-variance-weighted model as implemented in the software 
package METAL (Willer, Li, and Abecasis 2010), controlling for genomic inflation. Further 
details of the original analysis can be found in Hibar et al. (2015). Access to the summary 
statistics of ENIGMA was requested through the ENIGMA website (http://enigma.ini.
usc.edu/download-enigma-gwas-results/). All sites involved in this study obtained approval 
from local research ethics committees or Institutional Review Boards, and all participants 
gave written informed consent.
BIG
To assess subtype-specific association of identified genes and for mediation analysis, data 
from the Brain Imaging Genetics (BIG) study was used. This study was conducted at the 
Donders Institute for Brain, Cognition and Behavior (Franke et al. 2010), and consists 
of self-reported healthy adults who participated in smaller-scale imaging studies at the 
institute. Participants gave consent to use their acquired brain data, donated saliva and 
performed online testing. In the current study, a sub-sample of 501 subjects with available 
Reactive Proactive Questionnaire (RPQ) data (Raine et al. 2006), genome-wide genotype 
data, and structural MRI data was used (age range 18-45 years).
All participants were of Caucasian descent and were screened using a self-report 
questionnaire for the following exclusion criteria before study participation: a history of 
somatic disease potentially affecting the brain, current or past psychiatric or neurological 
disorder, medication (except hormonal contraceptives) or illicit drug use during the past 
6 months, history of substance abuse, current or past alcohol dependence, pregnancy, 
lactation, menopause, and magnetic resonance imaging contraindications (Gerritsen et al. 
2012). All participants gave written informed consent, and the study was approved by the 
regional ethics committee.
Behavioral and genetic measures in BIG
Aggression Questionnaire
The Reactive Proactive Questionnaire (RPQ) was used to assess subtypes of aggression 
in the BIG study (Raine et al. 2006). The RPQ is a self-report questionnaire consisting 
of 23 items. For each item, subjects are asked to indicate, how often they have engaged 
in a given type of behavior, like ‘had temper tantrums’. Items are rated on a three-point 
Likert scale (‘never’ =0, ‘sometimes’ =1, ‘often’ =2). Responses were summed to yield the 
three factors that best described the RPQ in earlier exploratory factor analysis (Smeets et 
al. 2016; Brugman et al. 2016) as well as in the current sample (van Donkelaar et al., in 
press): ‘proactive aggression’ (range 0-12), ‘reactive aggression due to internal frustration’ 
(range 0-9), and ‘reactive aggression due to external provocation or threat’ (range 0-10). 
RPQ proactive aggression scores were dichotomized into high- and low-scoring (score ≥ 
2 and score ≤ 1, respectively), because of a highly positively skewed distribution in both 
males and females (Supplementary Figure 1). An overview of RPQ items can be found in 
Supplementary Table 1.
Pleiotropic contribution of genes to aggression and subcortical brain volumes 
249
C
ha
pt
er
 6
Genotyping and imputation
Genetic analyses for the BIG study were carried out at the Department of Human Genetics 
of the Radboud university medical center. Saliva samples were collected using Oragene 
kits (DNA Genotek, Kanata, Canada), and genomic DNA was extracted as specified by 
the manufacturer. Genome-wide genotyping was performed on three different genotyping 
platforms; Affymetrix Genome-Wide Human SNP Array 6.0 (Affymetrix Inc., Santa Clara, 
CA, USA), Infinium PsychArray-24 v1.1 BeadChip (www.illumina.com), and Infinium 
OmniExpress-24 array (www.illumina.com). Quality control steps and imputation were 
performed using the Ricopili Rapid Imputation Consortium Pipeline (https://sites.
google.com/a/broadinstitute.org/ricopili/home). Pre-imputation quality control included 
pre-filtering of single nucleotide polymorphisms (SNPs) with call rate <0.95, filtering of 
individuals with a genotyping rate <.98 or inbreeding coefficient >.02, filtering of SNPs 
with a call rate <0.98 or Hardy-Weinberg p-value <1e-06, removal of invariant SNPs, 
and removal of population ancestry outliers. SHAPEIT (https://mathgen.stats.ox.ac.uk/
genetics_software/shapeit/shapeit.html) and IMPUTE2 (Howie, Donnelly, and Marchini 
2009) software were used for haplotype phasing and imputation with 1000 Genomes 
Phase 3.v5a reference data. For the current study, best-guess genotypes were inferred with 
a minimum probability threshold of 0.8. Post-imputation quality control included a strict 
SNP imputation quality threshold ≥0.8, removal of duplicated and related individuals (pi 
hat >0.25), removal of individuals with a call rate below 95%, and removal of SNPs with 
a call rate below 95%, a minor allele frequency of less than 1%, or failing the Hardy-
Weinberg equilibrium test at a threshold of p≤10–6.
Analyses
Genome-wide gene-based cross-trait meta-analyses 
We first conducted genome-wide cross-trait meta-analyses of aggression and three different 
aggression-related brain volume measures (amygdala, nucleus accumbens, caudate nucleus). 
We used summary statistic data of two large-scale genome-wide association studies of 1) 
aggressive behavior in children and adolescents (EAGLE, N=18,988) and 2) MRI-based 
volume measures of the aggression-relevant brain regions (ENIGMA2, N=13,171). First, 
four separate genome-wide gene-based analyses with a 50 kb flanking region around genes 
were performed for the summary statistic data of aggression and the volumes of amygdala, 
nucleus accumbens, and caudate nucleus using MAGMA v1.06 (de Leeuw et al. 2015). 
SNPs were mapped onto genes using 1000 Genomes Phase 3 reference data followed by 
computation of gene p-values by aggregating the effect of common variants within the genes. 
Next, fixed-effects meta-analyses where performed of aggression with amygdala volume, 
aggression with caudate nucleus volume, and aggression with nucleus accumbens volume, 
using the weighted Stouffer’s Z method as implemented in MAGMA software. Results 
were considered significant if they reached the Bonferroni-corrected P‐value-threshold for 
testing 18310 genes (p < 2.731e-6). Significant genes with stronger association p-values 
in meta-analysis, compared to the separate analyses of aggression and brain volume, were 
reported and selected for further investigation. 
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Gene-wide association analyses for aggression subtypes
Gene-wide association of selected genes with three subtypes of aggression, reactive 
aggression due to internal frustration, reactive aggression due to external provocation or 
threat, and proactive aggression, was assessed. One phenotypic outlier (>4 SD) was removed 
for all analyses. Gene-wide analyses again included a 50 kb flanking region. Three base 
gene analysis models are available in MAGMA, each of them sensitive to different genetic 
architectures; Principal Component Analysis, mean-SNP, and top-SNP models. For the 
current analysis, a multi-model approach was used, combining the results from the base 
analysis models into an aggregate p-value. Separate analyses were run for subjects genotyped 
on the three different genotyping arrays. Age and four population components derived 
from multidimensional scaling analysis were included as covariates. Sex was included as 
an interaction term in the model, yielding a gene p-value for main and interaction effects 
combined (P_full). This was followed by meta-analysis of the full model output of the three 
genotyping arrays, using the weighted Stouffer’s Z method as implemented in MAGMA 
software (de Leeuw et al. 2015). To protect against type I error, the conventional significance 
threshold was corrected for multiple comparisons (three aggression subtype outcomes) 
using the effective number of independent tests (Meff, see Li and Ji (2005)), calculated to 
be 2.5, taking into account the correlation matrix of the three aggression measures. Hence, 
results were considered significant if they reached a significance threshold of 0.02.
RESULTS
Genome-wide gene-based cross-trait (aggression-brain) meta-analyses 
The MDS1 and EVI1 complex locus gene (MECOM) was significantly associated with the 
cross-trait construct of aggression and nucleus accumbens volume (p=4.94E-07), and the 
Vasopressin Receptor 1A gene (AVPR1A) showed significant association with the cross-trait 
construct of aggression and amygdala volume (p=1.64E-06). Both associations were more 
significant compared to the separate analyses of aggression and the respective brain volume 
(Table 1).
Table 1: Significant results of the genome-wide cross-trait meta-analyses of aggression and aggression-related 
brain volumes using gene-wide association statistics.
Gene N SNPs Brain volume P
 EAGLE 
aggression
P 
ENIGMA2 
volume
P
cross-trait 
meta-analysis* 
MECOM 219 Nucleus 
accumbens
1.67E-06 2.10E-02 4.94E-07
AVPR1A 1132 Amygdala 3.40E-05 6.77E-03 1.64E-06
Displayed are genes showing genome-wide significant association in the cross-trait meta-analysis of aggression 
with an aggression-related brain volume. These genes show more significant association in meta-analysis com-
pared to gene-wide association with aggression and brain volume phenotypes separately. *Bonferroni-correct-
ed P‐value-threshold for testing 18310 genes: p<2.73e-6.
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Gene-wide association analyses for aggression subtypes
The general characteristics of the 501 participants from the BIG sample included in the 
aggression subtype analysis are shown in Supplementary Table 2. Gene-wide association 
analyses with three aggression subtypes were conducted for AVPR1A and MECOM to 
identify gene-behavior relationships, including sex as an interaction term in the model. 
The AVPR1A gene was significantly associated with the score for reactive aggression due 
to external provocation or threat (P_full =0.016) (Table 2). The interaction was driven by 
a significant association in males (P_males =0.037; P_females =0.517). The MECOM gene 
was not associated with any of the aggression subtypes in the population sample.
Table 2: Gene-wide association results for aggression subtypes in healthy adults from the BIG sample 
(N=501).
Gene Chr. N SNPs Start Stop P reactive P reactive P 
proactive*Internal* External*
MECOM 3 372 168751287 169431563 0.959 0.896 0.739
AVPR1A 12 1583 63486539 63597971 0.709 0.016 0.734
*P-value for main and sex interaction effect combined. Bold: Association significance corrected for multiple 
comparisons. 
Chr. = Chromosome.
DISCUSSION
Using cross-trait meta-analyses of gene-wide association statistics, this study identified two 
genes as potentially pleiotropic loci for aggression and aggression-related subcortical brain 
volumes. We identified MECOM as a gene potentially contributing to both aggression 
risk and nucleus accumbens volume, and we identified AVPR1A as a gene potentially 
contributing to both aggression risk and amygdala volume. We replicate the association 
of AVPR1A with aggression in an independent sample of healthy adults, showing gene-
wide sex-dependent, subtype-specific association of AVPR1A to reactive aggression due to 
external provocation/threat.
The MDS1 and EVI1 complex locus gene (MECOM) codes for a protein known as 
transcriptional regulator and oncoprotein (Yoshimi and Kurokawa 2011). MECOM plays 
an important role in early development, with Evi1 homozygous mutant mouse embryos 
dying approximately 10.5 days post coitum showing disrupted cell proliferation and disrupted 
development of cardiovascular and neural systems (Hoyt et al. 1997). The association p-value 
for MECOM in the study of aggression improved in the cross-trait meta-analysis of this 
behavioral trait with nucleus accumbens volume. According to our hypothesis, this might 
indicate that it exerts its effect on aggression through mechanisms involving the nucleus 
accumbens. However, we did not observe the association of MECOM with aggression when 
investigating specific subtypes of aggression in our own, smaller sample of adults. To our 
knowledge, little is known about MECOM in relation to psychiatric behavioral phenotypes 
so far, and future work needs to investigate this association in more detail.
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Our study provides further evidence for a role of candidate gene AVPR1A in aggression. 
The Arginine Vasopressin Receptor 1A gene (AVPR1A) codes for the primary receptor of 
arginine vasopressin (AVP) in the brain. AVP is a neuropeptide strongly implicated in 
complex social and emotional behaviors, including aggression, through a host of animal 
studies (Ebstein et al. 2010). Also in humans, AVP was shown to play a role in enhancing 
aggressive behavior. For example, evidence exists for a positive correlation between aggression 
and cerebro-spinal fluid AVP in humans (Coccaro et al. 1998). Additional evidence comes 
from genetic association studies. The original aggression GWAS-MA that we used for cross-
trait meta-analysis reported gene-wide association of the AVPR1A gene with childhood 
aggression (P=1.61E-03), using VEGAS gene-based analysis and correcting for 21 candidate 
genes tested (Pappa et al. 2015). Using the MAGMA multi-model approach, which has the 
advantage of yielding a more even distribution of statistical power and sensitivity for a wider 
range of different supposed underlying genetic architectures compared to other methods 
(de Leeuw et al. 2015), an even lower p-value was reported in the current study. The cross-
trait meta-analysis of aggression and amygdala volume resulted in gene-wide genome-wide 
significance. Other human genetic association studies of variants in the AVPR1A gene 
reported association with anger (Moons, Way, and Taylor 2014), gender-specific nominally 
significant association with pervasive aggression (Malik et al. 2014), but no association 
in an early study of antisocial traits (Prichard et al. 2007). The current study further 
extends such findings by showing evidence for a subtype-specific gene-wide association 
of the AVPR1A gene with reactive aggression due to external provocation or threat in a 
sample of healthy adults, an association driven by male subjects. This subtype of aggression 
specifically measures social responses to threat and provocation by others, or actions of 
self-defense in response to others. Our observed association of AVPR1A with this subtype 
is in line with existing data highlighting the importance of AVP in social context and 
social communication. Vasopressin signaling is thought to be an important determinant 
of the intensity and range of social responses displayed in different social situations (Albers 
2012). For example, AVP can alter the extent to which social stimuli are threatening, by 
modulating sensory information (Thompson et al. 2006). Sex-dependent association of 
AVPR1A to aggression is also in line with animal research, finding opposite effects of both 
vasopressin and V1a receptor blockade on aggressive behavior. For example, AVP injection 
increases aggression in male hamsters but decreases it in females, while injection of V1a 
receptor antagonists has the opposite results (Gutzler et al. 2010). This data suggests that 
there may be a difference between males and females in the effects of vasopressin signaling 
on aggression. Less is known about sex differences in V1a receptor expression. Nevertheless, 
research in a number of species indicates that receptor distribution might vary in a sex-
dependent manner as well (reviewed in (Albers 2015)). Moreover, gonadal hormones can 
modulate the expression of vasopressin and vasopressin receptors (e.g. (Young et al. 2000; 
Dubois-Dauphin et al. 1994)), thus partly explaining  sex differences in the vasopressin 
system. Our finding illustrates that reducing phenotypic heterogeneity and taking into 
account sex-related heterogeneity may facilitate the search for genes involved in the etiology 
of aggression.
Pleiotropic contribution of genes to aggression and subcortical brain volumes 
253
C
ha
pt
er
 6
Our cross-trait meta-analysis results indicate that that amygdala volume might serve as a 
(proxy for related) mechanisms through which the vasopressin receptor could influence 
aggressive behavior,  and that MECOM may exert its effect on aggression through 
mechanisms involving the nucleus accumbens. Thus, we provide specific hypotheses about 
shared genetic risk and generated specific hypotheses about links from gene to brain to 
behavior for future studies to focus on. It is often assumed in imaging genetics research 
that genetic risk for a neurodevelopmental disorder passes through the brain phenotype 
to behavior. However, another possibility is that genetic factors influencing behavior also 
influence the brain in a way that is independent of the behavioral phenotype of interest 
(Kendler and Neale 2010). Only a few studies have investigated this issue of causality earlier. 
Those studies showed that only part of the brain regions showing genotype effects actually 
do mediate between genetics and the behavior under study (Sokolova et al. 2015; van der 
Meer et al. 2015), proving the importance of such multilevel investigations to elucidate the 
biological mechanisms, by which brain alterations may be involved in aggression etiology. 
Currently, available methods for making causal inferences focus on SNP-level investigations, 
and future studies would benefit from the development of approaches for aggregating 
common genetic variant data to gene- or gene-set-level in mediation frameworks.  
This study has several strengths and limitations. The current study used the largest data-sets 
available to investigate pleiotropic genetic factors for aggression and brain volumes at gene-
level. Cross-trait meta-analysis of brain measures and psychiatric phenotypes is a useful 
way of detecting shared genetic risk and generating new hypotheses about specific links 
between genes, the brain, and behavior (Franke et al. 2016). We were also able to use a well-
phenotyped population cohort to clarify the specific subtypes of aggression involved. The 
added value of using data from such smaller cohorts over large consortium based data lies 
in the possibility of in-depth phenotyping and reducing sources of heterogeneity that come 
with the use of pooled data-sets. Nevertheless, some limitations apply to the current study. 
This study only investigated selected subcortical MRI measures, and future work should be 
extended to include cortical regions as well as connectivity measures that have been shown 
to play a role in aggression (Meyer-Lindenberg et al. 2006).
In summary, we identified MECOM and AVPR1A as genes contributing to aggression risk 
in conjunction with nucleus accumbens and amygdala brain volume, respectively. We find 
a subtype-specific gene-wide association of AVPR1A to reactive aggression due to external 
provocation/threat, when taking sex-related heterogeneity into account. In this, our findings 
may help in explaining previous contradictory association findings for this gene. Future 
studies may elucidate causality of gene-brain-behavior relationships. Comprehension 
of sex-specific physiological pathways associated with aggression subtypes is needed to 
enhance our understanding of the determinants of aggression. Only by understanding the 
mechanisms underlying different forms of aggression will we be able to develop effective 
treatment approaches and minimize the social costs of aggression.
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SUPPLEMENTARY MATERIAL
Supplementary Table 1: RPQ items relating to each of the aggression subtypes.
Item Proactive aggression
2 Had fights with others to show who was on top
4 Taken things from other students
6 Vandalized something for fun
9 Had a gang fight to be cool
10 Hurt others to win a game
12 Used physical force to get others to do what you want
15 Used force to obtain money or things from others
17 Threatened and bullied someone
18 Made obscene phone calls for fun
20 Gotten others to gang up on someone else
21 Carried a weapon to use in a fight
23 Yelled at others so they would do things for you
Item Reactive internal frustration
1 Yelled at others when they have annoyed you
5 Gotten angry when frustrated
8 Damaged things because you felt mad
11 Become angry or mad when you do not get your way
13 Gotten angry or mad when you lost a game
Item Reactive external provocation
3 Reacted angrily when provoked by others
7 Had temper tantrums
14 Gotten angry when others threatened you
16 Felt better after hitting or yelling at someone
19 Hit others to defend yourself
22 Gotten angry or mad or hit others when teased
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Supplementary table 2: Sample characteristics Brain Imaging Genetics sample.
  Total sample Males Females
N 501 215 286
Mean age (SD) 25.28 (4.62) 24.83 (3.83) 25.63 (5.12)
Mean reactive internal frustration score (SD) 3.00 (1.81) 3.14 (1.80) 2.9 (1.81)
Mean reactive external provocation score (SD) 2.36 (1.90) 2.53 (1.95) 2.23 (1.86)
Mean proactive score (SD) 1.38 (1.80) 1.93* (2.16) 0.97* (1.33)
*RPQ proactive aggression scores were dichotomized into high- and low-scoring (score ≥ 2 and score ≤ 1, 
respectively), because of a highly positively skewed distribution in both males and females. Males scored sig-
nificantly higher on proactive aggression than females (X2(1)=22.22, p <0.001; discussed in: (van Donkelaar 
et al., under review)).
Supplementary Figure 1: Distribution of RPQ proactive aggression score in males and females from our 
healthy adult population.
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OVERVIEW
The work described in this thesis is focused on improving our understanding of the genetic 
and neurobiological architecture of aggression. In general terms, aggression may be defined 
as hostile behavior with the intention of inflicting damage or harm (Miczek et al., 2002), 
but it is a behaviorally and etiologically complex phenomenon. It has been shown to 
have moderate but significant heritability (Veroude et al., 2016) and has been associated 
with several neuro-cognitive deficits (Blair et al., 2016). However, the research field of 
aggression has covered an exceptionally wide range of behaviors, contexts, and populations, 
presenting a constant challenge for researchers to integrate inconsistent research findings. 
This thesis explores the potential of reducing phenotypic heterogeneity to identify genetic 
mechanisms involved in aggression. It also investigates pathways to disease, integrating 
genetics and brain imaging disciplines to help shed light on differential etiological pathways 
to aggression. In this final chapter, the main findings of the thesis will be summarized and 
discussed in the context of the current literature. Opportunities for improvement of future 
aggression etiology research will be discussed, as well as clinical implications of the main 
findings from this thesis.
SUMMARY OF MAIN FINDINGS AND METHODOLOGICAL APPROACHES
Part 1 of this thesis (chapters 2-4) focuses on the identification of genetic mechanisms 
involved in aggression, and the potential of reducing phenotypic heterogeneity for 
uncovering genetic association. In part 2 of this thesis (chapters 5-6 ), we move the focus 
to imaging genetics approaches, to study associations between genes and brain phenotypes 
implicated in externalizing behaviors as well as potential links between genetic risk factors, 
brain correlates, and subtypes of aggression.
In chapter 2, a combination of hypothesis-driven and hypothesis-generating genetic 
association approaches was used with the aim to increase knowledge on the molecular 
genetics of oppositional behavior in children and adolescents with attention-deficit 
hyperactivity disorder (ADHD). Research on genetic factors underlying this behavior had 
been sparse, merely some candidate gene polymorphism associations had been described 
(DRD4 exon3 Variable Number Tandem Repeat polymorphism (VNTR), 5-HTTLPR, 
and seven OXTR Single Nucleotide Polymorphisms (SNPs)) in studies limited by small 
sample sizes (Beitchman et al., 2012; Campbell et al., 2011; DiLalla et al., 2009; Ficks and 
Waldman, 2014; Holmes et al., 2002; Johansson et al., 2012a; Johansson et al., 2012b; 
Malik et al., 2012; Park et al., 2010). To reduce the known heterogeneity of the phenotype, 
we defined conceptually meaningful dimensions and subtypes of oppositionality based on 
literature (a defiant/vindictive and an irritable dimension) and Latent Class Analysis (LCA, 
2 severity-based subtypes). We found no significant associations with oppositionality 
subtypes for previously postulated candidate SNPs, genes, or pathways related to serotonin, 
dopamine, and oxytocin. In contrast, parenting behavior (an environmental risk factor) was 
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moderately to strongly associated with all defined subtypes of oppositionality. Subsequent 
hypothesis-generating multivariate genome-wide association analysis (GWA) did not yield 
genome-wide significant associations, as expected based on sample size. However, by 
conducting bioinformatics analysis on top-ranked genes, we could provide new insights 
into the molecular basis of oppositionality, identifying neurite outgrowth as an important 
biological process involved. The strongest GWA signal resided in a region on chromosome 
20 including the BCL2L1 gene. This gene encodes an anti-apoptotic regulator expressed at 
high levels in both the developing and the adult brain (Krajewska et al., 2002). The protein 
regulates neurotransmitter release and retrieval of vesicles in neurons, thereby influencing 
presynaptic plasticity (Li et al., 2013).
This study contributed to the literature in several ways. First, we confirmed the existence of 
various subgroups of youths with different oppositional symptom profiles. This improved 
power of our genetic analyses by reducing the known heterogeneity of oppositional 
behavior in ADHD. Second, with a sample size of 750 subjects, and by aggregating effects 
of multiple common variants in our candidate based approach, power for candidate (gene-
set ) association analysis was higher than in many previous, smaller candidate studies. 
Third, by covering a wide range of genetic association approaches - covering hypothesis-
based analyses at candidate SNP level, gene-wide level, and pathway-wide level, as well 
as hypothesis-generating multivariate genome-wide association and genetic bioinformatics 
approaches – we conducted a large-scale overview of the genetics of oppositional behavior 
within ADHD. Fourth, using a multivariate association framework, we were able to 
incorporate genetic overlap as well as differences between subtypes of oppositionality and 
to maximize power of genome-wide analysis. To summarize, our findings suggest that 
oppositional behavior in childhood ADHD is not associated with genetic variation in 
serotonin, dopamine, and oxytocin systems specifically, but rather an extended landscape 
of molecular signaling cascades involved in neurite outgrowth might be of importance. 
Chapter 3 continues on the topic of aggressive behavior in ADHD, more specifically, it 
explores the genetic architecture of childhood aggression in adult ADHD. We performed 
genome- wide association tests to shed light on the genetic susceptibility loci and biological 
processes involved in the etiology of childhood aggression in ADHD. The measure of 
childhood aggression in adult ADHD was derived retrospectively from the Wender Utah 
Rating Scale (WURS) in several studies across Europe. Meta-analysis of GWAS in these 
separate samples yielded several nominally significant variants in biologically interesting 
genes. The strongest signal resided in the transcript of a lncRNA with uncertain coding 
potential. Non-protein-coding RNAs play a critical role in the regulation of gene expression 
and have been previously associated with neuropsychiatric disorders (Ning et al., 2014). 
The second most significant locus resided in the neurotrimin (NTM) gene, which codes 
for a cell adhesion molecule predominantly expressed in the central nervous system (CNS) 
(Struyk et al., 1995). In line with the findings of chapter 2, neurotrimin has important 
functions in neurite outgrowth, regulating the development of neuronal projections via 
attractive and repulsive mechanisms (Gil et al., 1998). Building on results from chapter 2, 
we also found significant enrichment of top-associated SNPs for adult ADHD in GWA 
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signals from both the defiant/vindictive and the irritable dimension in childhood ADHD. 
This study contributed significantly to ADHD literature, as childhood aggression is a 
feature of the disorder that is associated with worse outcomes later in life (Klassen et al., 
2010), but that nevertheless has received little attention so far. In summary, our GWAS 
meta-analysis results implicate mechanisms of cell adhesion as well as regulation of gene 
expression in the etiology of childhood aggression in adult ADHD. Moreover, the results 
tentatively support overlap of association signals with those of oppositionality in childhood 
ADHD, paving the way for more elaborate statistical methods to test this overlap.
In chapter 4, the focus was on reducing phenotypic heterogeneity to elucidate different 
genetic mechanisms involved in distinct aggression subtypes. The aim was to assess, 
whether common genetic variation in the main candidate genetic systems involved in 
aggression (the serotonin, dopamine, neuroendocrine system) show subtype- and sex-
specific patterns of association. This was investigated in a sample of healthy adults, where we 
could confirm the existence of three subtypes of aggression based on the Reactive Proactive 
Questionnaire- (RPQ) by use of Confirmatory Factor Analysis (CFA); the three aggression 
subtypes were proactive aggression, reactive aggression due to internal frustration, and 
reactive aggression due to external provocation or threat. Using gene-set tests, we found a 
significant female-specific association of reactive aggression due to internal frustration with 
genetic variation in a gene-set combining genes involved in serotonergic, dopaminergic, and 
neuroendocrine signaling. This association was mainly driven by variation in serotonergic 
and neuroendocrine signaling.
This study was the first to investigate the combined effect of common genetic variants 
related to monoaminergic and neuroendocrine signaling (rather than single candidate 
variants) on aggression subtypes, thereby increasing power to find association. Moreover, 
the study highlighted the value of reducing sources of heterogeneity in aggression research. 
The results identify variation in genes involved in neuroendocrine and serotonergic signaling 
as biological risk factors for frustration-based reactive aggression in females. Subtype 
specificity of the finding underscored a biological meaningfulness of reactive-proactive 
distinctions in aggression research.
In chapter 5, imaging genetics studies of the effect of disease-linked genetic variants on brain 
structure and function were systematically reviewed for a group of highly heritable, often 
comorbid neurodevelopmental disorders. The aim of this work was to extract core brain 
mechanisms affected by disease-linked genetic factors related to the individual disorders as 
well as mechanisms relating to their clinical overlap. Common neurodevelpmental disorders 
were selected for investigation based on their frequent comorbidity, and included ADHD, 
autism spectrum disorders (ASD), selected intellectual disability disorders (ID), oppositional 
defiant disorder (ODD), and conduct disorder (CD) (Vorstman and Ophoff, 2013). We 
report a remarkably coherent picture of functional genetic variation in SLC6A4 (5HTT; the 
serotonin transporter gene) leading to hyperactivation of the amygdala and connected areas 
in conjunction with functional dysconnectivity amongst those areas. Other alterations 
in brain volume, activity, and connecitivity were also observed, but no conclusions could 
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be drawn about shared mechanisms across disorders. In this chapter we provide specific 
recommendations for future imaging genetics research, highlighting the need for larger 
sample sizes, for hypothesis-free, brain-wide studies, and for extension of imaging genetics 
studies to a wider pool of genes. Additionally, there is a need to investigate, whether brain 
phenotypes are intermediate between genetic factors and behavioral outcomes.
This study contributed to the literature by providing a comprehensive overview of imaging 
genetics studies for five neurodevelopmental disorders with high comorbidity. In summary, 
results thus far confirm that imaging genetics approaches are suitable to provide more 
insight into the link between genes, the brain, and behavior in neurodevelopmental 
disorders. Nevertheless, the field should still be considered to be in its early stages and 
cannot yet provide definite conclusions for our understanding the comorbidity between 
different neurodevelopmental disorders.
In chapter 6, the aim was to gain more insight into the mechanisms leading from genetic 
risk factors for aggression to aggression phenotypes. This was investigated using a 2-step 
approach. Genome-wide gene-based cross-trait meta-analyses of aggression with the volumes 
of amygdala, nucleus accumbens, and caudate nucleus were conducted to identify genes 
influencing both aggression and aggression-related brain volumes. Then, the subtyping 
approach of chapter 4 was revisited, to study subtype-specific effects of identified genes. 
The meta-analysis identified significant associations of the MECOM and AVPR1A genes 
with both aggression and nucleus accumbens/amygdala volume, respectively. For AVPR1A, 
gene-wide association with aggression was found to be subtype- and sex-specific. AVPR1A 
was significantly associated with reactive aggression due to external provocation or threat, 
an association that was driven by males in the sample. 
This study contributed to the existing literature by pointing out possible gene-brain-behavior 
relationships for specific genes. This was done by combining use of large-scale consortium-
based association statistics with analyses in a well-phenotyped local cohort. MECOM was 
identified as a gene for aggression that potentially exerts its effect through a mechanism 
involving nucleus accumbens volume. Additionally, this study provided replication of the 
association of candidate gene AVPR1A with aggression in a cohort of healthy adults and 
showed that association is subtype- and sex-dependent. Potentially it exerts its effect on 
aggression through a mechanism involving amygdala volume.
GENERAL INTERPRETATION IN THE CONTEXT OF EXISTING LITERATURE
An integrated view on identified genetic systems
One of the main aims of this thesis was to identify genetic mechanisms involved in aggression 
etiology. The genetic association studies in part 1 of this thesis highlight a role for several 
biological systems. Hypothesis-based analyses stressed the importance of neuroendocrine 
and serotonergic systems in aggression (chapter 4), and hypothesis-generating investigations 
pointed us towards a role for neurite outgrowth and cell adhesion in the development of 
aggressive behavior (chapters 2 and 3).
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The relevance of alterations in the hypothalamic–pituitary–adrenocortical (HPA), sex 
steroid hormone, and serotonin systems for the regulation of aggression has long been 
studied and confirmed in rodent, primate, and other animal models (Veenema, 2009). Also 
in humans, multiple studies have been conducted to investigate, how key molecules in these 
systems relate to aggressive behavior. Those studies found associations for testosterone, 
cortisol, serotonin, and vasopressin (Rosell and Siever, 2015). This thesis further increases 
our insight into the role of neuroendocrine and serotonergic systems in human aggression, 
by showing that common genetic variation in related genes is associated specifically with 
reactive aggression (chapter 4). In previous literature, a large number of candidate gene 
studies for aggression and violence had been conducted, some investigating specific genetic 
markers relating to the above mentioned systems. However, meta-analysis has not yet picked 
up association significance for any polymorphism analyzed (Vassos et al., 2014), with the 
exception of two polymorphisms in MAOA and SLC6A4 (Ficks and Waldman, 2014). By 
aggregating genetic effects across multiple autosomal genes in biological systems of interest, 
we could now show association of these genetic systems to aggression. It should be noted 
that in this thesis, we restricted analyses to the most established candidate systems for 
aggression. Future studies could extend this approach to other promising candidate systems, 
like GABAergic signaling (de Almeida et al., 2015). In chapter 6 the AVPR1A gene, coding 
for a vasopressin receptor, was found to be of importance in reactive aggression. While 
this gene was not included in the neuroendocrine system studied in chapter 4 (we based 
our gene-selection on an independent database that had not yet incorporated information 
on vasopressin), recent literature has shown that it is nonetheless tightly linked to the 
neuroendocrine stress response (Ramos et al., 2016). Vasopressin has now been recognized 
as a principal nervous system regulator influencing HPA axis signaling in response to stress 
(Ramos et al., 2016), providing additional evidence for the association of common variance 
in the neuroendocrine system with aggression.
In chapter 2 and 3, hypothesis-generating approaches where used with the aim to find 
out more about the genetic architecture of aggression in ADHD. Our results pointed 
towards brain-related genetic mechanisms. More specifically, the results indicate that 
neurite outgrowth and cell adhesion mechanisms in the brain are important in aggression 
etiology. This is in line with brain imaging studies reporting many alterations in brain 
structure and brain function (for and overview see the introduction of this thesis). However, 
neurite outgrowth in general is a broad concept, and this begs the question, whether it is 
a brain-wide phenomenon that contributes to aggression or rather a localized one. A next 
step might be to map neurite outgrowth related genes on brain structure and function to 
identify genotype effects on the brain.
The connection of brain phenotypes with genes, neurotransmitters, and hormones in 
neuroendocrine and serotonergic systems has been investigated in previous literature, 
pointing to several brain regions of interest, where alterations in neurite outgrowth may 
specifically lead to changes associated with the development of aggressive behaviors. Effects 
of testosterone, cortisol, and serotonin on the brain mostly implicate amygdala-prefrontal 
circuitry (Montoya, 2012). For example, gonadal (sex steroid) hormones are thought to have 
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an important influence on the connection of the amygdala and the orbitofrontal cortex 
(OFC), influencing regulation of amygdala activity by the OFC (van Wingen et al., 2011). 
Testosterone has been observed to increase amygdala activity (Derntl et al., 2009; Manuck 
et al., 2010; van Wingen et al., 2009) and to reduce OFC coupling with the amygdala 
(Hermans et al., 2008; van Wingen et al., 2010), which can increase aggression (Mehta 
and Beer, 2010). Cortisol, on the other hand, has been shown to decrease amygdala activity 
(Henckens et al., 2010). Hence, it has been hypothesized that the testosterone/cortisol ratio 
can influence amygdala reactivity and inhibitory control by prefrontal regions, thereby 
influencing aggressive behaviors (Honk et al., 2003). Interestingly, a high serotonin receptor 
density has been found in these same regions as well. For example, 5-HT1A receptors, 
which inhibit the activity of target neurons, are abundant in both PFC and amygdala 
(Albert et al., 2014). Meta-analysis has revealed an inverse but small correlation between 
central serotonin functioning and aggression, so it has been suggested that the widely 
accepted view that decreased serotonin lead to increased aggression should be revised to 
account for serotonin’s functional complexity (Duke et al., 2013). From those and similar 
findings, the influential triple imbalance theory of aggression has been derived, which 
hypothesizes that a high testosterone/cortisol ratio combined with low serotonin levels 
increases aggression, by enhancing amygdala reactivity and reducing inhibitory control by 
the PFC (de Almeida et al., 2015; Montoya et al., 2012b). Although it is unknown what the 
underlying mediating mechanisms of neurite outgrowth are, it may be hypothesized that 
alterations in the efficiency or direction of neurite outgrowth specifically in these regions 
underlies aggression-related dysfunction.
In general, a useful next step in the research of aggression etiology would be to conduct more 
extensive research on how brain phenotypes in aggression relate to genetic variation and 
molecular and cellular alterations associated with the phenotype. Our genetic association 
findings for neuroendocrine and serotonergic signaling are in line with the triple imbalance 
theory of aggression development. However, the theory will be further discussed later in 
this chapter in the context of subtype- and sex-specificity of the findings described in this 
thesis.
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Brain phenotypes of aggression: the endophenotype model
The main aim of part 2 of this thesis was to gain more insight into how genes exert their 
effect on aggression and aggression-related phenotypes. In this section of the discussion, 
the findings are discussed in the context of the endophenotype model. While the specific 
biological mechanisms contributing to neurodevelopmental disorders are still largely 
unknown, it is thought that genetic variation will alter molecular and cellular processes, 
which in turn will lead to altered brain development, and subsequently to altered behavior 
(Figure 1; (Franke et al., 2009; Klein et al., 2017). Phenotypes that mediate the effects 
of genetic variation on behavioral phenotypes have been termed endophenotypes or 
intermediate phenotypes (for an overview of endophenotype criteria see Gottesman and 
Gould (2003); Kendler and Neale (2010)). This thesis focuses on Magnetic Resonance 
Imaging (MRI)-based endophenotypes.
Figure 1, published in Klein et al., 2017: This schematic convergence model shows potential pathways 
leading from gene to disease and suggest endophenotypes relevant to psychiatry at different levels of complex-
ity.  
Polygenicity (schematically depicted by gene A to I) is involved in causing disease symptoms. A reduced num-
ber of genes is involved in disease-related endophenotypes. These can be studied at various biological levels, 
e.g. biochemical processes and cell function can be assessed by biological assays in cell or animal models by 
measuring e.g. neuron morphology or synaptic functioning. Neuroimaging methods (structural and func-
tional) can be applied to assess relevant endophenotypes at the level of brain morphology (‘Morphology brain 
region A-C’). Endophenotypes, related to the ‘function of brain units’, can be e.g. investigated by functional 
MRI or through performance measurements on neuropsychological tests. Aberrations at this level can result 
in altered behavior and disease-related behavioral traits, that subsequently lead to disease symptoms. Environ-
mental influences can impact on all levels and need more attention in future studies. Bioinformatic pathway 
and network analyses can help to integrate data from various sources and to identify molecular networks or 
cellular processes in which ADHD-related genes are enriched.
Summary and general discussion
271
C
ha
pt
er
 7
While the model of endophenotypes has proven useful in understanding the mechanisms 
of genes (Franke et al., 2009), one should take caution not to oversimplify it. For example, 
genes can affect multiple (endo)phenotypes (Kendler and Neale, 2010; Matsumoto et al., 
2003), because they are expressed in many parts of the brain, and gene expression does not 
even predict or limit the location of effects of a genetic factor, most likely because of effects 
on brain connectivity (Braet et al., 2011). In addition, single endophenotypes can be linked 
to multiple disorders. We made use of this prior knowledge in chapter 5, and aimed to extract 
core brain mechanisms affected by disease-linked genetic factors, related both to individual 
neurodevelopmental disorders and to their clinical overlap. Reviewing available imaging-
genetics literature, we concluded that imaging-genetics studies of aggression (specifically 
ODD and CD) are still scarce, despite the need for the integration of genetic and brain 
imaging findings. Definite conclusions helping our understanding of the comorbidity with 
different neurodevelopmental disorders also could not be drawn yet (chapter 5). Partly, 
this was due to the limited number of genes investigated in imaging genetics studies to 
date. One exception is the SLC6A4 gene encoding the serotonin transporter, which has 
been investigated relatively frequently. Based on imaging genetics literature available, we 
concluded that aggression-relevant variation in this gene is associated with the above-
described pattern of hyperactivation of the amygdala and connected areas. This may 
be significant not only to cognition in ODD and CD, but also in ADHD and ASD. In 
general, knowing about the existence of phenotypic (and genetic) continuous distributions 
of psychiatric traits in the population, with clinical disorders being the extreme of such 
continua, the associations of genetic risk factors are likely to exist with behavioral traits, and 
not with disorders directly (e.g., (Hoogman et al., 2011). Likely the identified gene-brain 
relationship is associated with a trans-diagnostic phenotype, relating to symptoms expressed 
across all these disorders (Nolen-Hoeksema and Watkins, 2011). As this would have highly 
important implications for the way we conceptualize psychiatric disorders and for genetic and 
neurobiological research of neuropsychiatric disease, a separate subsection of this discussion 
is devoted to a more detailed discussion of diagnostic boundaries in aggression research (see: 
Crossing diagnostic boundaries). The conclusions we could draw based on existing imaging 
genetics literature were also limited, because studies to date had limited power. Although 
the endophenotype concept postulates that imaging genetics measures should have stronger 
effect sizes for gene effects than the behavioral measures (Gottesman and Gould, 2003), 
recent work has raised doubt about this assumption. Larger effect sizes have not been found 
for neuroimaging (endo)phenotypes, at least not for volumetric MRI measures (Franke et 
al., 2016), underscoring the need for larger sample sizes in imaging genetics literature, or 
better ways to measure (neuroimaging) phenotypes. Efforts to accomplish this are already 
underway, for example, large sample sizes with consistently preprossessed neuroimaging 
measures are continuously collected by the ENIGMA consortium (Thompson et al., 2014). 
Another factor hampering interpretation is the fact that there has been a strong focus on 
regions and cognitive domains of interest in most studies published to date. Hence, caution 
is warranted in claiming specificity of brain phenotypes for individual genes based on 
existing studies. This underscores the need for appropriately powered hypothesis-generating 
brain- and phenome-wide methods in the imaging genetics field.
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Since we found that imaging genetics literature, especially for aggression-related phenotypes, 
is still in its early stages (chapter 5), in chapter 6 we aimed to connect genes, brain 
phenotypes, and aggressive behavior in an hypothesis-generating way, using the largest 
available GWAS datasets on aggression and subcortical brain volumes available. Cross-
trait meta-analysis identified two genes with pleiotropic effects affecting both aggression 
and subcortical brain volumes (MECOM, AVPR1A). We hypothesized that these genes 
may thus exert their effect on aggression by affecting subcortical brain volumes. However, 
we should be careful about causality assumptions. It is often assumed that genetic risk 
passes through the endophenotype to behavior (Figure 1), but another possibility is that 
genetic factors influencing aggression also influence the brain in a way that is independent 
of the behavioural phenotype of interest. Only a few studies have investigated the issue of 
causality earlier. Those studies showed that only part of the brain regions showing genotype 
effects actually do mediate between genetics and the behavior under study, proving the 
importance of such multilevel investigations (Sokolova et al., 2015; van der Meer et al., 
2015).
On the one hand, this thesis aimed to identify common and unique genetic effects on the 
brain for genes implicated in different comorbid neurodevelopmental disorders. Specific 
gene-brain-behavior relationships could not be established based on existing imaging-
genetics literature, stressing the need for larger studies using standardized measures that 
investigate more genes and brain-wide phenotypes (chapter 5). On the other hand, this 
thesis aimed to identify subtype-specific pathways to aggression, that is, to draw lines from 
specific genes to specific brain regions to specific aggression subtypes. While specific genes 
with pleiotropic effects on aggression and subcortical brain volumes were detected, it is not 
certain that these brain volumes mediate the gene-behavior relations of interest (chapter 6 ).
Reducing heterogeneity in aggression research
Aggression subtypes
Across this thesis, it has been hypothesized that genetic overlap as well as differences exist 
among aggression subtypes, and broader, across different neurodevelopmental disorders. On 
the one hand, we tackled this by capturing both broad and specific effects across phenotypic 
subtypes, for example in chapter 2, by using a multivariate association model. On the other 
hand, we aimed to improve power for finding genetic effects by looking at subtype-specific 
gene association, for example in chapters 4 and 6. Chapter 4 showed that neuroendocrine 
and serotonergic genetic variation might be important specifically to a reactive type of 
aggression, and chapter 6 showed that the AVPR1A gene might also be of importance in 
reactive aggression. These subtype-specific genetic association results are in line with the 
triple imbalance theory of aggression, which is thought to be specific to reactive impulsive 
types of aggression (Montoya et al., 2012a; van Honk et al., 2010). As shortly mentioned 
above, it hypothesizes that levels of testosterone, cortisol, and serotonin in the brain work 
together, facilitating the fight/flight response through acting on amygdala-brainstem 
networks, and at the same time affecting prefrontal cortex regions responsible for impulse 
control. This is thought to lead to reduced top-down inhibitory control, thus giving rise to 
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reactive aggression (Montoya, 2012). While the association results are largely in line with 
the model of gene-to-behavior relationships depicted in Figure 1 of the thesis introduction, 
not all gene-subtype relationships could be confirmed. Previous literature speculated that 
serotonergic and dopaminergic neurotransmission regulate both reactive and proactive 
aggression, whereas endocrine signaling seems to be more involved in the regulation of 
reactive aggression (Waltes et al., 2016). While our association results affirm the role of 
neuroendocrine and serotonergic variation in reactive aggression, no link of serotonergic 
signaling with proactive aggression was found. Association was specific for the frustration-
based reactive subtype of aggression, which is thought to be related to poor decision-making 
(Blair et al., 2016). As the prefrontal cortex is important in decision-making (Fairchild et 
al., 2009), we may speculate that serotonergic effects are strongest on our cognitive control 
system. Results from chapter 6 suggest that for the AVPR1A gene, strongest association is 
with threat-/provocation-based reactive aggression. Hence, vasopressin signaling may be 
of specific importance in facilitating the acute threat response, which is regulated by the 
amygdala network (Coker-Appiah et al., 2013; Mobbs et al., 2010). This is in line with 
our finding that AVPR1A association significance increases, when meta-analyzing genetic 
association results for aggression and amygdala volume (chapter 6 ). 
While contributing to knowledge on the specificity of genes and neurobiological defects 
for aggression subtypes, we provide no specific evidence of genetic systems that might be 
related to proactive symptoms of aggression. The neurite outgrowth-related genes identified 
in chapter 2 may still play a role, but subtype specificity for this system has yet to be 
investigated. All in all, there is a need for increased knowledge on proactive aggression, also 
reflected by the limited treatment options available to date for this subtype.
Gender
Gender differences in aggressive behavior are pronounced (Card et al., 2008; Collett et al., 
2003; Georgiev et al., 2013; Hill, 2002; Stephenson et al., 2014), and might be an important 
factor accounting for another part of the inconsistent findings in aggression research. 
Therefore, work in this thesis included sex-specific gene identification in aggression. 
Association of serotonergic and neuroendocrine gene-sets with reactive aggression was 
female-specific. Moreover, we showed that association of AVPR1A candidate gene with 
reactive aggression was male-specific, possibly explaining previous contradictory association 
results (Malik et al., 2014; Moons et al., 2014; Prichard et al., 2007). Our findings are in 
line with numerous reports on the sex-specificity of neuroendocrine signaling. Multiple 
studies have sought to explain sex differences in aggression based on hormonal signaling. 
For example, a pattern of increased testosterone levels in competitive situations compared 
to defeat has been found in men but not women, and mediated effects of winning on 
aggressive behavior (Carre et al., 2013). Progesterone has been shown to interact with 
HPA axis function, influencing aggressive behavior of females (Kirschbaum et al., 1999; 
Ossewaarde et al., 2010). Opposite effects of vasopressin on eliciting aggressive behavior 
have been found in animal studies, as well as sex differences in receptor distribution (Albers, 
2015; Gutzler et al., 2010). Less is known about the role of serotonin in sex differences of 
aggressive behavior (Duke et al., 2013), but variations in the levels of sex hormones have 
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been shown to lead to changes in serotonin receptor distribution (Witte et al., 2009). Of 
note, gonadal hormones, glucocorticoids, and neuropeptides interact closely, and further 
research should be directed at elucidating the effect of these interactions on sex differences 
in aggression (de Almeida et al., 2015).
Our genetic findings are in line with current theories of reactive aggression, but suggest that 
these theories should be further specified to incorporate and allow for sexual dimorphism. 
Results confirm the idea that subtypes and sexes are (at least partly) different with regard to 
underlying pathophysiology. Heterogeneous genetic susceptibility patterns and the complex 
nature of the phenotype may explain the lack of robust association signals in aggression 
genetics to date. It is also likely that earlier, smaller association studies might have been 
underpowered to detect gender effects. Our work, combined with prior literature, points 
towards the crucial role of sex neuro-steroids and certain neurotransmitters for sex-specific 
aggression, and the investigation of those intricately connected systems might be the future 
of the aggression research field.
Crossing diagnostic boundaries
Progress in understanding the genetic etiology of aggression and other psychiatric disorders 
has been hampered by limited sample sizes available for genome-wide association approaches. 
Enormous sample sizes are necessary to detect genome-wide significant findings for 
neurodevelopmental disorders. Reasons for this are the phenotypic heterogeneity discussed 
above, as well as small expected effect sizes of common genetic variants and polygenicity. 
Additionally, diagnostic categories for neurodevelopmental disorders do not necessarily 
follow underlying biological mechanisms (Cross-Disorder Group of the Psychiatric 
Genomics et al., 2013), further limiting power of genetic association studies.
Population-based studies
Part of the research conducted in this thesis was performed in general population samples. 
Pleiotropic genetic effects for brain and behavior were detected based on one of the largest 
aggression GWAS meta-analyses to date, which investigated childhood aggressive behavior 
in healthy subjects (Pappa et al., 2015). In-depth analysis of detected pleiotropic genes 
(chapter 6 ) as well as genetic association studies of candidate gene-sets with aggression 
(chapter 4) were preformed in a large local sample of healthy volunteers (Brain Imaging 
Genetics). These latter subjects had detailed phenotyping available on reactive and proactive 
subtypes of aggression. Interestingly, the measures of reactive aggression followed a normal 
distribution in this general population sample. Moreover, we were able to find association for 
genetic variants, selected based on their implication in aggression disorders, with aggressive 
traits in the general population. This indicates that common genetic variants underlying 
aggression phenotypes are potentially similar in general and psychiatric populations. Our 
findings are in line with studies providing evidence that psychiatric disorders represent 
the extreme ends of continuous distributions of disorder-like traits within the general 
population. Several lines of research have shown that this model is relevant in psychiatric 
traits such as ADHD and ASD (Martin et al., 2014; Middeldorp et al., 2016; Riglin et al., 
Summary and general discussion
275
C
ha
pt
er
 7
2016; Robinson et al., 2016; Bralten et al., 2017). Shared genetic etiology between clinical 
disorders and population traits has also been shown to exist for these disorders. For example, 
genetic risk factors for clinical ASD predicted ASD-traits in adult and childhood general 
population samples (Bralten et al.,2017; Robinson et al., 2016). The use of association studies 
of disorder-like traits in the general population can greatly increase sample sizes at relatively 
low costs, providing tremendous opportunities for gene finding in neurodevelopmental 
disorders. For aggression, this point is highlighted by the recent publication of another 
large-scale population-based GWAS meta-analysis of antisocial behavior, providing new 
genome-wide suggestive (and sex-specific) signals of interest (Tielbeek et al., 2017). In the 
context of aggression, the existence of phenotypic (and genetic) continuous distributions of 
psychiatric traits in the population is especially relevant, particularly since aggressive traits 
in the general population at sub-diagnostic level give rise to increased crime rates, socially 
disruptive behaviors and inceased costs for society.
Cross-disorder studies
Another part of the research in this thesis focused on aggression phenotypes in comorbid 
psychiatric disorders (mainly ADHD). Currently, psychiatric disorders are classified based 
on clinical presentation rather than underlying etiology. It has been shown though, that 
substantial genetic correlations between psychiatric disorders exist (e.g. for five major 
disorders: Cross-Disorder Group of the Psychiatric Genomics et al., 2013), providing 
evidence for shared genetic etiology among different psychiatric disorders as currently 
classified in clinical practice. In chapter 2 of this thesis, genetic mechanisms underlying 
oppositional behavior in childhood ADHD were investigated. In line with evidence for 
shared genetic etiology, the association findings of this chapter may in part reflect shared 
genetic risk factors for psychiatric disorders. This notion is supported by the fact that 15 
out of the 53 top-associated genes in the study had previously been associated with other 
neuropsychiatric and neurodevelopmental disorders. As there is a substantial degree of overlap 
in aggressive behaviour among neuropsychiatric disorders, it could be beneficial to analyze 
conditions in which aggression is present together, in order to pin-point biological processes 
in dysfunctional forms of aggression. However, possibilities for this are limited to date, 
because, although aggression is a cross-disorder trait, aggression is often measured differently 
across disorders. More generally speaking, consistent investigations of traits occurring across 
different (co-morbid) neurodevelopmental disorders is needed to provide crucial insights 
into genetic and biological susceptibility factors that are common to multiple disorders. 
The importance of heterogeneity and specificity issues relating to categorical diagnostic 
groups in research of mental disorders is also emphasized by the strategic plans of the 
U.S. National Institute of Mental Health (NIMH). They underscore the Research Domain 
Criteria (RDoC) Project, which provides a research framework for a better understanding 
and classification of mental disorders based on behavioral and neurobiological dimensions 
(https://www.nimh.nih.gov/research-priorities/rdoc/index.shtml). Consistent assessment of 
genetic, molecular, cellular, neural, physiological, and behavioral variables might be able 
to contribute to this approach. By promoting the use of dimensional data for research 
purposes in psychiatry, the project aims to improve understanding of current diagnoses as 
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well as normal human behavior, and to improve the search for treatment targets in multiple 
domains. Reviewing imaging genetics literature across comorbid disorders in chapter 5, 
we found genetic variation in the SLC6A4 risk gene to be associated with hyperactivity of 
the amygdala and related regions, and impaired connecitivity amongst those areas. This 
could be an example of a possible trans-diagnostic phenotype at brain level. Given that this 
phenotype may be relevant in multiple of the investigated comorbid disorders, this finding 
provides more insight into the shared neurobiological features among diagnostic categories. 
Recent neuroimaging studies confirm the existence of shared as well as disorder-specific 
brain abnormalities in neurodevelopmental disorders (Goodkind et al., 2015). These 
findings support once more the potential of going beyond diagnostic boundaries to improve 
power for detecting certain neurobiological signals. Stepping away from clinical diagnosis 
will be a crucial starting point for defining alternative ways to classify (heterogeneous) 
psychiatric disorders.
In summary, we highlight the opportunities for sample size maximization offered by 
population-based studies of aggression, as well as the significance of going beyond diagnostic 
boundaries in aggression research and using dimensional approaches to the phenotype to 
shed light on comorbidity (Docherty et al., 2016).
Strengths and limitations
A great strength of the analyses in this thesis is that they try to integrate findings of 
many different samples and data-sets. We combined information derived from large-
scale, consortium-based association statistics (EAGLE, ENIGMA) with analyses in well-
phenotyped and appropriately powered local (BIG) and European (IMpACT, IMAGE) 
cohorts. Throughout this thesis, we stress that maximization of sample size is not the only 
important factor in increasing power of neurobiological studies. Rather, minimization of 
phenotypic heterogeneity is just as essential for finding genetic and neural associations 
related to neurodevelopmental disorders like aggression. By using different types of 
information from different datasets, optimized use was made of sample size on the one 
hand, and in-depth phenotyping on the other hand. 
Combination of information from the above-mentioned datasets was partly made possible 
by funding by the European Commission (EC). All work described in this thesis was 
performed within the context of the Aggressotype consortium, which focuses on aggression 
subtyping for improved insight and treatment innovation in paediatric psychiatric disorders 
(www.aggressotype.eu). Such large, multidisciplinary consortia are useful in bringing 
together not only data-sets, but also researchers from all over the world, stimulating 
discussion and dissemination of research results and methodology as well as the conception 
of new research ideas. Aggressotype is also successful in combining expertise on multiple 
levels of aggression research, from genetic, cellular, neuroimaging, and behavioral levels 
to treatment-focused approaches, thus contributing many pieces to the puzzle of the the 
complex multi-level etiology of aggression and comorbid neurodevelopmental phenotypes.
Well-phenotyped samples enabled us to study aggression at multiple levels of the 
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endophenotype model (Figure 1 of the thesis introduction). For our candidate genetic 
studies in BIG and IMAGE, data of hundreds of individuals was available for analyses, 
thus using sample sizes much larger than those used in much of the published literature to 
date (chapters 2, 4, and 6 ). We were able to study factors such as gender and comorbidity, 
that many smaller studies in literature have lacked power for. However, our hypothesis-
generating genome-wide approaches on childhood aggression in ADHD based on IMAGE 
and IMpACT data (chapters 2 and 3) suffered from being underpowered, and the suggestive 
threshold we used could contain false-positive findings. Nevertheless, we maximized power 
by using a multivariate statistical approach in chapter 2. Also, bioinformatics approaches 
confirmed relevance of top-findings for neurodevelopmental phenotypes, providing support 
for true association results. The genome-wide study in chapter 6, on the other hand, was 
based on the summary statistic of two of the largest available datasets on brain imaging 
and aggression. Thus we maximized power for this cross-trait genome-wide meta-analysis. 
The availability of large sample sizes in this thesis allowed for applying a wide range of 
genetic association approaches. These covered hypothesis-based analyses at candidate SNP 
level, gene-wide and pathway-wide levels, as well as hypothesis-generating (multivariate) 
genome-wide association and meta-analysis. The multivariate framework used in chapter 2 
enabled us to incorporate genetic overlap as well as differences between subtypes to maximize 
power of genome-wide analysis. In chapter 4, we were the first to investigate the combined 
effect of common genetic variants related to monoaminergic and neuroendocrine signaling 
(rather than single candidate variants/genes) on aggression subtypes. This methodological 
approach aggregates genetic variants to test their joint effect, combining information to 
increase statistical power. A downside of this approach is that it relies on prior hypotheses. 
This eliminates the possibility to find new, unexpected mechanisms. Hence, hypothesis-
based approaches and hypothesis-generating approaches were combined in this thesis to 
uncover different aspects of aggression etiology.
This thesis also contributes to the literature by providing a comprehensive overview of 
imaging genetics studies for five neurodevelopmental disorders with high comorbidity 
(CD, ODD, ADHD, ASD, selected IDs). Although we could not yet provide definite 
conclusions for understanding the comorbidity among these disorders, that observation is 
valuable in itself, and we were able to formulate important directions for future imaging 
genetics studies based on our extensive review.
Our results show that not only genetic, but also environmental influences play an important 
role in aggression. In chapter 2, parental ability to cope with disruptive behavior was found 
to be associated with our defined subtypes of oppositional behavior in children with 
ADHD. However, we did not address environmental influences in the rest of the chapters. 
This is a main limitation of the thesis, because environmental influences are another 
important source of heterogeneity in aggression. This is perhaps best illustrated by the 
association pattern of the most well-known aggression-related gene, MAOA. This X-linked 
gene contains a variable number tandem repeat polymorphism in its promoter region, 
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which influences activity of the encoded enzyme. Meta-analysis of 27 studies found an 
interaction effect of MAOA genotype and maltreatment in males, such that maltreatment 
presaged antisocial outcomes more strongly in persons with low-activity MAOA genotype 
compared to those with high-activity MAOA genotype (Byrd and Manuck, 2014). Future 
studies should further investigate interactions of the environment with genetic factors in 
contributing to development of aggressive behaviors, as gene-environment interactions may 
partly explain the lack of candidate genetic association findings in aggression literature to 
date (Vassos et al., 2014). 
Clinical implications
The results of this thesis provide new information on the underlying biology of aggression. 
Although the main perspective was not a clinical one, there are some implications of 
this work that may be of interest to clinicians. The underlying mechanisms of aggressive 
behavior are still poorly understood, and treatment options are limited. By increasing 
knowledge of aggression etiology, this thesis contributes to the search for diagnostic, 
preventive, and treatment options based on underlying mechanisms. First, our genetic 
association findings highlight the potential of pharmacological interventions targeting 
neuroendocrine molecules. Second, this thesis also shows that subtypes of aggression may 
be fundamentally different with regard to their underlying pathophysiology. Third, this 
thesis shows that sex differences exist with regard to the etiology of aggression. This is 
relevant for therapeutic interventions, in the sense that optimal treatment will have to be 
tailored to the individual patient. Hence, while genetic and neurological measures identified 
in this thesis cannot be used to diagnose aggression directly, they do emphasize the large 
neurobiological heterogeneity and behavioral dimensionality of aggression, indicating that 
detailed subtyping is highly useful in intervention frameworks. Current pharmacological 
interventions are especially effective in treating reactive forms aggression, stressing the 
need to develop new pharmacological and/or behavioral interventions for people with 
proactive aggression symptoms. At the same time, treating reactive components of disease 
symptomatology in patients with combined reactive and proactive aggression might alleviate 
part of the symptoms or create openings for behavioral interventions. Additionally, male 
and female needs of intervention might be quite different. Males and females might react 
differently to medication acting on neurotransmitter or neuroendocrine systems, stressing 
again that treatment should be tailored to the individual.
Recommendations for future research
Based on the findings described in this thesis, several suggestions for future research can be 
formulated. With regard to imaging genetics studies, results from this thesis lead to several 
specific recommendations necessary to successfully map the biological pathways from gene 
to disease. More genes need to be studied, and individual genes need to be investigated 
in larger samples. Imaging genetics studies also need to be combined with complementary 
approaches, such as the verification of gene functions and effects in animal models (van der 
Voet et al., 2016). It will also be important to determine, whether a brain (endo)phenotype 
is intermediate between a genetic factor and a behavioral outcome, or whether it is only an 
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epiphenomenon unrelated to the behavior of interest (Kendler and Neale, 2010; Preacher 
and Hayes, 2008). Furthermore, the future of imaging genetics studies might change 
significantly, as genome-wide approaches to imaging genetics are being developed. These 
methods will significantly contribute to knowledge on whether genes contributing to brain 
measures as observed in hypothesis-generating, genome-wide approaches also contribute to 
disease-related phenotypes (Franke et al., 2016; Klein et al., 2017). These statistical methods 
are highly dependent on sufficient polygenic signal of brain and behavior GWAS results 
(Bulik-Sullivan et al., 2015), again stressing the need for GWAS studies with sufficient 
power.
Both imaging studies and genetic studies will benefit from increasing sample sizes. This 
will increase reliability of neuroimaging findings as well as provide genome-wide significant 
associations of brain phenotypes with common genetic variants. Increasing sample size 
can be achieved by (international) collaborations, such as ENIGMA (http://enigma.ini.usc.
edu/; (Thompson et al., 2014)) or the Psychiatric Genomics Consortium (http://www.med.
unc.edu/pgc; (Cross-Disorder Group of the Psychiatric Genomics et al., 2013)). However, 
this thesis shows that one should not only focus on sample size to achieve maximal study 
power. Working on smart ways to maximize information within data-sets, and reducing 
heterogeneity, can be strong determinants of study power. Combining data from different 
studies often comes with a necessary increase in heterogeneity, as study methodology and 
measurements scales will likely differ between studies. New data collection within the 
context of large-scale collaborations, with standardized collection protocols, are needed 
to overcome this problem. For example, at the moment we are collecting a large imaging 
genetics sample, uniformly collected across different locations in Europe, within the context 
of Aggressotype. At the same time, already collected, deeply phenotyped data from single 
sites, which are more homogeneous than combined data-sets, will remain highly useful in 
elucidating the underlying mechanisms involved in different aspects of aggressive behavior.
Lastly, future studies should consider ways to take into account heterogeneity in the 
aggression phenotype. Subtype- and sex-specific findings in this thesis highlight a crucial 
role for sex neuro-steroids and certain neurotransmitters for sex-specific reactive aggression. 
Investigation of those intricately connected systems should become a main line of research 
in the aggression field. Other sources of heterogeneity, like environmental influences, should 
also be taken into account in future studies. Environmental exposures are also able to cause 
changes in epigenetic modifications, such as DNA methylation, and the study of epigenetic 
marks in aggression may identify genes that are differentially regulated in individuals with 
high and low levels of aggression (van Dongen et al., 2015).
Research frameworks looking across diagnostic boundaries, such as the RDoC approach, will 
be highly useful in improving our understanding of dimensions of functioning underlying 
the full range of human behavior from normal to abnormal. In a sense, the aggression 
research field can provide an example for other psychiatric phenotypes, as research has 
covered an exceptionally wide range of aspects, conditions, contexts, and populations related 
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to the behavior. Moreover, many different research fields have contributed information on 
aggression etiology. While lack of standardization and consensus about which measures to 
study has created a lot of information, integration of interdisciplinary research findings, 
and complementary approaches, whether looking at global or specific gene-brain-behavior 
relationships, will be necessary to paint a complete picture of aggression etiology.
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Key findings of this thesis
- Conceptually meaningful subtypes and dimensions of oppositionality exist in 
childhood ADHD (Chapter 2).
- Environmental influences like parenting style are promising determinants of the 
development of oppositionality in ADHD (Chapter 2).
- Neurite outgrowth plays a role in etiological mechanisms of aggressive behavior in 
ADHD (Chapters 2 and 3).
- Tentative support is provided for overlap of common genetic variants associated with 
childhood aggression measured in adult ADHD and oppositionality measured in 
childhood ADHD, paving the way for more elaborate statistical methods to test this 
hypothesis (Chapter 3).
- Common variation in genes involved in neuroendocrine and serotonergic signaling 
is a biological risk factor for frustration-based reactive aggression in females 
(Chapter 4). 
- Subtype- and sex-specific genetic association stresses the value of efforts to reduce 
heterogeneity in research of aggression etiology (Chapter 4 and 6 ).
- Population-based studies and studies crossing diagnostic boundaries of aggression 
offer opportunities for sample size maximization (Chapters 4 and 5).
- Large-scale and comprehensive overview of the imaging genetics literature showed 
that imaging genetics studies provide insight into the links between genes, disease-
related behavior, and the brain (Chapter 5). 
- The imaging genetics research field is still in its early stages, and conclusions 
about shared mechanisms of neurodevelopmental disorders cannot yet be drawn 
(Chapter 5).
- MECOM is a potential new candidate gene for aggression that may exert its effect 
through a mechanism involving nucleus accumbens (volume) (Chapter 6 ). 
- Association of candidate gene AVPR1A with aggression is subtype- and sex-
dependent (Chapter 6 ).
- AVPR1A potentially exerts its effect on aggression through a mechanism involving 
amygdala (volume) (Chapter 6 ).
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‘Agressie’ is een brede term waarmee veel verschillende soorten gedrag kunnen worden 
bedoeld, van verbale uitingen tot fysiek geweld. Deze complexiteit maakt het moeilijk 
om de onderliggende oorzaken van agressief gedrag te kunnen vinden, omdat ze wellicht 
verschillen voor de verschillende vormen van agressie. Wat we weten uit eerder onderzoek 
is dat genetische factoren een rol spelen. Daarnaast zijn er op groepsniveau verschillen 
gevonden in de bouw en het functioneren van de hersenen tussen mensen met en zonder 
agressieproblematiek. Het doel van dit proefschrift is om meer inzicht te krijgen in welke 
genetische en brein- gerelateerde factoren een rol spelen bij verschillende vormen van 
agressie.
Een deel van het onderzoek uit dit proefschrift, richt zich op vormen van agressief of 
oppositioneel gedrag die kunnen voorkomen bij ADHD (attention-deficit/hyperactivity 
disorder), een veelvoorkomende aandoening die gekenmerkt wordt door aandachtsproblemen 
en/of hyperactief en impulsief gedrag. Een ander deel van dit proefschrift maakt onderscheid 
tussen reactieve en proactieve agressie. Reactieve agressie wordt ook wel impulsieve agressie 
genoemd, en wordt gekenmerkt door een emotionele reactie op een bedreiging of frustratie. 
Proactieve agressie wordt ook wel instrumentele agressie genoemd, en wordt gekenmerkt 
door georganiseerd agressief gedrag om een doel te bereiken, waarbij meestal juist weinig 
emotie of empathie gevoeld wordt. Er wordt gedacht dat deze soorten agressie deels 
verschillende onderliggende oorzaken hebben.
Deel 1 van dit proefschrift (hoofdstuk 2 t/m 4) richt zich op de identificatie van genetische 
mechanismen die betrokken zijn bij agressie, en op hoe het verminderen van heterogeniteit 
op gedragsniveau kan helpen bij het vinden van genetische associaties. In deel 2 van dit 
proefschrift (hoofdstuk 5 en 6), ligt de nadruk op het combineren van hersenmaten met 
genetica, om verbanden te leggen tussen genetische risicofactoren, veranderingen in de 
hersenen, en vormen van agressief gedrag.
Hieronder wordt kort beschreven wat er in de individuele hoofdstukken werd onderzocht 
en gevonden.
In hoofdstuk 2 werd een combinatie van statistische methoden gebruikt om genetische 
associaties met oppositioneel gedrag bij kinderen met ADHD te vinden. Eerder werden 
hier al kleinschalige studies aan gewijd, waarbij slechts enkele genetische varianten 
werden onderzocht. In deze studie definieerden we conceptueel betekenisvolle subtypes 
van oppositioneel gedrag op basis van literatuur en Latent Class Analysis (LCA) om de 
heterogeniteit te verminderen op gedragsniveau. We vonden geen significante associaties 
met deze subtypes voor eerder onderzochte kandidaat genen, of sets van genen die te maken 
hebben met serotonine, dopamine en oxytocine. We vonden wel dat opvoedingsgedrag van 
ouders matig tot sterk geassocieerd was met oppositioneel gedrag van de kinderen. Daarna 
deden we een genoomwijde associatiestudie (GWAS) om nieuwe links met de genetica te 
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kunnen vinden. Door het toepassen van een krachtige multivariate associatie methode, 
konden we in deze analyse zowel de overlap als de verschillen tussen de subtypes van 
oppositioneel gedrag meenemen. Uitgaande van de sterkst geassocieerde genen, gebruikten 
we een bioinformatica methode om een moleculair landschap te bouwen voor oppositioneel 
gedrag. Hierdoor konden we identificeren dat de uitgroei van hersencellen een belangrijk 
biologisch proces is dat betrokken is bij oppositioneel gedrag.
In hoofdstuk 3 keken we ook naar agressief gedrag bij ADHD. We onderzochten deze 
keer volwassenen met ADHD, om inzicht te krijgen in de genetische factoren die een rol 
spelen bij de hoeveelheid agressie die zij ervaarden in de kindertijd. We deden genoomwijde 
associatiestudies in verschillende groepen deelnemers uit verschillende Europese landen, en 
meta-analyseerden de resultaten. Hoewel de gecombineerde groep nog niet groot genoeg 
was om significante genetische associaties te vinden, wees het onderzoek op verschillende 
genen die interessant zouden kunnen zijn voor aggressieproblematiek bij ADHD. Een van 
de gevonden genen, het neurotrimine (NTM) gen, speelt een rol bij celadhesie, en komt 
voornamelijk tot expressie in het centrale zenuwstelsel. Omdat het ook een belangrijke rol 
speelt in de uitgroei van hersencellen, sluit deze bevinding goed aan bij de resultaten van 
hoofdstuk 2, waarin kinderen met ADHD werden onderzocht. Het is belangrijk om meer 
te weten te komen over de oorzaken van agressie in de kindertijd, omdat dit bij volwassenen 
met ADHD geassocieerd is met een slechtere kwaliteit van leven. 
In hoofdstuk 4 keken we naar de biologische systemen die in de literatuur het meest in 
verband worden gebracht met agressie (serotonine, dopamine, en het neuro-endocriene 
systeem). We keken of genetische variatie in deze systemen subtype- en geslacht- specifiek 
geassocieerd is met agressie. Dit werd onderzocht in een groep van gezonde volwassen 
mannen en vrouwen, die een vragenlijst over reactieve en proactieve symptomen van 
agressie hadden ingevuld. Door het toepassen van Confirmatory Factor Analysis (CFA) 
vonden we drie verschillende subtypes: proactieve agressie, reactieve agressie als gevolg van 
interne frustratie, en reactieve agressie als gevolg van externe provocatie of bedreiging. We 
vonden dat de dopaminerge, serotonerge en neuroendocriene systemen associatie laten zien 
met reactieve agressie als gevolg van interne frustratie in de vrouwelijke deelnemers. De 
specifieke associatie met één van de subtypes, laat zien dat het onderscheid tussen subtypes 
van agressie ook op genetisch niveau relevant is.
In hoofdstuk 5 werd het effect van genetische risicofactoren op de structuur en de 
functie van de hersenen onderzocht. We gingen uit van bekende genetische risicofactoren 
voor een groep van aandoeningen die regelmatig samen voorkomen: ADHD, Autisme 
Spectrum Stoornis, oppositioneel- opstandige gedragsstoornis, antisociale gedragsstoornis 
en bepaalde vormen van verstandelijke beperkingen. We onderzochten per aandoening 
welke mechanismen in het brein worden beïnvloed door de genetische risicofactoren en 
probeerden mechanismen te vinden die geassocieerd zijn met de klinische overlap tussen 
de aandoeningen. We vonden dat genetische variatie in het serotonine transporter gen 
(SLC6A4/5HTT ) consistent geassocieerd is met verhoogde activiteit van de amygdala en 
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gerelateerde hersengebieden, in combinatie met een verminderde connectiviteit tussen deze 
gebieden. Op basis van de onderzochte literatuur, konden we specifieke aanbevelingen voor 
toekomstig onderzoek geven. Er is een grote noodzaak voor grotere studies, die hypothesevrij 
naar alle hersengebieden kijken, en die meer genen onderzoeken. Daarnaast is het nodig om 
te onderzoeken of veranderingen in de hersenen de effecten van genetische risicofactoren op 
het klinische fenotype kunnen verklaren. Naast het geven van een uitgebreid overzicht van 
de literatuur toonde dit onderzoek aan dat het combineren van genetica en hersenmaten 
nuttig is om meer te weten te komen over verbanden tussen genen, hersenen en gedrag. 
Toch is het werkveld nog in een vroeg stadium en kunnen er nog geen definitieve conclusies 
getrokken worden over de overlap tussen de verschillende onderzochte aandoeningen. 
In hoofdstuk 6 wilden we meer inzicht krijgen in de rol van genetische risicofactoren bij 
agressief gedrag. Dit werd onderzocht door een genoomwijde associatiestudie van agressie 
met genoomwijde associatiestudies van het volume van verschillende hersengebieden die 
betrokken zijn bij agressie te meta-analyseren op gen- niveau. Op deze manier konden genen 
geïdentificeerd worden die zowel agressie, als hersenvolume beïnvloeden. Het MECOM gen 
toonde associatie in de meta-analyse van agressie en de nucleus accumbens en het AVPR1A 
gen in de meta-analyse van agressie en de amygdala. Mogelijk beïnvloed genetische variatie 
in MECOM agressief gedrag via een mechanisme dat geassocieerd is met het volume van 
de nucleus accumbens, en mogelijk beïnvloed genetische variatie in AVPR1A agressief 
gedrag via een mechanisme dat geassocieerd is met het volume van de amygdala. We 
onderzochten deze genen in een groep gezonde volwassen mannen en vrouwen, en toonden 
aan dat AVPR1A geassocieerd is met reactieve agressie als gevolg van externe provocatie of 
bedreiging in mannen. Vervolgonderzoek moet uitwijzen of er een oorzakelijk verband is 
tussen genetische variatie in deze genen, veranderingen in de gevonden hersengebieden en 
agressie.
Door gebruik te maken van uiteenlopende analysemethoden, geven de studies beschreven 
in dit proefschrift nieuwe inzichten in de genetische risicofactoren en hersenmechanismen 
betrokken bij verschillende vormen van agressie.
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Donders Graduate School for Cognitive Neuroscience
For a successful research Institute, it is vital to train the next generation of young scientists. 
To achieve this goal, the Donders Institute for Brain, Cognition and Behaviour established 
the Donders Graduate School for Cognitive Neuroscience (DGCN), which was officially 
recognised as a national graduate school in 2009. The Graduate School covers training at 
both Master’s and PhD level and provides an excellent educational context fully aligned 
with the research programme of the Donders Institute. 
The school successfully attracts highly talented national and international students in 
biology, physics, psycholinguistics, psychology, behavioral science, medicine and related 
disciplines. Selective admission and assessment centers guarantee the enrolment of the best 
and most motivated students.
The DGCN tracks the career of PhD graduates carefully. More than 50% of PhD alumni 
show a continuation in academia with postdoc positions at top institutes worldwide, e.g. 
Stanford University, University of Oxford, University of Cambridge, UCL London, MPI 
Leipzig, Hanyang University in South Korea, NTNU Norway, University of Illinois, North 
Western University, Northeastern University in Boston, ETH Zürich, University of Vienna 
etc.. Positions outside academia spread among the following sectors: specialists in a medical 
environment, mainly in genetics, geriatrics, psychiatry and neurology. Specialists in a 
psychological environment, e.g. as specialist in neuropsychology, psychological diagnostics 
or therapy. Positions in higher education as coordinators or lecturers. A smaller percentage 
enters business as research consultants, analysts or head of research and development. Fewer 
graduates  stay in a research environment as lab coordinators, technical support or policy 
advisors. Upcoming possibilities are positions in the IT sector and management position in 
pharmaceutical industry. In general, the PhDs graduates almost invariably continue with 
high-quality positions that play an important role in our knowledge economy.
For more information on the DGCN as well as past and upcoming defenses please visit:
http://www.ru.nl/donders/graduate-school/phd/


